,words,labels,sentence_id,full sentence
349,Almost,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
350,all,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
351,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
352,is,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
353,used,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
354,for,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
355,cheese,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
356,production,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
357,and,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
358,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
359,consequently,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
360,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
361,milk,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
362,content,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
363,traits,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
364,are,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
365,very,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
366,important,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
367,.,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
533,At,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
534,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
535,moment,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
536,",",O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
537,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
538,most,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
539,effective,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
540,strategy,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
541,seems,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
542,to,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
543,be,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
544,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
545,strengthening,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
546,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
547,research,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
548,projects,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
549,aimed,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
550,at,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
551,finding,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
552,causal,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
553,mutations,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
554,along,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
555,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
556,genes,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
557,affecting,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
558,traits,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
559,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
560,economic,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
561,importance,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
562,.,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
891,Dietary,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
892,polyphenols,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
893,may,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
894,inhibit,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
895,α,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
896,-,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
897,amylase,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
898,and,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
899,α,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
900,-,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
901,glucosidase,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
902,",",O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
903,inhibit,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
904,glucose,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
905,absorption,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
906,in,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
907,the,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
908,intestine,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
909,by,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
910,sodium,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
911,-,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
912,dependent,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
913,glucose,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
914,transporter,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
915,1,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
916,(,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
917,SGLT1,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
918,),O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
919,",",O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
920,stimulate,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
921,insulin,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
922,secretion,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
923,and,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
924,reduce,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
925,hepatic,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
926,glucose,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
927,output,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
928,.,O,27.0,"Dietary polyphenols may inhibit α - amylase and α - glucosidase , inhibit glucose absorption in the intestine by sodium - dependent glucose transporter 1 ( SGLT1 ) , stimulate insulin secretion and reduce hepatic glucose output ."
1177,Education,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1178,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1179,promote,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1180,positive,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1181,choices,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1182,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1183,physical,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1184,activity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1185,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1186,resolute,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1187,public,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1188,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1189,interventions,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1190,on,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1191,food,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1192,delivery,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1193,are,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1194,requested,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1195,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1196,reduce,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1197,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1198,burden,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1199,of,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1200,obesity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1201,-,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1202,related,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1203,cancer,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1204,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1205,lighten,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1206,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1207,unsustainable,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1208,growing,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1209,expenses,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1210,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1211,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1212,systems,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1213,.,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1590,From,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1591,these,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1592,observations,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1593,",",O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1594,it,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1595,is,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1596,suggested,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1597,that,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1598,the,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1599,beta,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1600,-,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1601,glycosyl,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1602,bond,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1603,of,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1604,genistin,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1605,is,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1606,cleaved,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1607,to,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1608,produce,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1609,genistein,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1610,by,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1611,microbes,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1612,during,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1613,fermentation,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1614,to,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1615,yield,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1616,miso,B-http://purl.obolibrary.org/obo/FOODON_00003208,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1617,and,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1618,natto,B-http://purl.obolibrary.org/obo/FOODON_00002870,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1619,.,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1711,Squamous,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1712,head,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1713,and,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1714,neck,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1715,cancers,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1716,include,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1717,cancers,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1718,of,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1719,the,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1720,oral,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1721,cavity,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1722,",",O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1723,pharynx,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1724,and,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1725,larynx,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1726,are,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1727,the,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1728,sixth,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1729,leading,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1730,cause,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1731,of,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1732,cancer,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1733,mortality,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1734,worldwide,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1735,",",O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1736,resulting,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1737,in,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1738,more,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1739,than,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1740,"350,000",O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1741,deaths,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1742,annually,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
1743,.,O,53.0,"Squamous head and neck cancers include cancers of the oral cavity , pharynx and larynx are the sixth leading cause of cancer mortality worldwide , resulting in more than 350,000 deaths annually ."
2079,One,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2080,wonders,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2081,which,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2082,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2083,and,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2084,other,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2085,cocoa,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2086,derivatives,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2087,can,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2088,be,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2089,considered,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2090,as,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2091,biofunctional,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2092,food,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2093,products,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2094,.,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2095,This,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2096,review,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2097,explores,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2098,the,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2099,constituents,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2100,of,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2101,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2102,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2103,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2104,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2105,summarizes,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2106,evidence,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2107,about,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2108,the,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2109,role,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2110,of,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2111,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2112,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2113,chocolate,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2114,components,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2115,on,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2116,human,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2117,health,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2118,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2119,particularly,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2120,on,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2121,reproduction,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2122,.,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2123,On,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2124,the,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2125,basis,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2126,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2127,the,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2128,literature,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2129,review,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2130,",",O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2131,it,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2132,can,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2133,be,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2134,asserted,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2135,that,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2136,some,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2137,kinds,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2138,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2139,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2140,products,I-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2141,have,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2142,favorable,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2143,effects,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2144,on,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2145,human,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2146,health,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2147,at,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2148,different,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2149,stages,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2150,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2151,life,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2152,.,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2183,However,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2184,",",O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2185,many,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2186,aspects,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2187,remain,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2188,to,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2189,be,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2190,investigated,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2191,and,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2192,others,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2193,are,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2194,still,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2195,to,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2196,be,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2197,clarified,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2198,.,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2408,Additionally,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2409,",",O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2410,stimulation,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2411,of,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2412,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2413,browning,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2414,program,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2415,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2416,ginger,B-http://purl.obolibrary.org/obo/FOODON_00002718;http://purl.obolibrary.org/obo/FOODON_00003717;http://purl.obolibrary.org/obo/FOODON_00001901;http://purl.obolibrary.org/obo/NCBITaxon_94328,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2417,may,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2418,be,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2419,partly,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2420,regulated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2421,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2422,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2423,sirtuin-1,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2424,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2425,SIRT1)/AMP,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2426,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2427,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2428,protein,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2429,kinase,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2430,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2431,AMPK)/peroxisome,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2432,proliferator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2433,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2434,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2435,receptor,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2436,γ,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2437,coactivator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2438,1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2439,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2440,PGC-1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2441,),O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2442,pathway,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2443,.,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2550,The,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2551,LP,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2552,trait,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2553,has,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2554,been,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2555,independently,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2556,selected,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2557,at,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2558,least,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2559,4,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2560,times,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2561,and,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2562,is,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2563,under,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2564,rapid,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2565,positive,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2566,selection,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2567,",",O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2568,which,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2569,shows,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2570,that,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2571,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2572,consumption,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2573,has,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2574,positive,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2575,survival,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2576,benefits,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2577,.,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2816,The,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2817,evidence,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2818,base,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2819,for,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2820,the,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2821,benefits,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2822,of,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2823,yogurt,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2824,in,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2825,promoting,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2826,bone,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2827,health,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2828,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2829,maintaining,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2830,health,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2831,throughout,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2832,the,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2833,life,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2834,cycle,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2835,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2836,improving,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2837,diet,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2838,quality,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2839,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2840,and,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2841,reducing,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2842,the,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2843,incidence,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2844,of,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2845,chronic,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2846,diseases,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2847,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2848,such,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2849,as,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2850,obesity,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2851,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2852,metabolic,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2853,syndrome,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2854,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2855,and,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2856,cardiovascular,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2857,disease,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2858,",",O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2859,was,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2860,presented,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
2861,.,O,89.0,"The evidence base for the benefits of yogurt in promoting bone health , maintaining health throughout the life cycle , improving diet quality , and reducing the incidence of chronic diseases , such as obesity , metabolic syndrome , and cardiovascular disease , was presented ."
3069,Forty,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3070,-,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3071,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3072,subjects,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3073,(,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3074,33F/13,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3075,M,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3076,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3077,body,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3078,mass,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3079,index,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3080,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3081,32.5,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3082,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3083,0.7,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3084,kg,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3085,/,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3086,m²,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3087,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3088,age,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3089,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3090,50,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3091,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3092,1,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3093,years,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3094,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3095,mean,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3096,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3097,SEMs,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3098,),O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3099,consumed,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3100,a,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3101,standard,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3102,sandwich,B-http://purl.obolibrary.org/obo/FOODON_03301906,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3103,with,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3104,one,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3105,of,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3106,the,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3107,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3108,beverages,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3109,on,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3110,separate,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3111,mornings,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3112,in,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3113,randomized,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3114,order,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3115,.,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3130,Plasma,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3131,glucose,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3132,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3133,insulin,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3134,concentrations,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3135,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3136,measured,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3137,from,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3138,blood,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3139,obtained,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3140,pre-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3141,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3142,post,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3143,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3144,meal,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3145,at,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3146,30,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3147,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3148,min,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3149,intervals,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3150,for,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3151,4,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3152,h,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3153,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3154,incremental,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3155,areas,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3156,under,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3157,the,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3158,curve,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3159,(,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3160,AUC,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3161,),O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3162,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3163,computed,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3164,.,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3224,In,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3225,conclusion,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3226,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3227,consumption,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3228,of,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3229,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3230,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3231,reduced,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3232,-,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3233,energy,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3234,OJ,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3235,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3236,or,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3237,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3238,(,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3239,irrespective,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3240,of,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3241,fat,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3242,content,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3243,),O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3244,with,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3245,a,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3246,meal,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3247,may,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3248,be,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3249,preferable,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3250,to,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3251,consuming,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3252,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3253,-,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3254,sweetened,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3255,coffee,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3256,for,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3257,glucose,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3258,control,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3259,in,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3260,middle,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3261,-,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3262,aged,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3263,adults,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3264,who,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3265,are,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3266,overweight,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3267,and,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3268,obese,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3269,.,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
4142,In,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4143,a,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4144,survey,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4145,of,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4146,12,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4147,commercial,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4148,wines,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4149,from,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4150,the,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4151,south,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4152,of,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4153,Brazil,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4154,(,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4155,Rio,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4156,Grande,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4157,del,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4158,Sul,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4159,),O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4160,",",O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4161,levels,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4162,of,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4163,delta,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4164,-,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4165,viniferin,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4166,are,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4167,reported,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4168,for,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4169,the,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4170,first,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4171,time,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4172,in,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4173,different,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4174,varieties,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4175,of,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4176,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4177,wines,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4178,.,O,132.0,"In a survey of 12 commercial wines from the south of Brazil ( Rio Grande del Sul ) , levels of delta - viniferin are reported for the first time in different varieties of red wines ."
4253,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4254,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4255,Viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4256,contributes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4257,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4258,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4259,well,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4260,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4261,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4262,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4263,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4264,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4265,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4266,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4267,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4268,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4269,to,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4270,a,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4271,significant,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4272,proportion,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4273,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4274,stilbenes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4275,in,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4276,wine,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4277,dietary,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4278,intake,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4279,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4280,particularly,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4281,with,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4282,Merlot,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4283,varieties,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4284,containing,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4285,an,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4286,average,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4287,level,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4288,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4289,10,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4290,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4291,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4292,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4293,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4294,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4295,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4296,viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4297,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4298,15,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4299,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4300,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4301,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4302,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4303,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4304,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4305,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4306,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4307,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4308,13,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4309,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4310,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4311,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4312,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4313,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4314,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4315,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4316,.,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4576,Fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4577,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4578,beverages,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4579,and,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4580,food,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4581,other,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4582,than,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4583,fruits,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4584,were,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4585,available,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4586,in,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4587,2·5,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4588,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4589,74·3,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4590,and,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4591,80·8,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4592,%,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4593,of,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4594,the,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4595,vending,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4596,sites,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4597,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4598,respectively,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4599,.,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4873,Sixty,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4874,nude,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4875,mice,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4876,received,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4877,MDA,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4878,-,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4879,MB,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4880,231,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4881,human,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4882,breast,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4883,cancer,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4884,cells,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4885,and,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4886,were,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4887,fed,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4888,a,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4889,diet,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4890,containing,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4891,8,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4892,%,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4893,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4894,/,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4895,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4896,corn,B-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4897,oil,I-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4898,until,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4899,the,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4900,mean,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4901,tumor,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4902,volume,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4903,was,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4904,60,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4905,mm3,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4906,.,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
5090,Thus,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5091,",",O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5092,we,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5093,aimed,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5094,to,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5095,investigate,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5096,the,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5097,effect,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5098,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5099,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5100,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5101,in,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5102,a,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5103,preclinical,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5104,model,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5105,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5106,colon,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5107,cancer,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5108,by,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5109,targeting,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5110,genetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5111,and,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5112,epigenetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5113,mechanisms,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5114,.,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5163,Potent,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5164,anti,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5165,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5166,inflammatory,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5167,",",O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5168,anti,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5169,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5170,angiogenic,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5171,and,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5172,pro,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5173,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5174,apoptotic,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5175,activity,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5176,of,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5177,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5178,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5179,was,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5180,explored,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5181,by,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5182,gene,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5183,expression,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5184,and,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5185,immunohistochemical,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5186,studies,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5187,.,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5215,We,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5216,observed,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5217,that,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5218,olive,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5219,oil,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5220,administration,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5221,lowered,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5222,tumor,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5223,incidence,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5224,and,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5225,inhibited,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5226,the,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5227,development,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5228,of,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5229,tumors,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5230,in,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5231,DMH,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5232,-,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5233,treated,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5234,rats,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5235,.,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5236,Olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5237,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5238,markedly,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5239,decreased,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5240,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5241,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5242,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5243,inflammatory,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5244,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5245,angiogenic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5246,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5247,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5248,restored,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5249,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5250,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5251,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5252,pro,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5253,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5254,apoptotic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5255,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5256,in,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5257,DMH,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5258,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5259,treated,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5260,rats,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5261,.,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5424,The,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5425,most,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5426,studied,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5427,mechanism,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5428,underlying,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5429,the,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5430,antihypertensive,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5431,effects,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5432,of,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5433,milk,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5434,peptides,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5435,is,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5436,inhibition,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5437,of,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5438,angiotensin,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5439,-,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5440,converting,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5441,enzyme,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5442,.,O,175.0,The most studied mechanism underlying the antihypertensive effects of milk peptides is inhibition of angiotensin - converting enzyme .
5541,A,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5542,total,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5543,of,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5544,"1,586",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5545,cases,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5546,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5547,their,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5548,age-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5549,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5550,sex-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5551,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5552,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5553,race,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5554,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5555,matched,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5556,neighborhood,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5557,controls,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5558,were,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5559,interviewed,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5560,in,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5561,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5562,person,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5563,from,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5564,1987,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5565,to,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5566,1999,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5567,.,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5648,Compared,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5649,to,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5650,drinking,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5651,<,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5652,1,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5653,glass,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5654,of,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5655,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5656,per,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5657,day,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5658,",",O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5659,drinking,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5660,>,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5661,or,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5662,=,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5663,6,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5664,glasses,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5665,/,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5666,day,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5667,was,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5668,associated,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5669,with,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5670,0.91,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5671,(,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5672,95,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5673,%,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5674,confidence,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5675,interval,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5676,",",O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5677,0.67,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5678,-,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5679,1.22,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5680,),O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5681,times,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5682,the,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5683,risk,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5684,of,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5685,bladder,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5686,cancer,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5687,among,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5688,all,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5689,subjects,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5690,",",O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5691,0.94,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5692,(,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5693,0.67,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5694,-,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5695,1.32,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5696,),O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5697,times,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5698,the,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5699,risk,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5700,among,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5701,men,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5702,",",O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5703,and,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5704,0.69,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5705,(,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5706,0.36,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5707,-,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5708,1.33,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5709,),O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5710,times,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5711,the,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5712,risk,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5713,among,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5714,women,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5715,.,O,184.0,"Compared to drinking < 1 glass of water per day , drinking > or = 6 glasses / day was associated with 0.91 ( 95 % confidence interval , 0.67 - 1.22 ) times the risk of bladder cancer among all subjects , 0.94 ( 0.67 - 1.32 ) times the risk among men , and 0.69 ( 0.36 - 1.33 ) times the risk among women ."
5806,Patients,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5807,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5808,migraine,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5809,who,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5810,believed,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5811,that,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5812,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5813,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5814,but,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5815,not,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5816,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5817,in,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5818,general,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5819,had,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5820,a,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5821,headache,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5822,-,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5823,provoking,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5824,effect,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5825,on,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5826,them,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5827,were,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5828,challenged,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5829,either,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5830,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5831,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5832,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5833,or,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5834,with,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5835,a,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5836,vodka,B-http://purl.obolibrary.org/obo/FOODON_03305518,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5837,and,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5838,diluent,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5839,mixture,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5840,of,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5841,equivalent,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5842,alcohol,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5843,content,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5844,",",O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5845,both,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5846,consumed,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5847,cold,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5848,out,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5849,of,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5850,dark,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5851,bottles,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5852,to,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5853,disguise,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5854,colour,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5855,and,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5856,flavour,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5857,.,O,188.0,"Patients with migraine who believed that red wine but not alcohol in general had a headache - provoking effect on them were challenged either with red wine or with a vodka and diluent mixture of equivalent alcohol content , both consumed cold out of dark bottles to disguise colour and flavour ."
5908,These,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5909,findings,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5910,show,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5911,that,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5912,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5913,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5914,contains,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5915,a,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5916,migraine,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5917,-,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5918,provoking,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5919,agent,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5920,that,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5921,is,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5922,neither,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5923,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5924,nor,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5925,tyramine,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5926,.,O,191.0,These findings show that red wine contains a migraine - provoking agent that is neither alcohol nor tyramine .
5927,Polyphenols,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5928,have,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5929,been,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5930,reported,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5931,to,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5932,prevent,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5933,chronic,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5934,diseases,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5935,such,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5936,as,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5937,cardiovascular,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5938,diseases,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5939,",",O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5940,cancers,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5941,",",O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5942,diabetes,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5943,and,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5944,neurodegenerative,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5945,diseases,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
5946,.,O,192.0,"Polyphenols have been reported to prevent chronic diseases such as cardiovascular diseases , cancers , diabetes and neurodegenerative diseases ."
6152,Tomato,B-http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6153,also,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6154,contain,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6155,other,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6156,active,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6157,compounds,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6158,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6159,namely,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6160,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6161,neoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6162,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6163,lutein,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6164,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6165,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6166,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6167,cryptoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6168,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6169,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6170,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6171,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6172,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6173,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6174,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6175,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6176,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6177,cyclolycopene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6178,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6179,and,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6180,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6181,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6182,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6183,5,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6184,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6185,6,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6186,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6187,epoxide,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6188,.,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6189,These,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6190,components,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6191,provide,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6192,synergistic,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6193,effect,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6194,against,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6195,various,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6196,threats,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6197,but,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6198,still,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6199,need,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6200,further,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6201,attention,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6202,of,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6203,the,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6204,researchers,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6205,.,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
7061,The,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7062,purpose,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7063,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7064,this,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7065,study,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7066,was,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7067,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7068,determine,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7069,the,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7070,ideal,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7071,combination,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7072,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7073,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7074,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7075,cream,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7076,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7077,and,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7078,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7079,in,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7080,order,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7081,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7082,minimize,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7083,MG,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7084,consumption,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7085,.,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7660,For,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7661,rectal,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7662,cancer,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7663,",",O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7664,on,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7665,the,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7666,other,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7667,hand,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7668,",",O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7669,a,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7670,significant,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7671,effect,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7672,of,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7673,saturated,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7674,fat,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7675,",",O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7676,independent,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7677,of,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7678,other,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7679,food,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7680,items,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7681,or,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7682,groups,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7683,",",O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7684,was,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7685,only,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7686,found,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7687,for,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7688,females,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7689,in,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7690,the,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7691,highest,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7692,consumption,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7693,category,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7694,.,O,255.0,"For rectal cancer , on the other hand , a significant effect of saturated fat , independent of other food items or groups , was only found for females in the highest consumption category ."
7813,Thus,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7814,",",O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7815,these,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7816,results,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7817,confirm,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7818,the,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7819,previous,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7820,report,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7821,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7822,showing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7823,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7824,significant,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7825,effect,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7826,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7827,saturated,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7828,fat,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7829,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7830,increasing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7831,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7832,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7833,colon,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7834,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7835,but,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7836,suggest,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7837,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7838,contribution,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7839,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7840,meats,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7841,to,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7842,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7843,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7844,rectal,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7845,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7846,.,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
8026,Many,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8027,of,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8028,the,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8029,considered,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8030,GF,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8031,food,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8032,products,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8033,showed,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8034,very,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8035,high,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8036,contents,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8037,of,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8038,energy,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8039,(,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8040,33.5,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8041,%,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8042,),O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8043,",",O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8044,fats,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8045,(,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8046,28.5,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8047,%,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8048,),O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8049,",",O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8050,saturated,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8051,fatty,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8052,acids,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8053,(,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8054,30.0,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8055,%,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8056,),O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8057,",",O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8058,sugars,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8059,(,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8060,21.6,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8061,%,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8062,),O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8063,",",O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8064,and,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8065,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8066,(,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8067,28.3,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8068,%,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8069,),O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8070,.,O,268.0,"Many of the considered GF food products showed very high contents of energy ( 33.5 % ) , fats ( 28.5 % ) , saturated fatty acids ( 30.0 % ) , sugars ( 21.6 % ) , and salt ( 28.3 % ) ."
8385,We,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8386,evaluated,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8387,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8388,relation,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8389,between,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8390,a,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8391,wide,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8392,range,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8393,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8394,foods,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8395,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8396,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8397,risk,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8398,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8399,RCC,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8400,in,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8401,an,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8402,Italian,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8403,case,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8404,-,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8405,control,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8406,study,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8407,including,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8408,767,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8409,patients,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8410,(,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8411,494,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8412,men,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8413,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8414,273,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8415,women,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8416,),O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8417,younger,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8418,than,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8419,79,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8420,years,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8421,with,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8422,incident,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8423,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8424,histologically,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8425,confirmed,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8426,RCC,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8427,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8428,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8429,"1,534",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8430,controls,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8431,(,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8432,988,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8433,men,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8434,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8435,546,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8436,women,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8437,),O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8438,admitted,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8439,to,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8440,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8441,same,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8442,hospitals,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8443,as,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8444,cases,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8445,for,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8446,a,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8447,wide,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8448,spectrum,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8449,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8450,acute,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8451,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8452,non,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8453,-,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8454,neoplastic,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8455,conditions,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8456,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8457,not,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8458,related,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8459,to,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8460,long,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8461,term,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8462,diet,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8463,modifications,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8464,.,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8906,Whey,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8907,protein,B-http://purl.obolibrary.org/obo/CHEBI_36080,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8908,promotes,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8909,weight,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8910,loss,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8911,and,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8912,improves,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8913,diabetic,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8914,control,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8915,",",O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8916,however,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8917,",",O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8918,less,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8919,is,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8920,known,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8921,of,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8922,its,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8923,bioactive,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8924,components,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8925,that,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8926,produce,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8927,such,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8928,benefits,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8929,.,O,291.0,"Whey protein promotes weight loss and improves diabetic control , however , less is known of its bioactive components that produce such benefits ."
8961,Diet,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8962,-,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8963,induced,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8964,obese,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8965,rats,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8966,were,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8967,randomized,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8968,to,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8969,isocaloric,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8970,diets,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8971,:,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8972,Control,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8973,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8974,Whey,B-http://purl.obolibrary.org/obo/FOODON_03420244,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8975,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8976,Lactalbumin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8977,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8978,Lactoferrin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8979,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8980,or,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8981,pair,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8982,-,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8983,fed,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8984,to,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8985,lactoferrin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8986,.,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
9118,Dietary,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9119,lactalbumin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9120,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9121,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9122,improved,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9123,energy,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9124,balance,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9125,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9126,metabolism,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9127,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9128,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9129,decreased,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9130,adiposity,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9131,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9132,with,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9133,the,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9134,effects,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9135,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9136,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9137,being,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9138,partly,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9139,independent,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9140,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9141,caloric,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9142,intake,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9143,.,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9811,Brain,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9812,-,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9813,derived,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9814,cell,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9815,cultures,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9816,from,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9817,rats,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9818,were,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9819,prepared,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9820,and,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9821,grown,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9822,for,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9823,about,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9824,2,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9825,weeks,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9826,.,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
10314,Occurrence,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10315,data,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10316,were,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10317,available,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10318,only,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10319,for,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10320,α,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10321,-,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10322,solanine,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10323,and,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10324,α,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10325,-,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10326,chaconine,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10327,",",O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10328,mostly,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10329,for,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10330,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10331,.,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10657,Physicochemical,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10658,composition,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10659,",",O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10660,protein,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10661,and,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10662,fats,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10663,quality,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10664,",",O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10665,functional,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10666,properties,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10667,",",O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10668,effect,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10669,of,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10670,heat,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10671,and,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10672,high,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10673,-,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10674,pressure,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10675,treatment,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10676,is,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10677,also,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10678,provided,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10679,in,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10680,detail,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10681,.,O,360.0,"Physicochemical composition , protein and fats quality , functional properties , effect of heat and high - pressure treatment is also provided in detail ."
10922,For,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10923,individuals,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10924,with,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10925,isolated,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10926,impaired,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10927,glucose,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10928,tolerance,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10929,",",O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10930,a,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10931,higher,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10932,traditional,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10933,score,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10934,(,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10935,of,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10936,1,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10937,SD,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10938,),O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10939,predicted,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10940,an,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10941,annual,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10942,increase,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10943,in,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10944,2h,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10945,-,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10946,PG,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10947,of,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10948,0.083,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10949,mmol,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10950,/,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10951,L,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10952,(,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10953,P,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10954,<,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10955,0.0001,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10956,),O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
10957,.,O,367.0,"For individuals with isolated impaired glucose tolerance , a higher traditional score ( of 1 SD ) predicted an annual increase in 2h - PG of 0.083 mmol / L ( P < 0.0001 ) ."
11069,A,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11070,high,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11071,consumption,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11072,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11073,caloric,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11074,beverages,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11075,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11076,such,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11077,as,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11078,alcoholic,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11079,or,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11080,sweetened,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11081,drinks,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11082,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11083,may,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11084,particularly,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11085,contribute,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11086,to,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11087,weight,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11088,gain,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11089,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11090,and,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11091,lower,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11092,satiety,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11093,has,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11094,been,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11095,associated,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11096,with,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11097,the,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11098,intake,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11099,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11100,liquid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11101,instead,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11102,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11103,solid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11104,calories,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11105,.,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11323,Thus,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11324,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11325,this,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11326,study,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11327,found,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11328,that,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11329,replacing,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11330,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11331,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11332,-,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11333,sweetened,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11334,soda,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11335,beverage,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11336,or,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11337,beer,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11338,with,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11339,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11340,serving,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11341,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11342,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11343,per,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11344,day,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11345,at,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11346,baseline,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11347,was,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11348,related,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11349,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11350,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11351,lower,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11352,incidence,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11353,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11354,obesity,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11355,and,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11356,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11357,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11358,higher,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11359,weight,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11360,loss,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11361,over,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11362,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11363,four,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11364,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11365,year,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11366,period,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11367,time,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11368,in,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11369,the,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11370,case,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11371,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11372,beer,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11373,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11374,based,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11375,on,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11376,mathematical,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11377,models,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11378,.,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
12238,Dietary,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12239,guidelines,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12240,currently,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12241,suggest,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12242,a,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12243,maximum,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12244,intake,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12245,of,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12246,"2,300",O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12247,mg,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12248,of,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12249,sodium,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12250,(,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12251,6,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12252,g,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12253,of,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12254,sodium,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12255,chloride,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12256,),O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12257,per,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12258,day,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12259,",",O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12260,whereas,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12261,the,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12262,average,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12263,consumer,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12264,intake,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12265,is,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12266,"3,600",O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12267,mg,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12268,of,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12269,sodium,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12270,(,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12271,9,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12272,g,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12273,of,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12274,sodium,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12275,chloride,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12276,),O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12277,per,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12278,day,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12279,.,O,411.0,"Dietary guidelines currently suggest a maximum intake of 2,300 mg of sodium ( 6 g of sodium chloride ) per day , whereas the average consumer intake is 3,600 mg of sodium ( 9 g of sodium chloride ) per day ."
12731,The,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12732,possible,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12733,population,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12734,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12735,preventable,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12736,fraction,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12737,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12738,modifying,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12739,diet,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12740,in,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12741,relation,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12742,to,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12743,fruit,B-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12744,and,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12745,vegetable,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12746,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12747,was,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12748,calculated,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12749,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12750,well,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12751,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12752,an,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12753,overall,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12754,statement,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12755,about,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12756,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12757,degree,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12758,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12759,evidence,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12760,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12761,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12762,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12763,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12764,preventive,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12765,effect,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12766,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12767,fruit,B-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12768,and,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12769,vegetable,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12770,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12771,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12772,each,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12773,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12774,site,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12775,.,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12776,There,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12777,is,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12778,limited,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12779,evidence,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12780,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12781,a,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12782,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12783,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12784,preventive,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12785,effect,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12786,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12787,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12788,consumption,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12789,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12790,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12791,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12792,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12793,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12794,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12795,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12796,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12797,mouth,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12798,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12799,pharynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12800,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12801,esophagus,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12802,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12803,stomach,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12804,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12805,colon,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12806,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12807,rectum,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12808,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12809,larynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12810,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12811,lung,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12812,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12813,ovary,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12814,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12815,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12816,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12817,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12818,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12819,bladder,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12820,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12821,fruit,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12822,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12823,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12824,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12825,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12826,kidney,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12827,.,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
13594,Oats,B-http://purl.obolibrary.org/obo/FOODON_03315188;http://purl.obolibrary.org/obo/FOODON_00003429,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13595,were,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13596,introduced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13597,first,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13598,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13599,rapidly,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13600,outpaced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13601,by,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13602,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13603,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13604,the,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13605,intake,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13606,of,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13607,which,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13608,continued,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13609,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13610,increase,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13611,with,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13612,age,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13613,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13614,whereas,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13615,oats,B-http://purl.obolibrary.org/obo/FOODON_03315188;http://purl.obolibrary.org/obo/FOODON_00003429,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13616,started,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13617,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13618,decrease,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13619,at,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13620,12,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13621,months,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13622,.,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
27238,Non,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27239,-,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27240,selective,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27241,use,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27242,of,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27243,pesticide,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27244,to,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27245,increase,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27246,productivity,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27247,leaves,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27248,residues,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27249,on,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27250,crops,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27251,.,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27502,The,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27503,objective,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27504,of,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27505,this,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27506,study,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27507,was,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27508,to,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27509,derive,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27510,food,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27511,-,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27512,based,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27513,dietary,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27514,guidelines,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27515,for,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27516,the,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27517,Dutch,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27518,population,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27519,.,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27863,Furthermore,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27864,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27865,three,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27866,vegetables,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27867,(,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27868,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340;http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27869,spinach,I-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340;http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27870,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27871,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27872,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27873,and,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27874,summer,B-http://purl.obolibrary.org/obo/FOODON_00003708;http://purl.obolibrary.org/obo/FOODON_03310107;http://purl.obolibrary.org/obo/FOODON_00003539;http://purl.obolibrary.org/obo/FOODON_03301577,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27875,squash,I-http://purl.obolibrary.org/obo/FOODON_00003708;http://purl.obolibrary.org/obo/FOODON_03310107;http://purl.obolibrary.org/obo/FOODON_00003539;http://purl.obolibrary.org/obo/FOODON_03301577,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27876,),O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27877,containing,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27878,high,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27879,metal,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27880,concentrations,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27881,were,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27882,selected,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27883,to,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27884,further,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27885,analyze,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27886,metal,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27887,speciation,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27888,.,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27919,Heavy,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27920,metals,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27921,in,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27922,the,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27923,edible,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27924,parts,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27925,of,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27926,vegetables,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27927,also,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27928,exceeded,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27929,the,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27930,corresponding,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27931,standards,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27932,.,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
28013,A,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28014,high,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28015,proportion,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28016,of,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28017,ethanol,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28018,-,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28019,extractable,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28020,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28021,showed,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28022,that,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28023,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28024,bioactivity,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28025,and,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28026,toxic,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28027,effects,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28028,were,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28029,the,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28030,highest,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28031,.,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28340,Statistically,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28341,significant,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28342,protective,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28343,associations,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28344,were,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28345,identified,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28346,for,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28347,high,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28348,consumption,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28349,of,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28350,vegetables,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28351,",",O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28352,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28353,",",O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28354,cereals,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28355,and,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28356,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28357,.,O,959.0,"Statistically significant protective associations were identified for high consumption of vegetables , fruits , cereals and tea ."
28639,Overall,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28640,",",O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28641,this,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28642,review,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28643,updates,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28644,the,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28645,recent,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28646,studies,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28647,on,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28648,β,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28649,-,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28650,glucans,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28651,and,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28652,gut,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28653,microbiota,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28654,and,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28655,also,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28656,inputs,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28657,the,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28658,demanding,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28659,questions,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28660,to,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28661,be,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28662,addressed,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28663,in,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28664,β,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28665,-,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28666,glucans,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28667,-,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28668,microbiota,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28669,research,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28670,in,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28671,the,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28672,future,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28673,.,O,971.0,"Overall , this review updates the recent studies on β - glucans and gut microbiota and also inputs the demanding questions to be addressed in β - glucans - microbiota research in the future ."
28684,Adequate,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28685,consumption,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28686,of,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28687,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28688,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28689,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28690,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28691,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28692,especially,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28693,during,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28694,childhood,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28695,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28696,has,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28697,beneficial,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28698,health,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28699,outcomes,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28700,for,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28701,growth,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28702,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28703,development,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28704,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28705,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28706,reduced,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28707,risk,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28708,of,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28709,osteoporosis,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28710,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28711,hypertension,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28712,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28713,obesity,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28714,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28715,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28716,cancer,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28717,during,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28718,adulthood,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28719,.,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28888,The,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28889,change,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28890,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28891,form,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28892,of,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28893,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28894,offered,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28895,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28896,schools,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28897,to,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28898,lower,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28899,fat,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28900,and,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28901,lower,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28902,added,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28903,sugar,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28904,content,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28905,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28906,the,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28907,United,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28908,States,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28909,has,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28910,been,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28911,driven,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28912,by,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28913,government,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28914,-,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28915,mandated,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28916,school,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28917,lunch,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28918,calorie,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28919,and,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28920,fat,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28921,requirements,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28922,.,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
29483,Subjects,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29484,rated,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29485,their,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29486,liking,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29487,of,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29488,French,B-http://purl.obolibrary.org/obo/FOODON_03302695;http://purl.obolibrary.org/obo/HANCESTRO_0363;http://purl.obolibrary.org/obo/FOODON_03306255,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29489,toast,I-http://purl.obolibrary.org/obo/FOODON_03302695;http://purl.obolibrary.org/obo/HANCESTRO_0363;http://purl.obolibrary.org/obo/FOODON_03306255,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29490,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29491,sausage,B-http://purl.obolibrary.org/obo/FOODON_03315904,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29492,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29493,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29494,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29495,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29496,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29497,or,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29498,chicken,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29499,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29500,vegetables,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29501,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29502,pasta,B-http://purl.obolibrary.org/obo/FOODON_03306347,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29503,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29504,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29505,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29506,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29507,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29508,on,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29509,a,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29510,9,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29511,-,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29512,point,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29513,hedonic,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29514,Likert,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29515,scale,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29516,.,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,B-http://purl.obolibrary.org/obo/FOODON_03302695;http://purl.obolibrary.org/obo/HANCESTRO_0363;http://purl.obolibrary.org/obo/FOODON_03306255,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,I-http://purl.obolibrary.org/obo/FOODON_03302695;http://purl.obolibrary.org/obo/HANCESTRO_0363;http://purl.obolibrary.org/obo/FOODON_03306255,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29760,Male,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29761,Sprague,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29762,Dawley,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29763,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29764,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29765,8,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29766,weeks,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29767,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29768,old,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29769,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29770,were,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29771,grouped,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29772,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29773,6,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29774,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29775,/,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29776,group,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29777,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29778,in,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29779,four,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29780,experimental,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29781,groups,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29782,:,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29783,nan,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29784,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29785,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29786,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29787,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29788,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29789,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29790,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29791,NL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29792,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29793,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29794,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29795,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29796,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29797,juice,I-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29798,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29799,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29800,HA,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29801,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29802,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29803,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29804,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29805,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29806,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29807,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29808,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29809,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29810,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29811,HL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29812,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29813,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29814,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29815,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29816,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29817,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29818,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29819,juice,I-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29820,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29821,.,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29851,Although,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29852,the,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29853,H,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29854,diet,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29855,provoked,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29856,dislipemia,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29857,related,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29858,to,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29859,steatosis,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29860,",",O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29861,no,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29862,changes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29863,in,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29864,isoprostanes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29865,or,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29866,liver,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29867,malondialdehyde,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29868,(,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29869,MDA,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29870,),O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29871,were,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29872,observed,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29873,.,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29874,Changes,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29875,in,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29876,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29877,gene,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29878,expression,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29879,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29880,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29881,HA,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29882,group,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29883,were,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29884,produced,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29885,by,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29886,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29887,high,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29888,consumption,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29889,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29890,fat,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29891,",",O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29892,whereas,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29893,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29894,consumption,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29895,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29896,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29897,juice,I-http://purl.obolibrary.org/obo/FOODON_03301454;http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081;http://purl.obolibrary.org/obo/FOODON_03315552,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29898,had,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29899,different,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29900,effects,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29901,",",O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29902,depending,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29903,on,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29904,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29905,diet,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29906,.,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
30128,Therefore,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30129,",",O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30130,we,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30131,conclude,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30132,that,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30133,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30134,IgE,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30135,cross,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30136,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30137,reactivity,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30138,in,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30139,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30140,mugwort,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30141,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30142,birch,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30143,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30144,celery,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30145,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30146,spice,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30147,syndrome,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30148,to,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30149,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30150,spices,B-http://purl.obolibrary.org/obo/FOODON_00003520;http://purl.obolibrary.org/obo/FOODON_00003013;http://purl.obolibrary.org/obo/FOODON_00001649;http://purl.obolibrary.org/obo/FOODON_03309928,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30151,pepper,I-http://purl.obolibrary.org/obo/FOODON_00003520;http://purl.obolibrary.org/obo/FOODON_00003013;http://purl.obolibrary.org/obo/FOODON_00001649;http://purl.obolibrary.org/obo/FOODON_03309928,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30152,and,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30153,paprika,B-http://purl.obolibrary.org/obo/FOODON_03301105,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30154,is,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30155,not,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30156,caused,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30157,by,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30158,homologs,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30159,of,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30160,Bet,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30161,v,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30162,1,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30163,and,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30164,profilin,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30165,.,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30251,Particular,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30252,concerns,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30253,center,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30254,on,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30255,free,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30256,-,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30257,roaming,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30258,chickens,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30259,",",O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30260,given,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30261,their,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30262,proximity,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30263,to,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30264,children,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30265,in,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30266,rural,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30267,settings,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30268,",",O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30269,but,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30270,findings,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30271,to,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30272,date,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30273,have,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30274,been,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30275,inconclusive,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30276,.,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30899,To,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30900,assess,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30901,gene,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30902,expression,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30903,changes,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30904,",",O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30905,colonic,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30906,mucosal,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30907,cells,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30908,were,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30909,collected,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30910,after,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30911,the,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30912,mice,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30913,were,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30914,killed,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30915,.,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
32064,In,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32065,this,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32066,regard,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32067,",",O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32068,there,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32069,is,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32070,increasing,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32071,evidence,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32072,for,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32073,a,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32074,protective,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32075,effect,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32076,of,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32077,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32078,",",O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32079,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32080,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32081,and,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32082,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32083,consumption,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32084,against,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32085,this,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32086,disorder,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32087,.,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32213,It,O,1093.0,It has been grown since at least 1000 BC in China .
32214,has,O,1093.0,It has been grown since at least 1000 BC in China .
32215,been,O,1093.0,It has been grown since at least 1000 BC in China .
32216,grown,O,1093.0,It has been grown since at least 1000 BC in China .
32217,since,O,1093.0,It has been grown since at least 1000 BC in China .
32218,at,O,1093.0,It has been grown since at least 1000 BC in China .
32219,least,O,1093.0,It has been grown since at least 1000 BC in China .
32220,1000,O,1093.0,It has been grown since at least 1000 BC in China .
32221,BC,O,1093.0,It has been grown since at least 1000 BC in China .
32222,in,O,1093.0,It has been grown since at least 1000 BC in China .
32223,China,O,1093.0,It has been grown since at least 1000 BC in China .
32224,.,O,1093.0,It has been grown since at least 1000 BC in China .
32545,The,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32546,authors,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32547,conducted,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32548,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32549,case,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32550,-,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32551,control,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32552,study,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32553,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32554,Hawaii,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32555,and,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32556,Los,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32557,Angeles,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32558,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32559,California,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32560,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32561,to,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32562,examine,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32563,several,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32564,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32565,hypotheses,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32566,regarding,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32567,the,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32568,etiology,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32569,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32570,ovarian,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32571,cancer,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32572,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32573,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32574,population,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32575,with,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32576,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32577,broad,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32578,range,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32579,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32580,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32581,intakes,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32582,.,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32707,The,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32708,significant,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32709,dietary,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32710,association,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32711,was,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32712,limited,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32713,to,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32714,dairy,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32715,sources,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32716,of,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32717,calcium,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32718,(,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32719,p,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32720,for,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32721,trend,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32722,=,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32723,0.003,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32724,),O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32725,",",O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32726,although,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32727,a,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32728,nonsignificant,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32729,inverse,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32730,gradient,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32731,in,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32732,risk,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32733,was,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32734,also,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32735,found,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32736,in,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32737,relation,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32738,to,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32739,calcium,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32740,supplement,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32741,intake,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32742,.,O,1113.0,"The significant dietary association was limited to dairy sources of calcium ( p for trend = 0.003 ) , although a nonsignificant inverse gradient in risk was also found in relation to calcium supplement intake ."
32970,At,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32971,4,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32972,y,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32973,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32974,the,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32975,between,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32976,-,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32977,group,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32978,differences,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32979,were,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32980,65,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32981,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32982,for,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32983,vegetables,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32984,(,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32985,including,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32986,juice,B-http://purl.obolibrary.org/obo/FOODON_03315552,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32987,),O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32988,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32989,25,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32990,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32991,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32992,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32993,30,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32994,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32995,fiber,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32996,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32997,40,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32998,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32999,legumes,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33000,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33001,30,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33002,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33003,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33004,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33005,foods,I-http://purl.obolibrary.org/obo/FOODON_00003950,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33006,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33007,and,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33008,13,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33009,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33010,lower,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33011,intake,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33012,of,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33013,energy,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33014,from,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33015,fat,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33016,.,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33576,Rats,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33577,were,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33578,decapitated,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33579,",",O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33580,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33581,hepatic,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33582,tissue,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33583,was,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33584,used,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33585,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33586,phospholipid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33587,fatty,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33588,acid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33589,analysis,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33590,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33591,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33592,the,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33593,preparation,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33594,of,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33595,mitochondria,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33596,.,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
34551,It,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34552,is,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34553,known,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34554,for,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34555,its,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34556,beneficial,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34557,effects,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34558,against,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34559,degenerative,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34560,diseases,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34561,including,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34562,diabetes,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34563,",",O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34564,obesity,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34565,",",O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34566,hypertension,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34567,",",O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34568,and,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34569,colon,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34570,inflammation,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34571,which,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34572,are,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34573,associated,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34574,with,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34575,eating,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34576,habits,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34577,and,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34578,improper,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34579,lifestyles,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34580,.,O,1178.0,"It is known for its beneficial effects against degenerative diseases including diabetes , obesity , hypertension , and colon inflammation which are associated with eating habits and improper lifestyles ."
34599,Moreover,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34600,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34601,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34602,considered,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34603,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34604,a,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34605,good,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34606,source,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34607,of,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34608,starch,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34609,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34610,minerals,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34611,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34612,vitamins,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34613,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34614,and,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34615,protein,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34616,pose,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34617,it,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34618,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34619,an,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34620,ideal,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34621,food,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34622,supplement,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34623,.,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
35006,Purchase,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35007,intent,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35008,of,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35009,all,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35010,flavored,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35011,products,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35012,also,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35013,significantly,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35014,increased,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35015,once,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35016,consumers,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35017,had,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35018,been,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35019,given,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35020,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35021,information,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35022,about,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35023,potential,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35024,health,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35025,benefits,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35026,associated,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35027,with,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35028,RBO,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35029,and,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35030,SPC,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35031,in,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35032,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35033,spreads,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35034,.,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
36448,Concurrently,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36449,the,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36450,intake,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36451,of,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36452,vegetables,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36453,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36454,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36455,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36456,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36457,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36458,bread,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36459,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36460,cereals,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36461,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36462,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36463,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36464,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36465,milk,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36466,products,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36467,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36468,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36469,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36470,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36471,meat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36472,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36473,sausages,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36474,and,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36475,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36476,increased,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36477,significantly,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36478,.,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36530,Reduction,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36531,of,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36532,high,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36533,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36534,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36535,foods,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36536,and,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36537,increases,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36538,of,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36539,carbohydrate,B-http://purl.obolibrary.org/obo/CHEBI_16646,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36540,-,I-http://purl.obolibrary.org/obo/CHEBI_16646,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36541,rich,I-http://purl.obolibrary.org/obo/CHEBI_16646,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36542,foods,I-http://purl.obolibrary.org/obo/CHEBI_16646,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36543,were,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36544,more,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36545,pronounced,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36546,for,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36547,the,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36548,intervention,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36549,group,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36550,than,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36551,for,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36552,the,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36553,control,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36554,group,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36555,.,O,1248.0,Reduction of high - fat foods and increases of carbohydrate - rich foods were more pronounced for the intervention group than for the control group .
36556,Formal,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36557,education,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36558,influenced,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36559,dietary,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36560,changes,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36561,",",O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36562,and,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36563,dietary,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36564,counselling,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36565,should,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36566,therefore,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36567,ideally,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36568,be,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36569,adapted,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36570,to,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36571,education,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36572,level,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36573,.,O,1249.0,"Formal education influenced dietary changes , and dietary counselling should therefore ideally be adapted to education level ."
36675,Epidemiology,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36676,identifies,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36677,associations,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36678,between,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36679,aspects,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36680,of,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36681,diet,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36682,",",O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36683,nutrition,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36684,",",O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36685,and,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36686,physical,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36687,activity,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36688,with,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36689,one,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36690,or,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36691,more,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36692,cancers,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36693,;,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36694,there,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36695,is,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36696,evidence,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36697,for,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36698,plausible,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36699,mechanisms,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36700,that,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36701,imply,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36702,that,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36703,these,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36704,are,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36705,causal,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36706,.,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
37410,The,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37411,relationship,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37412,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37413,selected,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37414,bone,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37415,-,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37416,related,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37417,nutrients,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37418,to,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37419,these,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37420,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37421,fluxes,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37422,exhibits,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37423,both,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37424,constructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37425,and,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37426,destructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37427,interactions,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37428,that,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37429,affect,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37430,the,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37431,overall,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37432,state,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37433,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37434,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37435,balance,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37436,.,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37505,Potassium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37506,was,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37507,inversely,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37508,associated,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37509,with,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37510,both,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37511,urinary,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37512,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37513,excretion,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37514,and,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37515,intestinal,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37516,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37517,absorption,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37518,",",O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37519,yielding,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37520,no,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37521,significant,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37522,net,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37523,change,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37524,in,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37525,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37526,balance,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37527,.,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37661,Processed,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37662,meat,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37663,intake,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37664,is,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37665,associated,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37666,with,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37667,increased,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37668,risk,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37669,of,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37670,colorectal,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37671,cancer,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37672,.,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37673,This,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37674,association,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37675,may,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37676,be,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37677,explained,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37678,by,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37679,the,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37680,endogenous,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37681,formation,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37682,of,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37683,N,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37684,-,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37685,nitroso,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37686,compounds,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37687,(,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37688,NOC,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37689,),O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37690,.,O,1291.0,This association may be explained by the endogenous formation of N - nitroso compounds ( NOC ) .
37691,The,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37692,hypothesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37693,that,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37694,meat,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37695,intake,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37696,can,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37697,increase,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37698,fecal,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37699,NOC,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37700,levels,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37701,and,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37702,colon,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37703,carcinogenesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37704,was,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37705,tested,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37706,in,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37707,175,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37708,Fischer,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37709,344,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37710,rats,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37711,.,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37825,Results,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37826,show,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37827,that,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37828,feces,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37829,from,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37830,rats,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37831,fed,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37832,bacon,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37833,-,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37834,based,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37835,diets,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37836,contained,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37837,10,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37838,-,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37839,20,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37840,times,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37841,more,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37842,NOC,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37843,than,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37844,feces,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37845,from,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37846,control,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37847,rats,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37848,fed,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37849,a,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37850,casein,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37851,-,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37852,based,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37853,diet,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37854,(,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37855,all,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37856,p,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37857,<,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37858,0.0001,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37859,in,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37860,4,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37861,studies,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37862,),O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37863,.,O,1298.0,Results show that feces from rats fed bacon - based diets contained 10 - 20 times more NOC than feces from control rats fed a casein - based diet ( all p < 0.0001 in 4 studies ) .
37864,In,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37865,bacon,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37866,-,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37867,fed,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37868,rats,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37869,",",O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37870,the,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37871,amount,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37872,of,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37873,NOC,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37874,input,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37875,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37876,diet,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37877,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37878,and,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37879,output,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37880,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37881,feces,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37882,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37883,was,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37884,similar,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37885,.,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
38011,The,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38012,association,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38013,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38014,habitual,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38015,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38016,consumption,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38017,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38018,a,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38019,lower,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38020,risk,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38021,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38022,diseases,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38023,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38024,like,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38025,type,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38026,2,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38027,diabetes,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38028,mellitus,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38029,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38030,chronic,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38031,liver,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38032,disease,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38033,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38034,certain,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38035,cancer,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38036,types,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38037,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38038,or,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38039,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38040,reduced,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38041,all,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38042,-,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38043,cause,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38044,mortality,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38045,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38046,has,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38047,been,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38048,confirmed,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38049,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38050,prospective,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38051,cohort,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38052,studies,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38053,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38054,many,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38055,regions,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38056,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38057,the,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38058,world,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38059,.,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38365,The,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38366,age,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38367,-,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38368,adjusted,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38369,data,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38370,suggest,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38371,a,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38372,U,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38373,-,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38374,shape,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38375,curve,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38376,for,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38377,female,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38378,smokers,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38379,",",O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38380,although,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38381,this,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38382,was,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38383,not,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38384,confirmed,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38385,by,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38386,the,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38387,Cox,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38388,analysis,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38389,.,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38478,We,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38479,evaluated,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38480,the,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38481,antiproliferative,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38482,effect,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38483,of,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38484,aqueous,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38485,extracts,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38486,of,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38487,14,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38488,plant,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38489,foods,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38490,consumed,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38491,in,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38492,Mexico,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38493,on,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38494,the,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38495,breast,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38496,cancer,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38497,cell,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38498,line,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38499,MCF-7,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38500,.,O,1323.0,We evaluated the antiproliferative effect of aqueous extracts of 14 plant foods consumed in Mexico on the breast cancer cell line MCF-7 .
38694,We,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38695,examined,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38696,the,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38697,association,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38698,of,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38699,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38700,consumption,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38701,and,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38702,lung,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38703,cancer,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38704,risk,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38705,in,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38706,a,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38707,large,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38708,pooled,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38709,international,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38710,sample,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38711,",",O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38712,minimizing,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38713,potential,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38714,confounding,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38715,of,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38716,tobacco,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38717,consumption,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38718,by,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38719,restricting,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38720,analyses,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38721,to,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38722,never,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38723,smokers,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38724,.,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
39058,Major,O,1343.0,Major pollen allergens were not involved .
39059,pollen,O,1343.0,Major pollen allergens were not involved .
39060,allergens,O,1343.0,Major pollen allergens were not involved .
39061,were,O,1343.0,Major pollen allergens were not involved .
39062,not,O,1343.0,Major pollen allergens were not involved .
39063,involved,O,1343.0,Major pollen allergens were not involved .
39064,.,O,1343.0,Major pollen allergens were not involved .
39749,When,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39750,ghee,B-http://purl.obolibrary.org/obo/FOODON_03310185,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39751,was,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39752,included,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39753,as,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39754,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39755,sole,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39756,source,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39757,of,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39758,fat,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39759,at,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39760,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39761,10,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39762,%,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39763,level,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39764,",",O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39765,polyunsaturated,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39766,fatty,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39767,acids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39768,in,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39769,the,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39770,serum,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39771,and,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39772,liver,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39773,lipids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39774,were,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39775,reduced,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39776,significantly,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39777,.,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
40151,In,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40152,conclusion,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40153,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40154,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40155,middle,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40156,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40157,aged,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40158,and,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40159,elderly,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40160,moderately,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40161,hypercholesterolemic,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40162,subjects,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40163,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40164,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40165,consumption,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40166,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40167,reduced,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40168,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40169,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40170,diets,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40171,enriched,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40172,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40173,animal,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40174,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40175,or,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40176,vegetable,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40177,oils,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40178,with,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40179,a,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40180,relatively,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40181,wide,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40182,range,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40183,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40184,fatty,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40185,acid,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40186,profiles,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40187,did,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40188,not,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40189,alter,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40190,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40191,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40192,vitro,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40193,susceptibility,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40194,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40195,LDL,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40196,to,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40197,oxidation,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40198,.,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40492,Over,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40493,two,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40494,-,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40495,thirds,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40496,of,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40497,both,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40498,boys,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40499,and,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40500,girls,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40501,believed,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40502,that,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40503,daily,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40504,consumption,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40505,of,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40506,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40507,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40508,bread,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40509,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40510,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40511,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40512,eggs,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40513,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40514,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40515,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40516,meat,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40517,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40518,and,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40519,tomatoes,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40520,is,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40521,desirable,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40522,",",O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40523,and,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40524,about,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40525,two,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40526,-,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40527,thirds,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40528,stated,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40529,that,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40530,overeating,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40531,is,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40532,a,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40533,cause,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40534,of,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40535,obesity,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40536,.,O,1389.0,"Over two - thirds of both boys and girls believed that daily consumption of milk , bread , fruits , eggs , cheese , meat , and tomatoes is desirable , and about two - thirds stated that overeating is a cause of obesity ."
40537,More,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40538,overweight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40539,than,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40540,thin,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40541,and,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40542,normal,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40543,-,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40544,weight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40545,children,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40546,indicated,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40547,that,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40548,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40549,to,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40550,prevent,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40551,obesity,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40552,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40553,all,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40554,kinds,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40555,of,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40556,food,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40557,are,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40558,permissible,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40559,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40560,but,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40561,only,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40562,in,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40563,limited,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40564,amounts,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40565,.,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
41228,The,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41229,combination,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41230,of,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41231,cigarette,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41232,smoking,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41233,and,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41234,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41235,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41236,intake,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41237,was,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41238,associated,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41239,with,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41240,particularly,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41241,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41242,tHcy,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41243,concentrations,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41244,.,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41649,Therefore,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41650,",",O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41651,we,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41652,hypothesized,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41653,that,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41654,consumption,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41655,of,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41656,flavonoids,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41657,and,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41658,specific,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41659,food,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41660,and,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41661,beverage,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41662,sources,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41663,of,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41664,flavonoids,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41665,would,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41666,be,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41667,associated,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41668,with,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41669,reduced,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41670,risk,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41671,of,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41672,incident,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41673,diabetes,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
41674,.,O,1428.0,"Therefore , we hypothesized that consumption of flavonoids and specific food and beverage sources of flavonoids would be associated with reduced risk of incident diabetes ."
42016,A,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42017,total,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42018,of,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42019,"13,609",O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42020,subjects,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42021,aged,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42022,between,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42023,20,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42024,and,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42025,50,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42026,years,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42027,were,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42028,selected,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42029,.,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42030,Dyslipidemia,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42031,was,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42032,defined,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42033,primarily,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42034,according,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42035,to,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42036,the,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42037,National,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42038,Cholesterol,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42039,Education,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42040,Program,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42041,Adult,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42042,Treatment,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42043,Panel,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42044,III,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42045,guidelines,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42046,with,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42047,minor,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42048,modification,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42049,.,O,1442.0,Dyslipidemia was defined primarily according to the National Cholesterol Education Program Adult Treatment Panel III guidelines with minor modification .
42435,Also,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42436,",",O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42437,liver,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42438,PAP,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42439,activity,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42440,was,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42441,decreased,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42442,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42443,group,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42444,II,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42445,than,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42446,group,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42447,I,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42448,whereas,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42449,",",O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42450,the,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42451,decrease,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42452,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42453,its,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42454,activity,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42455,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42456,groups,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42457,III,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42458,and,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42459,IV,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42460,was,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42461,due,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42462,to,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42463,the,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42464,accumulation,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42465,of,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42466,triglyceride,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42467,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42468,liver,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42469,.,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42491,A,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42492,multi,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42493,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42494,centre,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42495,case,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42496,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42497,control,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42498,study,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42499,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42500,diet,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42501,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42502,gastric,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42503,cancer,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42504,was,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42505,carried,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42506,out,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42507,in,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42508,4,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42509,regions,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42510,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42511,Spain,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42512,(,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42513,Aragon,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42514,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42515,Castile,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42516,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42517,Catalonia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42518,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42519,Galicia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42520,),O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42521,.,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42651,Simultaneous,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42652,intake,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42653,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42654,2,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42655,groups,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42656,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42657,food,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42658,which,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42659,increase,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42660,or,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42661,decrease,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42662,the,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42663,risk,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42664,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42665,cancer,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42666,strengthens,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42667,the,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42668,respective,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42669,individual,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42670,effect,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42671,.,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42690,With,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42691,reference,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42692,to,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42693,past,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42694,diet,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42695,",",O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42696,a,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42697,possible,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42698,protective,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42699,effect,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42700,was,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42701,observed,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42702,for,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42703,daily,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42704,consumption,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42705,of,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42706,fresh,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42707,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42708,and,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42709,green,B-http://purl.obolibrary.org/obo/PATO_0000320,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42710,vegetables,I-http://purl.obolibrary.org/obo/PATO_0000320,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42711,.,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42777,Whilst,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42778,dietary,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42779,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42780,have,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42781,been,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42782,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42783,subject,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42784,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42785,breast,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42786,cancer,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42787,risk,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42788,-,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42789,reduction,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42790,",",O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42791,this,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42792,review,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42793,will,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42794,focus,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42795,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42796,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42797,clinical,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42798,effects,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42799,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42800,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42801,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42802,reducing,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42803,recurrence,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42804,.,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42979,A,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42980,more,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42981,complete,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42982,profile,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42983,of,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42984,phenolic,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42985,distributions,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42986,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42987,including,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42988,both,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42989,free,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42990,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42991,bound,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42992,phenolics,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42993,in,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42994,these,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42995,vegetables,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42996,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42997,is,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42998,reported,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42999,here,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43000,using,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43001,new,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43002,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43003,modified,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43004,methods,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43005,.,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43279,A,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43280,review,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43281,of,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43282,both,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43283,clinical,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43284,trial,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43285,databases,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43286,and,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43287,published,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43288,literature,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43289,yielded,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43290,15,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43291,registered,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43292,trials,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43293,and,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43294,7,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43295,published,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43296,studies,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43297,.,O,1486.0,A review of both clinical trial databases and published literature yielded 15 registered trials and 7 published studies .
43595,A,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43596,total,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43597,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43598,13,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43599,%,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43600,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43601,participants,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43602,consumed,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43603,≥1,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43604, ,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43605,serving,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43606,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43607,rice,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43608,/,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43609,day,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43610,.,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43611,Compared,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43612,with,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43613,individuals,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43614,consuming,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43615,<,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43616,1,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43617, ,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43618,serving,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43619,of,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43620,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43621,/,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43622,week,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43623,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43624,≥1,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43625, ,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43626,serving,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43627,of,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43628,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43629,/,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43630,day,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43631,was,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43632,not,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43633,associated,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43634,with,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43635,subclinical,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43636,markers,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43637,after,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43638,demographic,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43639,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43640,lifestyle,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43641,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43642,and,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43643,CVD,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43644,risk,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43645,factor,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43646,adjustment,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43647,(,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43648,eg,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43649,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43650,geometric,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43651,mean,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43652,ratio,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43653,[,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43654,95,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43655,%,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43656,CI,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43657,],O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43658,for,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43659,hsCRP,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43660,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43661,0.98,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43662,[,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43663,0.86,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43664,-,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43665,1.11,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43666,],O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43667,;,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43668,aortic,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43669,distensibility,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43670,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43671,0.99,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43672,[,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43673,0.91,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43674,-,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43675,1.07,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43676,],O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43677,;,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43678,and,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43679,carotid,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43680,intima,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43681,-,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43682,media,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43683,thickness,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43684,",",O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43685,0.98,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43686,[,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43687,0.91,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43688,-,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43689,1.06,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43690,],O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43691,),O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43692,.,O,1499.0,"Compared with individuals consuming < 1   serving of rice / week , ≥1   serving of rice / day was not associated with subclinical markers after demographic , lifestyle , and CVD risk factor adjustment ( eg , geometric mean ratio [ 95 % CI ] for hsCRP , 0.98 [ 0.86 - 1.11 ] ; aortic distensibility , 0.99 [ 0.91 - 1.07 ] ; and carotid intima - media thickness , 0.98 [ 0.91 - 1.06 ] ) ."
43817,Many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43818,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43819,these,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43820,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43821,cooperate,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43822,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43823,oxidative,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43824,stress,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43825,reduction,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43826,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43827,plants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43828,",",O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43829,and,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43830,we,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43831,hypothesize,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43832,that,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43833,many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43834,different,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43835,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43836,may,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43837,also,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43838,be,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43839,needed,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43840,for,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43841,the,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43842,proper,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43843,protection,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43844,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43845,animal,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43846,cells,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43847,.,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43866,Several,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43867,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43868,are,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43869,among,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43870,the,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43871,dietary,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43872,plants,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43873,with,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43874,the,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43875,highest,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43876,content,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43877,of,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43878,total,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43879,antioxidants,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43880,.,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43898,Walnuts,B-http://purl.obolibrary.org/obo/NCBITaxon_16718,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43899,contain,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43900,more,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43901,than,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43902,20,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43903,mmol,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43904,antioxidants,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43905,per,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43906,100,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43907,g,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43908,",",O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43909,mostly,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43910,in,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43911,the,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43912,walnut,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43913,pellicles,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43914,.,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43983,Hazard,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43984,ratio,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43985,was,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43986,0.89,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43987,(,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43988,CI,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43989,=,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43990,0.81,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43991,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43992,0.97,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43993,),O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43994,and,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43995,0.81,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43996,(,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43997,CI,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43998,=,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43999,0.75,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44000,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44001,0.88,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44002,),O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44003,for,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44004,nut,B-http://purl.obolibrary.org/obo/FOODON_03303171;http://purl.obolibrary.org/obo/FOODON_03306867;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310351,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44005,/,I-http://purl.obolibrary.org/obo/FOODON_03303171;http://purl.obolibrary.org/obo/FOODON_03306867;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310351,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44006,peanut,I-http://purl.obolibrary.org/obo/FOODON_03303171;http://purl.obolibrary.org/obo/FOODON_03306867;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310351,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44007,butter,I-http://purl.obolibrary.org/obo/FOODON_03303171;http://purl.obolibrary.org/obo/FOODON_03306867;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310351,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44008,intake,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44009,once,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44010,per,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44011,week,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44012,and,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44013,1,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44014,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44015,4,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44016,times,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44017,per,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44018,week,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44019,",",O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44020,respectively,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44021,.,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44119,Among,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44120,major,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44121,food,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44122,groups,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44123,",",O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44124,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44125,and,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44126,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44127,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44128,as,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44129,well,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44130,as,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44131,added,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44132,lipids,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44133,were,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44134,marginally,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44135,positively,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44136,associated,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44137,with,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44138,risk,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44139,for,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44140,prostate,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44141,cancer,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44142,.,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44377,The,O,1528.0,The 25 % of patients with hypertension became normotensive .
44378,25,O,1528.0,The 25 % of patients with hypertension became normotensive .
44379,%,O,1528.0,The 25 % of patients with hypertension became normotensive .
44380,of,O,1528.0,The 25 % of patients with hypertension became normotensive .
44381,patients,O,1528.0,The 25 % of patients with hypertension became normotensive .
44382,with,O,1528.0,The 25 % of patients with hypertension became normotensive .
44383,hypertension,O,1528.0,The 25 % of patients with hypertension became normotensive .
44384,became,O,1528.0,The 25 % of patients with hypertension became normotensive .
44385,normotensive,O,1528.0,The 25 % of patients with hypertension became normotensive .
44386,.,O,1528.0,The 25 % of patients with hypertension became normotensive .
44387,Chemicals,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44388,in,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44389,the,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44390,home,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44391,environment,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44392,can,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44393,make,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44394,this,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44395,testing,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44396,difficult,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44397,for,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44398,outpatients,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44399,.,O,1529.0,Chemicals in the home environment can make this testing difficult for outpatients .
44758,We,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44759,speculated,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44760,that,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44761,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44762,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44763,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44764,beef,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44765,or,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44766,bacon,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44767,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44768,increase,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44769,and,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44770,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44771,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44772,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44773,chicken,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44774,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44775,decrease,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44776,colon,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44777,carcinogenesis,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44778,in,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44779,rats,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44780,.,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
45382,Dietary,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45383,habits,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45384,were,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45385,established,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45386,through,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45387,a,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45388,self,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45389,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45390,administered,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45391,semi,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45392,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45393,quantitative,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45394,food,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45395,frequency,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45396,questionnaire,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45397,.,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45440,We,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45441,observed,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45442,an,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45443,indication,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45444,of,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45445,a,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45446,positive,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45447,association,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45448,between,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45449,melanoma,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45450,risk,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45451,and,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45452,consumption,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45453,of,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45454,cereals,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45455,and,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45456,cereal,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45457,products,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45458,(,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45459,OR,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45460,=,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45461,1.32,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45462,;,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45463,95,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45464,%,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45465,CI,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45466,0.89,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45467,-,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45468,1.96,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45469,",",O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45470,higher,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45471,vs.,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45472,lowest,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45473,tertile,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45474,),O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45475,",",O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45476,sweets,B-http://purl.obolibrary.org/obo/FOODON_03316428,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45477,(,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45478,OR,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45479,=,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45480,1.22,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45481,;,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45482,95,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45483,%,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45484,CI,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45485,0.84,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45486,-,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45487,1.76,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45488,),O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45489,",",O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45490,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45491,",",O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45492,candy,B-http://purl.obolibrary.org/obo/FOODON_03301051,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45493,bars,I-http://purl.obolibrary.org/obo/FOODON_03301051,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45494,.,O,1572.0,"We observed an indication of a positive association between melanoma risk and consumption of cereals and cereal products ( OR = 1.32 ; 95 % CI 0.89 - 1.96 , higher vs. lowest tertile ) , sweets ( OR = 1.22 ; 95 % CI 0.84 - 1.76 ) , chocolate , candy bars ."
45829,Therefore,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45830,",",O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45831,the,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45832,inhibition,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45833,of,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45834,pol,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45835,alpha,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45836,activity,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45837,by,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45838,SQDG,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45839,may,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45840,lead,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45841,to,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45842,cell,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45843,growth,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45844,suppression,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45845,.,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
46269,Comparisons,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46270,of,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46271,diets,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46272,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46273,disease,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46274,rates,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46275,between,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46276,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46277,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46278,non,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46279,-,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46280,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46281,",",O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46282,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46283,prospective,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46284,cohort,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46285,studies,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46286,among,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46287,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46288,",",O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46289,have,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46290,contributed,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46291,greatly,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46292,to,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46293,our,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46294,general,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46295,understanding,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46296,of,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46297,nutrition,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46298,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46299,health,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46300,.,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46361,Although,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46362,much,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46363,progress,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46364,has,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46365,been,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46366,made,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46367,",",O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46368,many,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46369,issues,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46370,remain,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46371,unresolved,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46372,.,O,1602.0,"Although much progress has been made , many issues remain unresolved ."
46504,The,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46505,unusually,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46506,wide,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46507,range,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46508,of,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46509,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46510,consumption,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46511,in,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46512,Adventists,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46513,will,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46514,be,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46515,particularly,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46516,informative,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46517,with,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46518,regard,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46519,to,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46520,these,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46521,relations,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46522,.,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46551,There,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46552,are,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46553,many,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46554,synergies,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46555,between,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46556,a,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46557,diet,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46558,that,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46559,is,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46560,healthy,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46561,for,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46562,the,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46563,heart,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46564,and,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46565,one,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46566,that,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46567,is,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46568,healthy,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46569,for,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46570,the,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46571,planet,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46572,",",O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46573,but,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46574,there,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46575,may,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46576,also,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46577,be,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46578,tensions,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46579,.,O,1610.0,"There are many synergies between a diet that is healthy for the heart and one that is healthy for the planet , but there may also be tensions ."
46834,Total,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46835,oxalate,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46836,content,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46837,was,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46838,comparably,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46839,high,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46840,in,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46841,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46842,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46843,products,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46844,of,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46845,T.,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46846,aestivum,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46847,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46848,that,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46849,is,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46850,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46851,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46852,flakes,I-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46853,and,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46854,flour,B-http://purl.obolibrary.org/obo/FOODON_03301116,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46855,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46856,as,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46857,well,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46858,as,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46859,in,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46860,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46861,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46862,products,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46863,of,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46864,T.,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46865,durum,I-http://purl.obolibrary.org/obo/FOODON_00003950,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46866,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46867,that,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46868,is,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46869,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46870,couscous,B-http://purl.obolibrary.org/obo/FOODON_03303207,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46871,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46872,bulgur,B-http://purl.obolibrary.org/obo/FOODON_00003143,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46873,",",O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46874,and,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46875,pasta,B-http://purl.obolibrary.org/obo/FOODON_03306347,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
46876,.,O,1619.0,"Total oxalate content was comparably high in whole grain products of T. aestivum , that is , wheat flakes and flour , as well as in whole grain products of T. durum , that is , couscous , bulgur , and pasta ."
47259,Although,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47260,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47261,may,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47262,thus,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47263,represent,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47264,an,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47265,important,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47266,source,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47267,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47268,dietary,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47269,antioxidants,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47270,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47271,many,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47272,societies,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47273,",",O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47274,the,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47275,role,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47276,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47277,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47278,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47279,reducing,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47280,risk,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47281,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47282,major,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47283,disease,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47284,states,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47285,needs,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47286,to,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47287,be,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47288,investigated,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47289,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47290,more,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47291,detail,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47292,.,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47323,Among,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47324,traditional,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47325,treatments,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47326,",",O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47327,dietary,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47328,habits,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47329,represent,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47330,one,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47331,of,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47332,the,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47333,most,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47334,difficult,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47335,and,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47336,controversial,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47337,aspects,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47338,to,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47339,implement,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47340,in,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47341,handling,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47342,metabolic,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47343,disturbances,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47344,.,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47477,Dietary,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47478,patterns,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47479,are,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47480,a,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47481,major,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47482,risk,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47483,factor,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47484,for,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47485,cardiovascular,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47486,morbidity,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47487,and,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47488,mortality,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47489,;,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47490,however,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47491,",",O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47492,few,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47493,studies,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47494,have,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47495,examined,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47496,this,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47497,relationship,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47498,in,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47499,older,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47500,adults,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47501,.,O,1642.0,"Dietary patterns are a major risk factor for cardiovascular morbidity and mortality ; however , few studies have examined this relationship in older adults ."
47798,Avoiding,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47799,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47800,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47801,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47802,fat,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47803,/,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47804,low,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47805,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47806,fibre,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47807,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47808,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47809,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47810,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47811,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47812,sugar,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47813,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47814,dietary,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47815,components,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47816,may,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47817,reduce,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47818,the,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47819,risk,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47820,of,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47821,cardiovascular,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47822,events,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47823,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47824,all,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47825,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47826,cause,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47827,mortality,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47828,in,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47829,older,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47830,adults,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47831,.,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
48655,These,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48656,findings,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48657,imply,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48658,acceptance,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48659,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48660,sodium,B-http://purl.obolibrary.org/obo/CHEBI_26708;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48661,-,I-http://purl.obolibrary.org/obo/CHEBI_26708;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48662,reduced,I-http://purl.obolibrary.org/obo/CHEBI_26708;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48663,potato,I-http://purl.obolibrary.org/obo/CHEBI_26708;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48664,chips,I-http://purl.obolibrary.org/obo/CHEBI_26708;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48665,and,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48666,puffed,B-http://purl.obolibrary.org/obo/FOODON_00002656;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48667,rice,I-http://purl.obolibrary.org/obo/FOODON_00002656;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48668,is,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48669,possible,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48670,by,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48671,focusing,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48672,on,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48673,these,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48674,identified,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48675,drivers,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48676,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48677,liking,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48678,.,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
49488,The,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49489,milk,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49490,prolactin,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49491,level,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49492,in,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49493,early,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49494,lactation,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49495,did,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49496,not,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49497,differ,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49498,between,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49499,NAS,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49500,-,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49501,infected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49502,and,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49503,noninfected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49504,quarters,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49505,either,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49506,.,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49961,Tissues,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49962,were,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49963,collected,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49964,at,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49965,week,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49966,0,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49967,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49968,12,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49969,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49970,18,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49971,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49972,and,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49973,24,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49974,.,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
50324,Therefore,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50325,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50326,this,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50327,review,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50328,focused,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50329,on,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50330,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50331,differences,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50332,between,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50333,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50334,effects,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50335,of,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50336,miso,B-http://purl.obolibrary.org/obo/FOODON_00003208,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50337,intake,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50338,and,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50339,those,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50340,of,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50341,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50342,equivalent,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50343,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50344,intake,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50345,on,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50346,sympathetic,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50347,nerve,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50348,activity,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50349,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50350,blood,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50351,pressure,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50352,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50353,and,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50354,heart,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50355,rate,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50356,.,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50988,These,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50989,results,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50990,are,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50991,very,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50992,similar,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50993,to,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50994,those,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50995,described,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50996,for,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50997,vegetables,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50998,consumed,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
50999,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51000,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51001,United,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51002,States,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51003,",",O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51004,with,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51005,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51006,exception,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51007,of,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51008,calcot,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51009,",",O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51010,which,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51011,is,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51012,common,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51013,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51014,Catalonia,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51015,but,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51016,is,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51017,not,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51018,grown,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51019,or,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51020,consumed,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51021,widely,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51022,in,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51023,the,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51024,United,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51025,States,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51026,.,O,1751.0,"These results are very similar to those described for vegetables consumed in the United States , with the exception of calcot , which is common in Catalonia but is not grown or consumed widely in the United States ."
51223,After,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51224,adjustment,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51225,for,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51226,daily,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51227,energy,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51228,intake,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51229,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51230,the,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51231,"""",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51232,meat,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51233,"""",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51234,pattern,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51235,was,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51236,positively,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51237,associated,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51238,with,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51239,body,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51240,mass,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51241,index,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51242,(,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51243,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51244,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51245,0.17,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51246,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51247,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51248,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51249,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51250,0.0001,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51251,),O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51252,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51253,whereas,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51254,the,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51255,other,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51256,three,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51257,patterns,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51258,showed,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51259,negative,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51260,relationships,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51261,to,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51262,body,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51263,mass,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51264,index,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51265,(,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51266,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51267,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51268,-0.076,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51269,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51270,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51271,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51272,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51273,0.084,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51274,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51275,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51276,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51277,-0.13,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51278,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51279,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51280,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51281,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51282,0.003,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51283,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51284,and,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51285,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51286,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51287,-0.13,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51288,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51289,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51290,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51291,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51292,0.003,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51293,),O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51294,for,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51295,vegetables,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51296,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51297,beans,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51298,and,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51299,cold,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51300,foods,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51301,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51302,respectively,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51303,.,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51702,Fasting,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51703,blood,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51704,samples,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51705,were,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51706,taken,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51707,on,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51708,days,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51709,0,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51710,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51711,14,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51712,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51713,28,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51714,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51715,and,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51716,42,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51717,for,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51718,the,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51719,determination,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51720,of,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51721,total,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51722,plasma,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51723,cholesterol,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51724,",",O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51725,high,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51726,-,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51727,density,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51728,-,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51729,lipoprotein,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51730,(,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51731,HDL)-cholesterol,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51732,and,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51733,triacylglycerols,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
51734,.,O,1773.0,"Fasting blood samples were taken on days 0 , 14 , 28 , and 42 for the determination of total plasma cholesterol , high - density - lipoprotein ( HDL)-cholesterol and triacylglycerols ."
52095,The,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52096,mean,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52097,FA,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52098,content,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52099,of,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52100,bread,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52101,was,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52102,2020,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52103,+,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52104,/-,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52105,940,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52106,micro,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52107,g,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52108,/,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52109,kg,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52110,.,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52619,The,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52620,obesity,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52621,risk,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52622,decreased,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52623,in,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52624,men,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52625,(,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52626,P,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52627,=,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52628,0.010,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52629,),O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52630,and,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52631,women,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52632,(,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52633,P,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52634,=,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52635,0.013,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52636,),O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52637,with,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52638,increasing,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52639,adherence,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52640,to,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52641,the,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52642,traditional,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52643,Mediterranean,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52644,dietary,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52645,pattern,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52646,.,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52896,and,O,1816.0,and Lactobacillus spp .
52897,Lactobacillus,O,1816.0,and Lactobacillus spp .
52898,spp,O,1816.0,and Lactobacillus spp .
52899,.,O,1816.0,and Lactobacillus spp .
52910,Cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52911,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52912,oregano,B-http://purl.obolibrary.org/obo/FOODON_03301482;http://purl.obolibrary.org/obo/NCBITaxon_39352,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52913,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52914,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52915,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52916,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52917,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52918,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52919,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52920,Fusobacterium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52921,strains,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52922,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52923,cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52924,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52925,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52926,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52927,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52928,turmeric,B-http://purl.obolibrary.org/obo/NCBITaxon_136217;http://purl.obolibrary.org/obo/FOODON_00003753,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52929,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52930,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52931,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52932,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52933,Clostridium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52934,spp,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52935,.,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
53259,However,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53260,",",O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53261,the,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53262,insulinaemic,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53263,response,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53264,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53265,mashed,B-http://purl.obolibrary.org/obo/FOODON_03302333;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53266,potato,I-http://purl.obolibrary.org/obo/FOODON_03302333;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53267,with,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53268,chicken,B-http://purl.obolibrary.org/obo/FOODON_00002703;http://purl.obolibrary.org/obo/FOODON_03303012;http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53269,breast,I-http://purl.obolibrary.org/obo/FOODON_00002703;http://purl.obolibrary.org/obo/FOODON_03303012;http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53270,and,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53271,rapeseed,B-http://purl.obolibrary.org/obo/FOODON_03310482;http://purl.obolibrary.org/obo/FOODON_00003407;http://purl.obolibrary.org/obo/FOODON_03310387,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53272,oil,I-http://purl.obolibrary.org/obo/FOODON_03310482;http://purl.obolibrary.org/obo/FOODON_00003407;http://purl.obolibrary.org/obo/FOODON_03310387,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53273,was,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53274,lower,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53275,than,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53276,that,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53277,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53278,mashed,B-http://purl.obolibrary.org/obo/FOODON_03302333;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53279,potato,I-http://purl.obolibrary.org/obo/FOODON_03302333;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53280,alone,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53281,.,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53356,The,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53357,aim,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53358,of,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53359,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53360,study,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53361,was,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53362,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53363,investigate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53364,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53365,nutritional,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53366,status,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53367,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53368,adherence,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53369,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53370,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53371,Mediterranean,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53372,Diet,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53373,(,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53374,MD,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53375,),O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53376,in,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53377,GEP,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53378,-,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53379,NET,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53380,patients,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53381,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53382,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53383,correlate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53384,them,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53385,with,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53386,tumor,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53387,aggressiveness,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53388,.,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53731,Ketogenic,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53732,diets,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53733,appear,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53734,to,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53735,be,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53736,more,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53737,effective,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53738,than,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53739,low,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53740,-,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53741,fat,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53742,diets,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53743,for,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53744,treatment,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53745,of,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53746,obesity,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53747,and,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53748,diabetes,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53749,.,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53970,The,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53971,aim,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53972,of,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53973,this,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53974,work,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53975,was,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53976,to,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53977,study,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53978,the,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53979,relationship,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53980,between,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53981,water,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53982,stress,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53983,",",O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53984,color,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53985,and,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53986,polyphenols,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53987,in,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53988,hydroSOStainable,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53989,almonds,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
53990,.,O,1860.0,"The aim of this work was to study the relationship between water stress , color and polyphenols in hydroSOStainable almonds ."
54083,Hazard,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54084,ratios,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54085,for,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54086,dietary,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54087,factors,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54088,were,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54089,calculated,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54090,by,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54091,Cox,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54092,'s,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54093,proportional,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54094,hazards,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54095,model,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54096,.,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54254,The,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54255,clinical,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54256,features,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54257,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54258,84,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54259,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54260,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54261,rhinitis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54262,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54263,asthma,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54264,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54265,urticaria,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54266,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54267,and/or,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54268,anaphylaxis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54269,whose,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54270,inhalant,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54271,allergy,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54272,was,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54273,exclusively,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54274,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54275,Artemisia,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54276,vulgaris,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54277,were,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54278,studied,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54279,and,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54280,compared,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54281,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54282,a,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54283,control,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54284,group,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54285,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54286,50,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54287,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54288,monosensitized,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54289,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54290,grass,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54291,pollen,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54292,.,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54293,The,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54294,mean,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54295,age,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54296,for,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54297,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54298,beginning,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54299,of,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54300,symptoms,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54301,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54302,30.2,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54303,years,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54304,",",O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54305,and,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54306,this,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54307,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54308,higher,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54309,than,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54310,in,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54311,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54312,control,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54313,group,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54314,(,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54315,P,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54316,<,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54317,0.05,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54318,),O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54319,.,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54531,The,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54532,relation,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54533,between,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54534,vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54535,and,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54536,fruit,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54537,consumption,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54538,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54539,colorectal,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54540,cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54541,risk,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54542,was,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54543,comprehensively,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54544,assessed,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54545,in,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54546,the,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54547,Netherlands,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54548,Cohort,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54549,Study,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54550,on,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54551,Diet,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54552,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54553,Cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54554,using,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54555,a,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54556,validated,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54557,150,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54558,-,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54559,item,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54560,food,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54561,frequency,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54562,questionnaire,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54563,.,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
55017,Positively,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55018,tested,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55019,edibles,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55020,were,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55021,staple,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55022,foods,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55023,such,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55024,as,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55025,maize,B-http://purl.obolibrary.org/obo/NCBITaxon_4577;http://purl.obolibrary.org/obo/NCBITaxon_381124,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55026,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55027,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55028,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55029,wheat,B-http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55030,flour,I-http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55031,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55032,millet,B-http://purl.obolibrary.org/obo/FOODON_03309702,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55033,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55034,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55035,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55036,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55037,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55038,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55039,also,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55040,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55041,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55042,popcorn,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55043,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55044,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55045,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55046,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55047,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55048,pineapple,B-http://purl.obolibrary.org/obo/FOODON_03301831;http://purl.obolibrary.org/obo/NCBITaxon_4615,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55049,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55050,kiwi,B-http://purl.obolibrary.org/obo/FOODON_03414363,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55051,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55052,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55053,apples,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55054,.,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55055,No,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55056,myosmine,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55057,was,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55058,detectable,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55059,in,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55060,other,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55061,vegetables,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55062,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55063,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55064,such,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55065,as,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55066,lettuce,B-http://purl.obolibrary.org/obo/FOODON_00003423;http://purl.obolibrary.org/obo/FOODON_00001998;http://purl.obolibrary.org/obo/FOODON_00003507,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55067,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55068,spinach,B-http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55069,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55070,cucumber,B-http://purl.obolibrary.org/obo/NCBITaxon_3659;http://purl.obolibrary.org/obo/FOODON_00003415;http://purl.obolibrary.org/obo/FOODON_03301545,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55071,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55072,onion,B-http://purl.obolibrary.org/obo/NCBITaxon_4679;http://purl.obolibrary.org/obo/FOODON_03301704,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55073,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55074,banana,B-http://purl.obolibrary.org/obo/FOODON_03311513;http://purl.obolibrary.org/obo/FOODON_03316257;http://purl.obolibrary.org/obo/NCBITaxon_4641,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55075,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55076,tangerines,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55077,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55078,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55079,grapes,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55080,.,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55152,Polyphenols,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55153,from,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55154,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55155,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55156,guava,B-http://purl.obolibrary.org/obo/FOODON_00003622;http://purl.obolibrary.org/obo/NCBITaxon_120290;http://purl.obolibrary.org/obo/FOODON_03305317,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55157,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55158,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55159,whortleberry,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55160,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55161,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55162,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55163,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55164,propolis,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55165,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55166,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55167,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55168,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55169,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55170,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55171,grape,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55172,seed,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55173,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55174,and,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55175,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55176,have,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55177,been,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55178,reported,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55179,to,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55180,show,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55181,anti,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55182,-,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55183,diabetic,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55184,effects,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55185,in,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55186,T2D,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55187,patients,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55188,through,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55189,increasing,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55190,glucose,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55191,metabolism,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55192,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55193,improving,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55194,vascular,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55195,function,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55196,as,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55197,well,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55198,as,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55199,reducing,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55200,insulin,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55201,resistance,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55202,and,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55203,HbA1c,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55204,level,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55205,.,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55896,This,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55897,review,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55898,aims,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55899,to,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55900,characterize,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55901,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55902,assess,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55903,food,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55904,consumption,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55905,patterns,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55906,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55907,nutrient,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55908,intakes,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55909,amongst,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55910,school,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55911,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55912,aged,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55913,children,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55914,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55915,5,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55916,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55917,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55918,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55919,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55920,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55921,adolescents,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55922,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55923,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55924,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55925,19,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55926,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55927,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55928,in,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55929,countries,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55930,of,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55931,the,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55932,EMR,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55933,.,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
56222,In,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56223,subgroup,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56224,analyses,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56225,restricted,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56226,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56227,38,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56228,normal,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56229,weight,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56230,women,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56231,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56232,women,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56233,in,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56234,the,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56235,intervention,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56236,group,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56237,compared,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56238,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56239,control,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56240,group,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56241,had,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56242,a,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56243,significant,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56244,decline,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56245,in,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56246,estrone,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56247,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56248,pg,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56249,/,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56250,mL,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56251,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56252,and,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56253,testosterone,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56254,levels,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56255,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56256,pg,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56257,/,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56258,mL,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56259,):,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56260,pomegranate,B-http://purl.obolibrary.org/obo/NCBITaxon_22663;http://purl.obolibrary.org/obo/FOODON_00003066,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56261,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56262,-61.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56263,[,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56264,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56265,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56266,confidence,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56267,interval,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56268,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56269,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56270,):,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56271,-175.8,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56272,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56273,52.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56274,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56275,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56276,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56277,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56278,1.1,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56279,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56280,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56281,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56282,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56283,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56284,-5.4,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56285,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56286,7.7,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56287,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56288,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56289,P,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56290,=,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56291,0.05,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56292,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56293,and,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56294,pomegranate,B-http://purl.obolibrary.org/obo/NCBITaxon_22663;http://purl.obolibrary.org/obo/FOODON_00003066,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56295,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56296,-289.1,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56297,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56298,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56299,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56300,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56301,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56302,-630.7,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56303,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56304,52.5,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56305,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56306,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56307,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56308,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56309,79.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56310,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56311,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56312,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56313,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56314,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56315,-77.8,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56316,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56317,236.9,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56318,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56319,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56320,P,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56321,=,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56322,0.03,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56323,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56324,respectively,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56325,.,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56495,The,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56496,oxidation,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56497,level,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56498,used,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56499,in,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56500,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56501,study,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56502,did,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56503,not,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56504,alter,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56505,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56506,gelatinization,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56507,temperature,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56508,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56509,most,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56510,starches,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56511,",",O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56512,but,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56513,increased,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56514,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56515,peak,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56516,pasting,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56517,viscosity,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56518,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56519,both,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56520,types,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56521,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56522,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56523,and,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56524,rice,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56525,starches,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56526,and,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56527,decreased,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56528,that,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56529,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56530,tapioca,B-http://purl.obolibrary.org/obo/FOODON_03307663;http://purl.obolibrary.org/obo/NCBITaxon_3983;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56531,and,I-http://purl.obolibrary.org/obo/FOODON_03307663;http://purl.obolibrary.org/obo/NCBITaxon_3983;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56532,potato,I-http://purl.obolibrary.org/obo/FOODON_03307663;http://purl.obolibrary.org/obo/NCBITaxon_3983;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56533,starches,I-http://purl.obolibrary.org/obo/FOODON_03307663;http://purl.obolibrary.org/obo/NCBITaxon_3983;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56534,.,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56755,This,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56756,review,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56757,summarizes,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56758,critical,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56759,information,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56760,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56761,nutritional,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56762,profiles,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56763,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56764,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56765,and,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56766,their,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56767,processed,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56768,products,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56769,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56770,describes,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56771,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56772,state,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56773,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56774,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56775,science,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56776,relative,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56777,to,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56778,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56779,influence,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56780,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56781,in,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56782,-,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56783,home,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56784,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56785,common,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56786,commercial,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56787,processing,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56788,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56789,nutritional,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56790,quality,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56791,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56792,potential,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56793,impacts,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56794,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56795,human,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56796,health,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56797,.,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56959,Different,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56960,studies,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56961,have,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56962,compared,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56963,the,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56964,benefits,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56965,of,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56966,omnivorous,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56967,and,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56968,vegetarian,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56969,diets,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
56970,.,O,1966.0,Different studies have compared the benefits of omnivorous and vegetarian diets .
57018,The,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57019,aim,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57020,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57021,this,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57022,expert,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57023,opinion,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57024,recommendation,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57025,was,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57026,to,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57027,elucidate,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57028,the,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57029,different,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57030,impact,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57031,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57032,animal,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57033,vs,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57034,vegetable,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57035,protein,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57036,on,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57037,modifying,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57038,cardiometabolic,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57039,risk,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57040,factors,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57041,.,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57093,Red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57094,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57095,intake,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57096,correlates,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57097,with,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57098,increased,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57099,CVD,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57100,risk,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57101,",",O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57102,mainly,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57103,because,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57104,of,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57105,its,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57106,non,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57107,-,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57108,protein,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57109,ingredients,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57110,(,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57111,saturated,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57112,fats,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57113,),O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57114,.,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57165,Apart,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57166,from,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57167,meat,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57168,",",O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57169,other,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57170,animal,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57171,-,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57172,source,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57173,proteins,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57174,",",O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57175,like,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57176,those,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57177,found,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57178,in,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57179,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57180,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57181,(,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57182,especially,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57183,whey,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57184,protein,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57185,),O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57186,are,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57187,inversely,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57188,correlated,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57189,to,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57190,hypertension,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57191,",",O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57192,obesity,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57193,and,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57194,insulin,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57195,resistance,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57196,.,O,1975.0,"Apart from meat , other animal - source proteins , like those found in dairy products ( especially whey protein ) are inversely correlated to hypertension , obesity and insulin resistance ."
57353,Three,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57354,-,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57355,fourths,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57356,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57357,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57358,participants,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57359,had,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57360,a,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57361,family,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57362,history,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57363,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57364,at,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57365,least,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57366,one,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57367,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57368,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57369,life,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57370,-,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57371,style,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57372,diseases,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57373,addressed,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57374,by,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57375,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57376,course,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57377,.,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57548,We,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57549,recruited,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57550,65,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57551,Saharawi,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57552,type,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57553,II,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57554,diabetic,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57555,women,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57556,taking,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57557,orally,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57558,glucose,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57559,-,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57560,lowering,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57561,drugs,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57562,only,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57563,.,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57564,Dietary,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57565,habits,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57566,were,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57567,investigated,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57568,using,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57569,qualitative,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57570,24,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57571,h,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57572,recall,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57573,carried,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57574,out,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57575,over,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57576,three,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57577,non,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57578,-,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57579,consecutive,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57580,days,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57581,.,O,1992.0,Dietary habits were investigated using qualitative 24 h recall carried out over three non - consecutive days .
57668,Women,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57669,in,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57670,the,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57671,higher,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57672,tertile,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57673,of,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57674,adherence,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57675,to,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57676,the,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57677,unhealthy,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57678,dietary,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57679,pattern,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57680,had,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57681,a,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57682,higher,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57683,homeostatic,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57684,model,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57685,assessment,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57686,for,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57687,insulin,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57688,resistance,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57689,(,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57690,HOMA,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57691,),O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57692,index,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57693,(,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57694,b,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57695,=,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57696,2.49,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57697,;,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57698,95,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57699,%,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57700,CI,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57701,:,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57702,0.41,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57703,-,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57704,4.57,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57705,;,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57706,While,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57707,differences,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57708,in,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57709,glucose,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57710,and,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57711,insulin,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57712,responses,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57713,to,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57714,specific,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57715,carbohydrate,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57716,foods,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57717,have,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57718,been,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57719,reported,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57720,",",O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57721,few,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57722,data,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57723,are,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57724,available,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57725,for,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57726,mixed,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57727,meals,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57728,incorporating,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57729,such,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57730,foods,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57731,.,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57809,The,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57810,postprandial,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57811,PG,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57812,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57813,SI,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57814,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57815,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57816,CP,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57817,responses,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57818,to,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57819,two,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57820,of,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57821,the,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57822,test,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57823,breakfasts,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57824,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57825,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57826,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57827,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57828,eggs,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57829,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57830,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57831,wholemeal,B-http://purl.obolibrary.org/obo/FOODON_03301119,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57832,bread,I-http://purl.obolibrary.org/obo/FOODON_03301119,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57833,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57834,orange,B-http://purl.obolibrary.org/obo/FOODON_03301103;http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/FOODON_03315552,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57835,juice,I-http://purl.obolibrary.org/obo/FOODON_03301103;http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/FOODON_03315552,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57836,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57837,margarine,B-http://purl.obolibrary.org/obo/FOODON_03301672,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57838,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57839,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57840,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57841,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57842,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57843,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57844,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57845,wheatflake,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57846,biscuits,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57847,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57848,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57849,wholemeal,B-http://purl.obolibrary.org/obo/FOODON_03301119,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57850,bread,I-http://purl.obolibrary.org/obo/FOODON_03301119,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57851,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57852,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57853,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57854,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57855,margarine,B-http://purl.obolibrary.org/obo/FOODON_03301672,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57856,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57857,were,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57858,similar,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57859,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57860,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57861,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57862,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57863,104.3,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57864,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57865,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57866,23.0,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57867,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57868,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57869,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57870,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57871,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57872,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57873,5996,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57874,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57875,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57876,1108,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57877,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57878,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57879,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57880,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57881,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57882,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57883,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57884,89.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57885,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57886,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57887,25.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57888,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57889,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57890,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57891,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57892,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57893,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57894,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57895,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57896,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57897,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57898,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57899,104.9,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57900,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57901,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57902,21.6,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57903,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57904,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57905,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57906,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57907,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57908,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57909,6268,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57910,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57911,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57912,1161,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57913,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57914,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57915,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57916,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57917,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57918,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57919,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57920,99.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57921,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57922,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57923,26.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57924,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57925,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57926,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57927,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57928,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57929,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57930,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57931,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57932,.,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
58435,UPF,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58436,and,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58437,UPF,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58438,subgroups,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58439,were,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58440,categorised,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58441,according,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58442,to,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58443,the,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58444,distribution,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58445,of,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58446,their,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58447,contribution,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58448,to,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58449,total,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58450,energy,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58451,intake,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58452,.,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58794,Whether,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58795,these,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58796,milk,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58797,bioactive,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58798,components,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58799,will,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58800,replace,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58801,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58802,entirely,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58803,in,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58804,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58805,immediate,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58806,future,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58807,is,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58808,still,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58809,unclear,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58810,",",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58811,but,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58812,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58813,increasing,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58814,appreciation,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58815,of,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58816,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58817,drug,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58818,foods,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58819,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58820,or,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58821,nutraceuticals,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58822,plays,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58823,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58824,complementary,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58825,rather,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58826,than,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58827,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58828,substitutional,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58829,role,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58830,to,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58831,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58832,synthetic,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58833,pharmacological,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58834,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58835,.,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
59433,Olive,B-http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59434,and,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59435,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59436,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59437,",",O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59438,a,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59439,traditional,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59440,food,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59441,product,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59442,with,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59443,thousands,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59444,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59445,years,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59446,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59447,history,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59448,",",O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59449,are,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59450,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59451,essential,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59452,components,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59453,of,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59454,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59455,Mediterranean,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59456,diet,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59457,and,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59458,are,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59459,largely,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59460,consumed,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59461,in,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59462,the,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59463,world,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
59464,.,O,2057.0,"Olive and olive oil , a traditional food product with thousands of years of history , are the essential components of the Mediterranean diet and are largely consumed in the world ."
60614,The,O,2101.0,The ranked data were analyzed using analysis of variance .
60615,ranked,O,2101.0,The ranked data were analyzed using analysis of variance .
60616,data,O,2101.0,The ranked data were analyzed using analysis of variance .
60617,were,O,2101.0,The ranked data were analyzed using analysis of variance .
60618,analyzed,O,2101.0,The ranked data were analyzed using analysis of variance .
60619,using,O,2101.0,The ranked data were analyzed using analysis of variance .
60620,analysis,O,2101.0,The ranked data were analyzed using analysis of variance .
60621,of,O,2101.0,The ranked data were analyzed using analysis of variance .
60622,variance,O,2101.0,The ranked data were analyzed using analysis of variance .
60623,.,O,2101.0,The ranked data were analyzed using analysis of variance .
60652,There,O,2103.0,There was no significant difference between genders .
60653,was,O,2103.0,There was no significant difference between genders .
60654,no,O,2103.0,There was no significant difference between genders .
60655,significant,O,2103.0,There was no significant difference between genders .
60656,difference,O,2103.0,There was no significant difference between genders .
60657,between,O,2103.0,There was no significant difference between genders .
60658,genders,O,2103.0,There was no significant difference between genders .
60659,.,O,2103.0,There was no significant difference between genders .
61156,Male,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61157,ZDF,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61158,rats,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61159,were,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61160,fed,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61161,a,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61162,control,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61163,or,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61164,cocoa,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61165,-,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61166,rich,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61167,diet,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61168,(,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61169,10,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61170,%,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61171,),O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61172,",",O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61173,and,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61174,Zucker,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61175,lean,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61176,animals,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61177,received,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61178,the,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61179,control,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61180,diet,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61181,.,O,2123.0,"Male ZDF rats were fed a control or cocoa - rich diet ( 10 % ) , and Zucker lean animals received the control diet ."
61383,This,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61384,review,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61385,considers,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61386,whether,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61387,current,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61388,intakes,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61389,of,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61390,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61391,are,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61392,harmful,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61393,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61394,health,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61395,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61396,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61397,analyses,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61398,recent,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61399,literature,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61400,using,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61401,a,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61402,systematic,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61403,approach,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61404,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61405,collate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61406,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61407,rank,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61408,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61409,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61410,evaluate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61411,published,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61412,studies,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61413,from,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61414,1995,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61415,-,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61416,2006,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61417,.,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61418,Results,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61419,from,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61420,high,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61421,quality,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61422,obesity,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61423,studies,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61424,did,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61425,not,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61426,suggest,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61427,a,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61428,positive,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61429,association,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61430,between,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61431,body,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61432,mass,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61433,index,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61434,and,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61435,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61436,intake,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61437,.,O,2131.0,Results from high quality obesity studies did not suggest a positive association between body mass index and sugar intake .
61438,Some,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61439,studies,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61440,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61441,specifically,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61442,on,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61443,sweetened,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61444,beverages,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61445,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61446,highlighted,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61447,a,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61448,potential,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61449,concern,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61450,in,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61451,relation,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61452,to,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61453,obesity,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61454,risk,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61455,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61456,although,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61457,these,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61458,were,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61459,limited,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61460,by,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61461,important,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61462,methodological,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61463,issues,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61464,.,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61824,More,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61825,studies,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61826,are,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61827,required,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61828,in,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61829,animals,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61830,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61831,humans,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61832,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61833,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61834,kinetics,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61835,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61836,ginger,B-http://purl.obolibrary.org/obo/FOODON_00002718;http://purl.obolibrary.org/obo/FOODON_00003717;http://purl.obolibrary.org/obo/FOODON_00001901;http://purl.obolibrary.org/obo/NCBITaxon_94328,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61837,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61838,its,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61839,constituents,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61840,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61841,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61842,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61843,effects,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61844,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61845,their,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61846,consumption,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61847,over,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61848,a,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61849,long,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61850,period,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61851,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61852,time,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61853,.,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61886,Substantial,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61887,experimental,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61888,studies,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61889,indicated,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61890,that,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61891,many,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61892,dietary,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61893,natural,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61894,products,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61895,could,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61896,affect,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61897,the,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61898,development,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61899,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61900,progression,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61901,of,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61902,breast,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61903,cancer,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61904,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61905,such,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61906,as,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61907,soy,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61908,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61909,pomegranate,B-http://purl.obolibrary.org/obo/NCBITaxon_22663;http://purl.obolibrary.org/obo/FOODON_00003066,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61910,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61911,mangosteen,B-http://purl.obolibrary.org/obo/FOODON_00003110;http://purl.obolibrary.org/obo/FOODON_00003568,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61912,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61913,citrus,B-http://purl.obolibrary.org/obo/NCBITaxon_2706;http://purl.obolibrary.org/obo/FOODON_00001151;http://purl.obolibrary.org/obo/FOODON_03304644,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61914,fruits,I-http://purl.obolibrary.org/obo/NCBITaxon_2706;http://purl.obolibrary.org/obo/FOODON_00001151;http://purl.obolibrary.org/obo/FOODON_03304644,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61915,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61916,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61917,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61918,grape,B-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61919,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61920,mango,B-http://purl.obolibrary.org/obo/FOODON_00003538;http://purl.obolibrary.org/obo/NCBITaxon_29780;http://purl.obolibrary.org/obo/FOODON_03301813,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61921,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61922,cruciferous,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61923,vegetables,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61924,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61925,ginger,B-http://purl.obolibrary.org/obo/FOODON_00002718;http://purl.obolibrary.org/obo/FOODON_00003717;http://purl.obolibrary.org/obo/FOODON_00001901;http://purl.obolibrary.org/obo/NCBITaxon_94328,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61926,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61927,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61928,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61929,black,B-http://purl.obolibrary.org/obo/FOODON_00002966;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_00003024;http://purl.obolibrary.org/obo/FOODON_03311872;http://purl.obolibrary.org/obo/FOODON_00003396;http://purl.obolibrary.org/obo/NCBITaxon_52462,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61930,cumin,I-http://purl.obolibrary.org/obo/FOODON_00002966;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_00003024;http://purl.obolibrary.org/obo/FOODON_03311872;http://purl.obolibrary.org/obo/FOODON_00003396;http://purl.obolibrary.org/obo/NCBITaxon_52462,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61931,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61932,edible,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61933,macro,B-http://purl.obolibrary.org/obo/NCBITaxon_4751;http://purl.obolibrary.org/obo/FOODON_03411261,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61934,-,I-http://purl.obolibrary.org/obo/NCBITaxon_4751;http://purl.obolibrary.org/obo/FOODON_03411261,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61935,fungi,I-http://purl.obolibrary.org/obo/NCBITaxon_4751;http://purl.obolibrary.org/obo/FOODON_03411261,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61936,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61937,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61938,cereals,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61939,.,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
62418,Much,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62419,higher,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62420,RAST,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62421,uptakes,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62422,were,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62423,obtained,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62424,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62425,sera,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62426,from,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62427,four,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62428,asthmatic,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62429,bakers,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62430,when,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62431,tested,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62432,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62433,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62434,and,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62435,its,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62436,close,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62437,relatives,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62438,",",O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62439,but,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62440,there,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62441,was,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62442,still,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62443,reasonably,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62444,high,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62445,reactivity,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62446,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62447,more,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62448,distantly,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62449,related,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62450,cereals,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62451,.,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62551,Food,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62552,extracts,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62553,for,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62554,diagnostic,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62555,purposes,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62556,often,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62557,lack,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62558,sufficient,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62559,activity,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62560,and,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62561,consistency,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62562,.,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62733,The,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62734,storage,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62735,stability,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62736,of,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62737,skin,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62738,test,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62739,solutions,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62740,from,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62741,plant,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62742,foods,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62743,can,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62744,be,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62745,improved,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62746,by,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62747,avoiding,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62748,phenol,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62749,as,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62750,an,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62751,additive,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62752,and,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62753,by,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62754,including,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62755,50,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62756,%,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62757,of,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62758,glycerol,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62759,.,O,2178.0,The storage stability of skin test solutions from plant foods can be improved by avoiding phenol as an additive and by including 50 % of glycerol .
62760,For,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62761,model,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62762,studies,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62763,considering,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62764,neoallergens,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62765,",",O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62766,IgE,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62767,was,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62768,raised,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62769,in,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62770,mice,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62771,against,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62772,native,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62773,and,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62774,heated,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62775,celery,B-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781;http://purl.obolibrary.org/obo/PO_0025522;http://purl.obolibrary.org/obo/FOODON_00001146,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62776,tuber,I-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781;http://purl.obolibrary.org/obo/PO_0025522;http://purl.obolibrary.org/obo/FOODON_00001146,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62777,",",O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62778,respectively,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62779,.,O,2179.0,"For model studies considering neoallergens , IgE was raised in mice against native and heated celery tuber , respectively ."
62972,Components,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62973,varied,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62974,as,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62975,follows,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62976,:,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62977,4.94%-15.05,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62978,%,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62979,for,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62980,carob,B-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62981,germ,I-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62982,flour,I-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62983,",",O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62984,0.05%-3.75,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62985,%,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62986,HPMC,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62987,",",O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62988,and,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62989,65.25%-83.75,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62990,%,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62991,H₂O,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62992,(,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62993,percents,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62994,are,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62995,on,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62996,a,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62997,flour,B-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62998,basis,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
62999,",",O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63000,where,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63001,carob,B-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63002,germ,I-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63003,flour,I-http://purl.obolibrary.org/obo/FOODON_03301116,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63004,in,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63005,combination,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63006,with,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63007,maize,B-http://purl.obolibrary.org/obo/NCBITaxon_4577;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/CHEBI_28017,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63008,starch,I-http://purl.obolibrary.org/obo/NCBITaxon_4577;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/CHEBI_28017,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63009,equals,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63010,100,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63011,%,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63012,),O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63013,.,O,2186.0,"Components varied as follows : 4.94%-15.05 % for carob germ flour , 0.05%-3.75 % HPMC , and 65.25%-83.75 % H₂O ( percents are on a flour basis , where carob germ flour in combination with maize starch equals 100 % ) ."
63578,Response,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63579,surface,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63580,methodology,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63581,(,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63582,RSM,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63583,),O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63584,was,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63585,used,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63586,to,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63587,optimize,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63588,the,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63589,cooking,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63590,conditions,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63591,.,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63786,We,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63787,aimed,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63788,to,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63789,identify,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63790,dietary,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63791,patterns,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63792,in,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63793,a,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63794,Danish,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63795,adult,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63796,population,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63797,and,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63798,assess,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63799,the,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63800,reproducibility,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63801,of,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63802,the,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63803,dietary,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63804,patterns,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63805,identified,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
63806,.,O,2214.0,We aimed to identify dietary patterns in a Danish adult population and assess the reproducibility of the dietary patterns identified .
64343,At,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64344,birth,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64345,",",O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64346,calves,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64347,are,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64348,functionally,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64349,monogastric,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64350,and,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64351,remain,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64352,so,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64353,for,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64354,the,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64355,first,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64356,weeks,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64357,of,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64358,life,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64359,.,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64401,The,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64402,aim,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64403,of,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64404,this,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64405,study,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64406,was,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64407,to,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64408,use,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64409,radiography,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64410,to,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64411,estimate,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64412,the,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64413,lowest,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64414,milk,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64415,temperature,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64416,that,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64417,can,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64418,be,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64419,given,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64420,to,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64421,dairy,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64422,calves,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64423,at,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64424,high,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64425,and,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64426,low,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64427,intake,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64428,rates,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64429,without,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64430,causing,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64431,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64432,in,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64433,the,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64434,rumen,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
64435,.,O,2239.0,The aim of this study was to use radiography to estimate the lowest milk temperature that can be given to dairy calves at high and low intake rates without causing milk in the rumen .
65159,The,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65160,low,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65161,rate,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65162,of,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65163,coronary,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65164,heart,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65165,disease,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65166,(,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65167,CHD,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65168,),O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65169,in,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65170,France,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65171,compared,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65172,with,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65173,other,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65174,developed,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65175,countries,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65176,with,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65177,comparable,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65178,dietary,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65179,intake,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65180,has,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65181,been,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65182,called,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65183,the,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65184,French,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65185,paradox,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65186,.,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65292,Beer,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65293,and,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65294,spirits,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65295,were,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65296,only,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65297,weakly,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65298,inversely,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65299,correlated,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65300,with,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65301,CHD,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65302,.,O,2275.0,Beer and spirits were only weakly inversely correlated with CHD .
65350,Although,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65351,light,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65352,to,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65353,moderate,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65354,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65355,consumption,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65356,may,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65357,improve,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65358,longevity,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65359,",",O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65360,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65361,abuse,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65362,--,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65363,which,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65364,sharply,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65365,reduces,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65366,longevity,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65367,--,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65368,is,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65369,correlated,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65370,with,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65371,average,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65372,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65373,consumption,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65374,in,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65375,populations,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65376,.,O,2279.0,"Although light to moderate alcohol consumption may improve longevity , alcohol abuse -- which sharply reduces longevity -- is correlated with average alcohol consumption in populations ."
65406,Although,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65407,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65408,is,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65409,often,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65410,cited,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65411,as,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65412,an,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65413,allergenic,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65414,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65415,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65416,very,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65417,few,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65418,studies,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65419,have,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65420,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65421,devoted,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65422,to,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65423,the,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65424,identification,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65425,of,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65426,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65427,allergens,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65428,and,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65429,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65430,allergy,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65431,has,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65432,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65433,rarely,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65434,confirmed,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65435,by,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65436,double,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65437,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65438,blind,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65439,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65440,placebo,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65441,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65442,controlled,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65443,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65444,challenge,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65445,(,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65446,DBPCFC,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65447,),O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65448,.,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65796,Our,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65797,results,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65798,do,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65799,not,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65800,support,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65801,a,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65802,positive,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65803,association,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65804,between,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65805,total,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65806,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65807,",",O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65808,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65809,and,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65810,prostate,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65811,cancer,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65812,.,O,2295.0,"Our results do not support a positive association between total alcohol , coffee and prostate cancer ."
65980,While,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65981,Plenish,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65982,induced,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65983,less,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65984,insulin,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65985,resistance,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65986,than,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65987,conventional,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65988,soybean,B-http://purl.obolibrary.org/obo/FOODON_03302776;http://purl.obolibrary.org/obo/FOODON_03310387,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65989,oil,I-http://purl.obolibrary.org/obo/FOODON_03302776;http://purl.obolibrary.org/obo/FOODON_03310387,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65990,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65991,it,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65992,resulted,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65993,in,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65994,hepatomegaly,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65995,and,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65996,liver,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65997,dysfunction,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65998,as,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65999,did,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66000,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66001,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66002,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66003,which,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66004,has,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66005,a,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66006,similar,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66007,fatty,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66008,acid,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66009,composition,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66010,.,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66332,There,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66333,is,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66334,accumulating,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66335,evidence,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66336,that,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66337,much,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66338,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66339,the,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66340,health,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66341,-,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66342,promoting,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66343,potential,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66344,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66345,these,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66346,plant,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66347,foods,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66348,may,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66349,come,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66350,from,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66351,phytochemicals,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66352,",",O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66353,bioactive,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66354,compounds,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66355,not,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66356,designated,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66357,as,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66358,traditional,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66359,nutrients,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66360,.,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66425,Furthermore,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66426,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66427,strawberry,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66428,extracts,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66429,have,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66430,been,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66431,shown,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66432,to,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66433,inhibit,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66434,COX,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66435,enzymes,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66436,in,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66437,vitro,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66438,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66439,which,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66440,would,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66441,modulate,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66442,the,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66443,inflammatory,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66444,process,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66445,.,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66496,Cancer,O,2322.0,Cancer is one of the leading causes of death worldwide .
66497,is,O,2322.0,Cancer is one of the leading causes of death worldwide .
66498,one,O,2322.0,Cancer is one of the leading causes of death worldwide .
66499,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66500,the,O,2322.0,Cancer is one of the leading causes of death worldwide .
66501,leading,O,2322.0,Cancer is one of the leading causes of death worldwide .
66502,causes,O,2322.0,Cancer is one of the leading causes of death worldwide .
66503,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66504,death,O,2322.0,Cancer is one of the leading causes of death worldwide .
66505,worldwide,O,2322.0,Cancer is one of the leading causes of death worldwide .
66506,.,O,2322.0,Cancer is one of the leading causes of death worldwide .
66539,Genotoxins,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66540,are,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66541,also,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66542,involved,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66543,in,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66544,the,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66545,pathogenesis,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66546,of,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66547,several,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66548,chronic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66549,degenerative,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66550,diseases,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66551,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66552,including,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66553,hepatic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66554,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66555,neurodegenerative,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66556,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66557,and,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66558,cardiovascular,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66559,disorders,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66560,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66561,diabetes,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66562,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66563,arthritis,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66564,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66565,cancer,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66566,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66567,chronic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66568,inflammation,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66569,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66570,and,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66571,ageing,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66572,.,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66709,An,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66710,association,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66711,between,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66712,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66713,consumption,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66714,and,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66715,prostate,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66716,cancer,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66717,risk,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66718,remains,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66719,uncertain,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66720,.,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66904,Red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66905,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66906,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66907,liquor,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66908,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66909,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66910,beer,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66911,were,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66912,not,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66913,associated,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66914,with,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66915,prostate,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66916,cancer,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66917,nor,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66918,was,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66919,total,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66920,alcohol,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66921,consumed,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66922,at,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66923,ages,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66924,18,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66925,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66926,30,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66927,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66928,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66929,45,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66930,.,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66931,Associations,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66932,of,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66933,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66934,use,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66935,with,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66936,prostate,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66937,cancer,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66938,are,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66939,modest,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66940,and,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66941,complex,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66942,.,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
67206,Boiling,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67207,red,B-http://purl.obolibrary.org/obo/FOODON_00003077;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023;http://purl.obolibrary.org/obo/FOODON_03301641,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67208,rice,I-http://purl.obolibrary.org/obo/FOODON_00003077;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023;http://purl.obolibrary.org/obo/FOODON_03301641,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67209,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67210,ghee,B-http://purl.obolibrary.org/obo/FOODON_03310185,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67211,or,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67212,cooking,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67213,red,B-http://purl.obolibrary.org/obo/FOODON_00003077;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023;http://purl.obolibrary.org/obo/FOODON_03301641,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67214,rice,I-http://purl.obolibrary.org/obo/FOODON_00003077;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023;http://purl.obolibrary.org/obo/FOODON_03301641,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67215,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67216,ghee,B-http://purl.obolibrary.org/obo/FOODON_03310185,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67217,pilaf,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67218,-,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67219,style,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67220,may,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67221,provide,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67222,beneficial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67223,effects,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67224,on,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67225,postprandial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67226,blood,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67227,glucose,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67228,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67229,insulin,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67230,concentrations,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67231,",",O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67232,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67233,improve,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67234,colonic,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67235,health,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67236,.,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67417,Among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67418,men,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67419,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67420,the,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67421,risk,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67422,of,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67423,stomach,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67424,cancer,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67425,was,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67426,significantly,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67427,elevated,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67428,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67429,current,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67430,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67431,(,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67432,OR,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67433,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67434,1.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67435,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67436,95,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67437,%,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67438,CI,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67439,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67440,1.1,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67441,-,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67442,2.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67443,),O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67444,but,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67445,not,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67446,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67447,former,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67448,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67449,.,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67511,Alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67512,consumption,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67513,was,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67514,not,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67515,clearly,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67516,related,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67517,to,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67518,risk,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67519,",",O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67520,and,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67521,no,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67522,association,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67523,was,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67524,found,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67525,for,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67526,drinking,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67527,regular,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67528,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67529,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67530,herbal,B-http://purl.obolibrary.org/obo/FOODON_03311585;http://purl.obolibrary.org/obo/FOODON_03315081,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67531,tea,I-http://purl.obolibrary.org/obo/FOODON_03311585;http://purl.obolibrary.org/obo/FOODON_03315081,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67532,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67533,using,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67534,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67535,/,I-http://purl.obolibrary.org/obo/UBERON_0001913,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67536,cream,I-http://purl.obolibrary.org/obo/UBERON_0001913,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67537,in,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67538,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67539,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67540,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67541,.,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67877,Amaranth,B-http://purl.obolibrary.org/obo/CHEBI_34533;http://purl.obolibrary.org/obo/NCBITaxon_3567,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67878,and,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67879,quinoa,B-http://purl.obolibrary.org/obo/NCBITaxon_63459;http://purl.obolibrary.org/obo/FOODON_03310193,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67880,have,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67881,been,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67882,cultivated,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67883,since,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67884,ancient,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67885,times,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67886,and,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67887,were,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67888,two,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67889,of,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67890,the,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67891,major,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67892,crops,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67893,of,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67894,the,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67895,Pre,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67896,-,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67897,Colombian,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67898,cultures,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67899,in,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67900,Latin-,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67901,America,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
67902,.,O,2371.0,Amaranth and quinoa have been cultivated since ancient times and were two of the major crops of the Pre - Colombian cultures in Latin- America .
68201,This,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68202,article,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68203,provides,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68204,a,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68205,concise,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68206,account,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68207,of,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68208,wheat,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68209,gluten,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68210,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68211,focusing,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68212,on,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68213,properties,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68214,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68215,and,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68216,features,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68217,which,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68218,are,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68219,relevant,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68220,to,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68221,its,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68222,role,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68223,in,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68224,triggering,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68225,coeliac,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68226,disease,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68227,and,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68228,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68229,to,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68230,a,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68231,lesser,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68232,extent,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68233,",",O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68234,other,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68235,gluten,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68236,-,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68237,related,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68238,disorders,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68239,.,O,2381.0,"This article provides a concise account of wheat gluten , focusing on properties , and features which are relevant to its role in triggering coeliac disease and , to a lesser extent , other gluten - related disorders ."
68592,In,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68593,this,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68594,large,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68595,prospective,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68596,cohort,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68597,",",O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68598,we,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68599,observed,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68600,an,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68601,association,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68602,between,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68603,dietary,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68604,cholesterol,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68605,and,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68606,type,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68607,2,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68608,diabetes,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68609,",",O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68610,but,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68611,no,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68612,association,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68613,with,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68614,egg,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68615,consumption,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68616,.,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
69352,Mixing,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69353,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69354,meals,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69355,significantly,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69356,increased,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69357,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69358,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69359,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69360,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69361,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69362,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69363,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69364,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69365,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69366,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69367,introduced,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69368,a,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69369,positive,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69370,correlation,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69371,between,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69372,glycemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69373,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69374,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69375,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69376,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69377,n,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69378,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69379,6,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69380,",",O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69381,r,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69382,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69383,0.903,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69384,;,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69385,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69386,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69387,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69388,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69389,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69390,.,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
70020,The,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70021,aim,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70022,of,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70023,this,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70024,study,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70025,was,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70026,to,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70027,evaluate,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70028,peanuts,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70029,and,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70030,its,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70031,products,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70032,as,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70033,sources,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70034,of,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70035,PS,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70036,in,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70037,the,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70038,American,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70039,diet,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70040,.,O,2440.0,The aim of this study was to evaluate peanuts and its products as sources of PS in the American diet .
70041,Roasted,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70042,peanuts,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70043,contain,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70044,61,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70045,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70046,114,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70047,mg,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70048,PS/100,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70049,g,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70050,depending,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70051,on,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70052,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70053,peanut,B-http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70054,variety,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70055,",",O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70056,78,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70057,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70058,83,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70059,%,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70060,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70061,which,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70062,is,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70063,in,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70064,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70065,form,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70066,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70067,beta,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70068,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70069,sitosterol,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70070,.,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70826,We,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70827,computed,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70828,flavonol,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70829,intakes,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70830,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70831,dietary,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70832,data,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70833,collected,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70834,by,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70835,validated,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70836,food,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70837,frequency,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70838,questionnaires,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70839,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70840,1991,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70841,and,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70842,1995,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70843,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70844,"90,630",O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70845,women,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70846,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70847,the,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70848,Nurses,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70849,Health,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70850,Study,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70851,II,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70852,.,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
71698,The,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71699,aim,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71700,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71701,this,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71702,study,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71703,was,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71704,to,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71705,test,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71706,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71707,effect,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71708,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71709,replacing,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71710,soybean,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71711,hulls,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71712,with,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71713,different,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71714,doses,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71715,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71716,cocoa,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71717,husk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71718,(,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71719,CH,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71720,),O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71721,on,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71722,milk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71723,production,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71724,traits,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71725,and,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71726,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71727,hematological,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71728,profile,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71729,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71730,dairy,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71731,ewes,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71732,.,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71799,In,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71800,the,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71801,second,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71802,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71803,",",O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71804,soybean,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71805,hulls,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71806,were,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71807,replaced,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71808,with,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71809,50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71810,g,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71811,of,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71812,CH,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71813,/,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71814,d,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71815,(,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71816,CH50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71817,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71818,),O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71819,.,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71941,Most,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71942,of,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71943,the,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71944,hematological,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71945,parameters,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71946,were,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71947,not,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71948,affected,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71949,by,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71950,treatments,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71951,except,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71952,for,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71953,basophiles,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71954,",",O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71955,which,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71956,were,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71957,significantly,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71958,higher,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71959,in,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71960,the,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71961,SBH,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71962,group,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71963,than,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71964,in,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71965,the,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71966,CH50,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71967,and,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71968,CH100,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71969,groups,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
71970,.,O,2503.0,"Most of the hematological parameters were not affected by treatments except for basophiles , which were significantly higher in the SBH group than in the CH50 and CH100 groups ."
72223,Quality,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72224,of,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72225,life,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72226,(,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72227,QoL,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72228,),O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72229,is,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72230,an,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72231,important,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72232,clinical,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72233,outcome,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72234,in,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72235,cancer,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72236,patients,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72237,.,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72397,Patients,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72398,following,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72399,a,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72400,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72401,Western,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72402,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72403,diet,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72404,had,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72405,lower,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72406,chances,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72407,to,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72408,improve,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72409,in,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72410,physical,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72411,functioning,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72412,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72413,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72414,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72415,0.45,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72416,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72417,0.21,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72418,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72419,0.99,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72420,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72421,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72422,",",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72423,constipation,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72424,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72425,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72426,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72427,0.30,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72428,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72429,0.13,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72430,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72431,0.72,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72432,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72433,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72434,and,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72435,diarrhea,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72436,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72437,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72438,:,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72439,0.44,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72440,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72441,0.20,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72442,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72443,0.98,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72444,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72445,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72446,over,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72447,time,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72448,.,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72876,Reduced,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72877,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72878,milk,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72879,was,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72880,the,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72881,most,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72882,commonly,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72883,consumed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72884,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72885,product,I-http://purl.obolibrary.org/obo/ENVO_00003862,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72886,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72887,235,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72888,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72889,200,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72890,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72891,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72892,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72893,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72894,",",O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72895,followed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72896,by,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72897,whole,B-http://purl.obolibrary.org/obo/UBERON_0001913,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72898,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72899,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72900,63,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72901,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72902,128,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72903,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72904,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72905,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72906,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72907,and,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72908,yoghurt,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72909,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72910,53,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72911,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72912,66,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72913,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72914,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72915,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72916,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72917,.,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
73415,The,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73416,medians,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73417,of,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73418,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73419,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73420,yogurt,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73421,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73422,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73423,consumption,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73424,were,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73425,293,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73426,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73427,interquartile,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73428,range,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73429,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73430,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73431,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73432,146,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73433,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73434,439,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73435,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73436,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73437,35·3,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73438,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73439,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73440,8·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73441,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73442,71·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73443,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73444,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73445,14·6,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73446,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73447,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73448,4·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73449,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73450,26·9,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73451,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73452,g,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73453,/,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73454,d,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73455,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73456,respectively,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73457,.,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73907,Preconception,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73908,food,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73909,frequency,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73910,data,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73911,were,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73912,collected,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73913,retrospectively,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73914,in,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73915,309,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73916,women,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73917,.,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73926,Perinatal,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73927,outcomes,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73928,were,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73929,collected,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73930,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73931,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73932,with,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73933,birth,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73934,weight,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73935,data,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73936,calculated,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73937,into,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73938,percentiles,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73939,to,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73940,assess,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73941,small,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73942,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73943,large,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73944,for,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73945,gestational,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73946,age,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73947,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73948,preterm,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73949,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73950,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73951,<,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73952,37,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73953,wk,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73954,.,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
74221,Poor,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74222,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74223,behaviors,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74224,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74225,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74226,periconceptional,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74227,period,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74228,could,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74229,be,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74230,altered,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74231,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74232,promote,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74233,behavior,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74234,change,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74235,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74236,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74237,intake,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74238,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74239,improve,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74240,perinatal,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74241,outcomes,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74242,and,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74243,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74244,long,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74245,-,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74246,term,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74247,health,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74248,of,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74249,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74250,child,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74251,.,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74782,Mandatory,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74783,folic,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74784,acid,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74785,fortification,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74786,of,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74787,wheat,B-http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74788,flour,I-http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/FOODON_03301116;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74789,for,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74790,making,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74791,bread,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74792,was,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74793,implemented,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74794,in,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74795,Australia,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74796,in,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74797,September,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74798,2009,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74799,",",O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74800,to,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74801,improve,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74802,the,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74803,dietary,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74804,folate,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74805,status,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74806,of,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74807,women,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74808,of,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74809,child,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74810,-,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74811,bearing,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74812,age,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74813,",",O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74814,and,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74815,help,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74816,reduce,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74817,the,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74818,incidence,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74819,of,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74820,neural,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74821,tube,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74822,defects,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74823,in,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74824,the,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74825,population,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
74826,.,O,2599.0,"Mandatory folic acid fortification of wheat flour for making bread was implemented in Australia in September 2009 , to improve the dietary folate status of women of child - bearing age , and help reduce the incidence of neural tube defects in the population ."
75551,It,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75552,is,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75553,therefore,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75554,concluded,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75555,that,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75556,the,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75557,dietary,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75558,intake,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75559,of,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75560,chloride,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75561,",",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75562,which,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75563,was,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75564,previously,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75565,considered,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75566,a,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75567,"""",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75568,mendicant,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75569,"""",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75570,ion,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75571,",",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75572,plays,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75573,a,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75574,crucial,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75575,role,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75576,in,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75577,acid,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75578,-,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75579,base,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75580,and,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75581,salt,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75582,balance,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75583,.,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75688,Although,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75689,fat,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75690,and,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75691,saturated,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75692,fat,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75693,intakes,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75694,increased,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75695,",",O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75696,these,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75697,changes,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75698,were,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75699,not,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75700,accompanied,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75701,by,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75702,an,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75703,increase,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75704,in,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75705,CHD,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75706,mortality,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75707,rates,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75708,.,O,2632.0,"Although fat and saturated fat intakes increased , these changes were not accompanied by an increase in CHD mortality rates ."
75741,Diet,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75742,appears,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75743,to,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75744,have,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75745,an,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75746,important,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75747,role,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75748,in,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75749,this,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75750,paradox,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75751,",",O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75752,but,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75753,it,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75754,may,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75755,not,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75756,be,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75757,as,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75758,critical,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75759,as,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75760,other,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75761,factors,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
75762,.,O,2634.0,"Diet appears to have an important role in this paradox , but it may not be as critical as other factors ."
76208,Although,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76209,dietary,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76210,factors,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76211,alone,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76212,may,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76213,not,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76214,fully,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76215,explain,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76216,the,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76217,excellent,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76218,health,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76219,of,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76220,Mediterranean,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76221,populations,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76222,",",O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76223,available,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76224,evidence,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76225,strongly,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76226,suggests,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76227,important,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76228,contributions,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76229,of,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76230,high,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76231,consumption,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76232,of,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76233,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76234,",",O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76235,vegetables,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76236,",",O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76237,and,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76238,whole,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76239,grains,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76240,;,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76241,moderate,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76242,intake,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76243,of,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76244,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76245,;,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76246,and,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76247,low,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76248,consumption,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76249,of,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76250,animal,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76251,products,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76252,",",O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76253,saturated,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76254,and,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76255,hydrogenated,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76256,fats,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76257,",",O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76258,and,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76259,refined,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76260,carbohydrates,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76261,.,O,2647.0,"Although dietary factors alone may not fully explain the excellent health of Mediterranean populations , available evidence strongly suggests important contributions of high consumption of fruit , vegetables , and whole grains ; moderate intake of alcohol ; and low consumption of animal products , saturated and hydrogenated fats , and refined carbohydrates ."
76568,We,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76569,hypothesized,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76570,that,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76571,dietary,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76572,factors,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76573,associated,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76574,with,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76575,breast,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76576,cancer,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76577,risk,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76578,might,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76579,differentially,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76580,influence,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76581,the,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76582,HER-2,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76583,status,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76584,of,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76585,the,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76586,cancers,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76587,that,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76588,develop,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76589,",",O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76590,and,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76591,investigated,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76592,this,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76593,hypothesis,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76594,by,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76595,analyzing,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76596,the,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76597,data,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76598,of,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76599,the,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76600,ORDET,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76601,prospective,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76602,study,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76603,.,O,2661.0,"We hypothesized that dietary factors associated with breast cancer risk might differentially influence the HER-2 status of the cancers that develop , and investigated this hypothesis by analyzing the data of the ORDET prospective study ."
76624,By,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76625,December,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76626,31,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76627,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76628,2001,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76629,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76630,238,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76631,cases,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76632,had,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76633,occurred,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76634,in,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76635,which,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76636,HER-2,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76637,status,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76638,was,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76639,known,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76640,.,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76985,In,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76986,this,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76987,high,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76988,-,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76989,risk,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76990,area,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76991,",",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76992,where,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76993,the,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76994,frequency,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76995,of,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76996,esophageal,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76997,cancer,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76998,is,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76999,higher,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77000,among,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77001,females,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77002,than,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77003,among,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77004,males,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77005,",",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77006,a,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77007,special,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77008,diet,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77009,known,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77010,as,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77011,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77012,majoweh,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77013,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77014,or,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77015,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77016,majum,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77017,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77018,is,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77019,given,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77020,to,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77021,pregnant,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77022,women,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77023,.,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77604,The,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77605,decreasing,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77606,mortality,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77607,rates,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77608,from,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77609,cerebrovascular,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77610,disease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77611,are,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77612,thought,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77613,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77614,reflect,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77615,the,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77616,increases,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77617,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77618,animal,B-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77619,foods,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77620,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77621,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77622,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77623,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77624,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77625,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77626,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77627,consequently,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77628,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77629,saturated,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77630,fatty,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77631,acids,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77632,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77633,calcium,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77634,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77635,together,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77636,with,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77637,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77638,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77639,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77640,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77641,intake,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77642,which,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77643,may,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77644,have,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77645,led,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77646,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77647,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77648,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77649,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77650,blood,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77651,pressure,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77652,.,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77653,This,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77654,decrease,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77655,in,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77656,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77657,and,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77658,highly,B-http://purl.obolibrary.org/obo/FOODON_03460173,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77659,salted,I-http://purl.obolibrary.org/obo/FOODON_03460173,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77660,foods,I-http://purl.obolibrary.org/obo/FOODON_03460173,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77661,also,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77662,seems,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77663,to,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77664,account,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77665,for,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77666,the,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77667,decrease,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77668,in,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77669,stomach,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77670,cancer,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77671,.,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77672,The,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77673,typical,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77674,Japanese,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77675,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77676,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77677,characterized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77678,by,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77679,plant,B-http://purl.obolibrary.org/obo/CHEBI_33290,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77680,food,I-http://purl.obolibrary.org/obo/CHEBI_33290,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77681,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77682,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77683,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77684,well,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77685,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77686,modest,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77687,Westernized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77688,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77689,such,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77690,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77691,meat,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77692,",",O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77693,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77694,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77695,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77696,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77697,might,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77698,be,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77699,associated,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77700,with,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77701,longevity,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77702,in,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77703,Japan,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77704,.,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
78107,Vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78108,but,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78109,not,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78110,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78111,consumption,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78112,was,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78113,found,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78114,to,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78115,possibly,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78116,exhibit,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78117,beneficial,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78118,effects,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78119,on,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78120,the,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78121,risk,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78122,of,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78123,EOC,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78124,",",O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78125,whereas,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78126,high,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78127,meat,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78128,consumption,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78129,may,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78130,be,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78131,associated,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78132,with,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78133,an,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78134,increased,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78135,risk,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78136,.,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78137,A,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78138,protective,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78139,effect,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78140,on,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78141,risk,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78142,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78143,EOC,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78144,for,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78145,whole,B-http://purl.obolibrary.org/obo/CHEBI_33290,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78146,-,I-http://purl.obolibrary.org/obo/CHEBI_33290,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78147,grain,I-http://purl.obolibrary.org/obo/CHEBI_33290,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78148,food,I-http://purl.obolibrary.org/obo/CHEBI_33290,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78149,consumption,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78150,as,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78151,well,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78152,as,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78153,for,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78154,consumption,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78155,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78156,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78157,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78158,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78159,milk,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78160,is,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78161,suggested,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78162,by,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78163,the,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78164,results,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78165,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78166,the,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78167,studies,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78168,.,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79016,Thus,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79017,the,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79018,present,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79019,study,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79020,gives,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79021,support,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79022,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79023,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79024,protective,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79025,effect,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79026,associated,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79027,with,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79028,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79029,fiber,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79030,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79031,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79032,or,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79033,vegetable,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79034,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79035,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79036,diet,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79037,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79038,while,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79039,it,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79040,indicates,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79041,that,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79042,frequent,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79043,consumption,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79044,of,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79045,refined,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79046,starchy,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79047,foods,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79048,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79049,eggs,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79050,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79051,fat,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79052,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79053,rich,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79054,foods,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79055,such,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79056,as,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79057,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79058,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79059,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79060,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79061,is,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79062,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79063,risk,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79064,factor,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79065,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79066,colo,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79067,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79068,rectal,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79069,cancer,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79070,.,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
80029,Orange,B-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80030,-,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80031,yellow,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80032,foods,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80033,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80034,including,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80035,oranges,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80036,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80037,tangerines,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80038,and,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80039,lemons,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80040,contain,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80041,citrus,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80042,flavonoids,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80043,.,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80462,The,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80463,current,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80464,study,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80465,aimed,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80466,to,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80467,investigate,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80468,the,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80469,role,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80470,of,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80471,cooking,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80472,with,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80473,mustard,B-http://purl.obolibrary.org/obo/FOODON_03301152;http://purl.obolibrary.org/obo/FOODON_03310387,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80474,oil,I-http://purl.obolibrary.org/obo/FOODON_03301152;http://purl.obolibrary.org/obo/FOODON_03310387,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80475,and,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80476,other,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80477,dietary,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80478,factors,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80479,in,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80480,relation,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80481,to,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80482,gallbladder,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80483,cancer,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80484,(,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80485,GBC,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80486,),O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80487,in,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80488,high-,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80489,and,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80490,low,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80491,-,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80492,incidence,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80493,regions,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80494,of,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80495,India,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80496,.,O,2785.0,The current study aimed to investigate the role of cooking with mustard oil and other dietary factors in relation to gallbladder cancer ( GBC ) in high- and low - incidence regions of India .
80950,The,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80951,total,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80952,lipid,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80953,release,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80954,was,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80955,comparable,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80956,between,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80957,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80958,after,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80959,the,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80960,in,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80961,vitro,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80962,intestinal,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80963,phase,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80964,(,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80965,P,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80966,>,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80967,0·05,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80968,),O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80969,.,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
81512,This,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81513,implies,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81514,that,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81515,fat,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81516,and,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81517,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81518,addition,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81519,could,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81520,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81521,avoided,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81522,in,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81523,foods,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81524,for,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81525,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81526,without,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81527,having,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81528,an,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81529,impact,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81530,on,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81531,palatability,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81532,",",O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81533,allowing,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81534,the,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81535,energy,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81536,density,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81537,of,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81538,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81539,'s,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81540,diet,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81541,to,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81542,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81543,limited,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81544,.,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81569,Levels,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81570,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81571,specific,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81572,serum,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81573,IgE,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81574,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81575,cow,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81576,'s,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81577,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81578,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81579,whole,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81580,hen,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81581,'s,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81582,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81583,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81584,egg,B-http://purl.obolibrary.org/obo/FOODON_03304840;http://purl.obolibrary.org/obo/UBERON_0008944;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81585,white,I-http://purl.obolibrary.org/obo/FOODON_03304840;http://purl.obolibrary.org/obo/UBERON_0008944;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81586,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81587,and,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81588,egg,B-http://purl.obolibrary.org/obo/UBERON_0007378;http://purl.obolibrary.org/obo/FOODON_03315772,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81589,yolk,I-http://purl.obolibrary.org/obo/UBERON_0007378;http://purl.obolibrary.org/obo/FOODON_03315772,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81590,were,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81591,compared,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81592,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81593,the,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81594,outcome,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81595,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81596,double,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81597,-,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81598,blind,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81599,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81600,placebo,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81601,-,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81602,controlled,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81603,food,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81604,challenge,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81605,(,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81606,DBPCFC,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81607,),O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81608,with,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81609,fresh,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81610,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81611,and/or,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81612,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81613,in,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81614,21,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81615,adults,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81616,with,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81617,a,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81618,case,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81619,history,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81620,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81621,immediate,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81622,hypersensitivity,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81623,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81624,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81625,and/or,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81626,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81627,.,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
82277,Gastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82278,pH,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82279,was,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82280,measured,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82281,with,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82282,a,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82283,noninvasive,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82284,intragastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82285,probe,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82286,",",O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82287,demonstrating,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82288,that,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82289,administration,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82290,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82291,125,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82292,mL,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82293,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82294,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82295,or,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82296,red,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82297,wine,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82298,to,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82299,healthy,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82300,volunteers,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82301,stimulated,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82302,gastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82303,acid,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82304,secretion,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82305,more,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82306,potently,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82307,than,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82308,the,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82309,administration,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82310,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82311,equivalent,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82312,amounts,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82313,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82314,ethanol,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82315,.,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82983,Both,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82984,heme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82985,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82986,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82987,and,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82988,nonheme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82989,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82990,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82991,were,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82992,higher,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82993,when,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82994,high,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82995,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82996,30,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82997,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82998,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82999,rather,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83000,than,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83001,low,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83002,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83003,5,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83004,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83005,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83006,dietary,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83007,fat,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83008,was,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83009,fed,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83010,.,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83240,No,O,2884.0,No significant increased risk was observed for occupational activities .
83241,significant,O,2884.0,No significant increased risk was observed for occupational activities .
83242,increased,O,2884.0,No significant increased risk was observed for occupational activities .
83243,risk,O,2884.0,No significant increased risk was observed for occupational activities .
83244,was,O,2884.0,No significant increased risk was observed for occupational activities .
83245,observed,O,2884.0,No significant increased risk was observed for occupational activities .
83246,for,O,2884.0,No significant increased risk was observed for occupational activities .
83247,occupational,O,2884.0,No significant increased risk was observed for occupational activities .
83248,activities,O,2884.0,No significant increased risk was observed for occupational activities .
83249,.,O,2884.0,No significant increased risk was observed for occupational activities .
83562,Because,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83563,the,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83564,Korean,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83565,rice,B-http://purl.obolibrary.org/obo/FOODON_03309985;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83566,cake,I-http://purl.obolibrary.org/obo/FOODON_03309985;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83567,",",O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83568,Seolgitteok,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83569,",",O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83570,is,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83571,mainly,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83572,prepared,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83573,with,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83574,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03301116,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83575,flour,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03301116,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83576,containing,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83577,no,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83578,gluten,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83579,-,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83580,protein,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83581,associated,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83582,with,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83583,celiac,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83584,disease,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83585,",",O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83586,it,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83587,can,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83588,be,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83589,considered,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83590,for,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83591,inclusion,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83592,in,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83593,a,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83594,gluten,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83595,-,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83596,free,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83597,diet,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83598,.,O,2897.0,"Because the Korean rice cake , Seolgitteok , is mainly prepared with rice flour containing no gluten - protein associated with celiac disease , it can be considered for inclusion in a gluten - free diet ."
83734,Moreover,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83735,",",O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83736,consumer,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83737,acceptability,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83738,of,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83739,Seolgitteok,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83740,varied,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83741,with,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83742,respect,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83743,to,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83744,nonsensory,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83745,factors,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83746,.,O,2903.0,"Moreover , consumer acceptability of Seolgitteok varied with respect to nonsensory factors ."
83815,Reduced,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83816,-,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83817,fat,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83818,food,B-http://purl.obolibrary.org/obo/CHEBI_33290,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83819,products,I-http://purl.obolibrary.org/obo/CHEBI_33290,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83820,can,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83821,help,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83822,to,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83823,prevent,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83824,obesity,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83825,and,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83826,other,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83827,diet,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83828,-,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83829,related,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83830,diseases,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
83831,.,O,2906.0,Reduced - fat food products can help to prevent obesity and other diet - related diseases .
84226,Consumption,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84227,of,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84228,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84229,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84230,fats,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84231,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84232,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84233,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84234,and,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84235,fluids,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84236,was,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84237,substantially,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84238,less,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84239,than,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84240,recommended,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84241,.,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84242,The,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84243,children,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84244,used,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84245,mostly,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84246,(,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84247,semi-)skimmed,B-http://purl.obolibrary.org/obo/UBERON_0001913,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84248,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84249,products,I-http://purl.obolibrary.org/obo/UBERON_0001913,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84250,and,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84251,non,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84252,-,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84253,refined,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84254,bread,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84255,and,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84256,cereals,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84257,",",O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84258,as,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84259,recommended,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84260,.,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
85520,Appropriate,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85521,nutritional,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85522,education,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85523,helps,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85524,children,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85525,with,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85526,diabetes,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85527,to,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85528,find,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85529,this,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85530,balance,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85531,and,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85532,enjoy,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85533,a,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85534,better,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85535,quality,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85536,of,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85537,life,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85538,.,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85693,Subsequent,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85694,16th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85695,to,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85696,early,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85697,20th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85698,century,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85699,manuscripts,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85700,produced,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85701,in,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85702,Europe,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85703,and,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85704,New,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85705,Spain,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85706,revealed,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85707,>,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85708,100,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85709,medicinal,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85710,uses,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85711,for,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85712,cacao,B-http://purl.obolibrary.org/obo/NCBITaxon_3641,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85713,/,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85714,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85715,.,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85775,Additional,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85776,medical,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85777,complaints,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85778,treated,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85779,with,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85780,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85781,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85782,cacao,B-http://purl.obolibrary.org/obo/NCBITaxon_3641,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85783,have,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85784,included,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85785,anemia,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85786,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85787,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85788,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85789,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85790,mental,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85791,fatigue,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85792,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85793,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85794,breast,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85795,milk,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85796,production,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85797,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85798,consumption,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85799,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85800,tuberculosis,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85801,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85802,fever,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85803,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85804,gout,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85805,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85806,kidney,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85807,stones,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85808,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85809,reduced,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85810,longevity,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85811,and,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85812,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85813,sexual,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85814,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85815,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85816,low,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85817,virility,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85818,.,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
86053,Preliminary,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86054,evidence,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86055,suggests,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86056,that,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86057,mushrooms,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86058,may,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86059,support,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86060,healthy,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86061,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86062,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86063,inflammatory,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86064,responses,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86065,through,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86066,interaction,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86067,with,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86068,the,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86069,gut,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86070,microbiota,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86071,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86072,enhancing,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86073,development,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86074,of,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86075,adaptive,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86076,immunity,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86077,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86078,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86079,improved,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86080,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86081,cell,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86082,functionality,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86083,.,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86407,The,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86408,peripheral,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86409,glucagon,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86410,concentration,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86411,was,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86412,decreased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86413,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86414,ingestion,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86415,of,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86416,glucose,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86417,alone,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86418,and,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86419,increased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86420,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86421,all,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86422,the,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86423,meals,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86424,containing,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86425,protein,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86426,.,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86568,After,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86569,adjusting,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86570,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86571,these,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86572,effects,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86573,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86574,case,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86575,-,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86576,control,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86577,differences,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86578,were,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86579,found,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86580,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86581,several,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86582,dietary,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86583,variables,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86584,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86585,assessed,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86586,by,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86587,asking,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86588,about,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86589,the,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86590,usual,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86591,frequency,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86592,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86593,consumption,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86594,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86595,146,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86596,food,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86597,items,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86598,and,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86599,beverages,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86600,.,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86786,Our,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86787,findings,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86788,indicate,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86789,that,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86790,dietary,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86791,factors,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86792,contribute,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86793,to,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86794,the,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86795,regional,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86796,variation,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86797,of,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86798,stomach,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86799,cancer,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86800,occurrence,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86801,in,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86802,Italy,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86803,",",O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86804,and,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86805,offer,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86806,clues,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86807,for,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86808,further,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86809,etiologic,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86810,and,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86811,prevention,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86812,research,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86813,.,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
87740,In,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87741,a,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87742,cross,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87743,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87744,sectional,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87745,design,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87746,",",O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87747,we,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87748,compared,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87749,IGF,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87750,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87751,I,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87752,levels,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87753,between,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87754,women,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87755,with,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87756,high,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87757,and,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87758,low,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87759,soy,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87760,intake,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87761,.,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87854,The,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87855,respective,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87856,mean,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87857,IGF,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87858,-,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87859,I,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87860,levels,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87861,were,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87862,213,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87863,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87864,257,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87865,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87866,and,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87867,255,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87868,ng,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87869,/,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87870,ml,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87871,for,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87872,Japanese,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87873,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87874,Japan,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87875,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87876,Japanese,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87877,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87878,Hawaii,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87879,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87880,and,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87881,Caucasians,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87882,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87883,Hawaii,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87884,.,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
88206,Furthermore,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88207,",",O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88208,long,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88209,-,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88210,term,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88211,trials,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88212,investigating,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88213,the,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88214,effect,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88215,of,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88216,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88217,on,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88218,clinical,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88219,outcomes,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88220,are,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88221,also,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88222,needed,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88223,to,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88224,assess,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88225,whether,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88226,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88227,has,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88228,an,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88229,effect,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88230,on,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88231,cardiovascular,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88232,events,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88233,.,O,3055.0,"Furthermore , long - term trials investigating the effect of cocoa on clinical outcomes are also needed to assess whether cocoa has an effect on cardiovascular events ."
88336,Women,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88337,with,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88338,toxemia,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88339,were,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88340,identified,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88341,",",O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88342,and,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88343,women,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88344,without,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88345,toxemia,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88346,served,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88347,as,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88348,controls,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88349,.,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88696,Casein,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88697,infused,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88698,alone,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88699,increased,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88700,milk,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88701,protein,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88702,yield,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88703,numerically,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88704,",",O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88705,with,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88706,25,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88707,%,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88708,recovery,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88709,of,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88710,the,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88711,infused,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88712,casein,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88713,in,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88714,milk,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88715,protein,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88716,.,O,3073.0,"Casein infused alone increased milk protein yield numerically , with 25 % recovery of the infused casein in milk protein ."
88956,Goats,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88957,were,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88958,fed,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88959,a,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88960,mixed,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88961,ration,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88962,with,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88963,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88964,grain,I-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88965,(,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88966,control,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88967,",",O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88968,CON,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88969,),O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88970,or,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88971,CON,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88972,plus,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88973,lemon,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88974,leaves,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88975,[,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88976,189,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88977,g,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88978,/,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88979,kg,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88980,of,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88981,dry,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88982,matter,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88983,(,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88984,DM,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88985,),O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88986,],O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88987,and,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88988,rice,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88989,straw,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88990,(,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88991,120,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88992,g,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88993,/,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88994,kg,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88995,of,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88996,DM,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88997,),O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88998,in,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
88999,place,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89000,of,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89001,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89002,grain,I-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89003,(,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89004,LRS,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89005,),O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89006,.,O,3082.0,"Goats were fed a mixed ration with barley grain ( control , CON ) or CON plus lemon leaves [ 189 g / kg of dry matter ( DM ) ] and rice straw ( 120 g / kg of DM ) in place of barley grain ( LRS ) ."
89177,Greater,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89178,concentrations,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89179,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89180,monounsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89181,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89182,14.94,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89183,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89184,11.96,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89185,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89186,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89187,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89188,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89189,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89190,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89191,and,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89192,polyunsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89193,fatty,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89194,acids,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89195,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89196,4.53,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89197,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89198,4.03,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89199,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89200,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89201,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89202,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89203,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89204,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89205,were,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89206,detected,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89207,in,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89208,the,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89209,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89210,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89211,goats,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89212,fed,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89213,LRS,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89214,compared,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89215,with,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89216,CON,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89217,.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89567,Coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89568,is,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89569,among,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89570,the,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89571,highest,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89572,found,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89573,in,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89574,plants,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89575,",",O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89576,ranging,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89577,from,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89578,4,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89579,to,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89580,14,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89581,%,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89582,.,O,3102.0,"Coffee is among the highest found in plants , ranging from 4 to 14 % ."
89783,The,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89784,increasing,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89785,interest,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89786,has,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89787,prompted,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89788,extensive,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89789,research,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89790,into,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89791,the,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89792,development,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89793,of,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89794,gluten,B-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89795,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89796,free,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89797,foodstuffs,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89798,that,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89799,resemble,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89800,gluten,B-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89801,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89802,containing,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89803,foods,I-http://purl.obolibrary.org/obo/FOODON_03420177,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
89804,.,O,3110.0,The increasing interest has prompted extensive research into the development of gluten - free foodstuffs that resemble gluten - containing foods .
90341,The,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90342,purpose,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90343,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90344,this,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90345,review,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90346,is,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90347,to,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90348,examine,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90349,recent,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90350,literature,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90351,on,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90352,the,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90353,relationship,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90354,between,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90355,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90356,consumption,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90357,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90358,risk,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90359,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90360,cardiovascular,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90361,disease,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90362,incidence,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90363,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90364,mortality,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90365,.,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90472,Future,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90473,research,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90474,need,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90475,not,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90476,replicate,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90477,the,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90478,body,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90479,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90480,literature,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90481,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90482,total,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90483,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90484,consumption,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90485,and,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90486,associated,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90487,risk,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90488,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90489,disease,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90490,",",O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90491,but,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90492,rather,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90493,should,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90494,focus,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90495,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90496,the,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90497,effects,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90498,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90499,individual,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90500,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90501,foods,I-http://purl.obolibrary.org/obo/ENVO_00003862,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90502,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90503,cardiovascular,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90504,events,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90505,in,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90506,male,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90507,and,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90508,female,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90509,populations,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90510,.,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90716,Adding,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90717,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90718,had,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90719,correlation,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90720,with,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90721,mechanical,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90722,properties,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90723,whereas,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90724,adding,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90725,oil,B-http://purl.obolibrary.org/obo/FOODON_03310387,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90726,had,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90727,correlation,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90728,with,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90729,film,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90730,suspension,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90731,characteristics,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90732,",",O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90733,allowed,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90734,the,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90735,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90736,and,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90737,oil,B-http://purl.obolibrary.org/obo/FOODON_03310387,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90738,to,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90739,interact,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90740,and,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90741,inhibited,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90742,starch,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90743,chain,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90744,mobility,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90745,due,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90746,to,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90747,concentration,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90748,",",O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90749,sugar,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90750,type,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90751,",",O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90752,and,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90753,oil,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90754,type,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
90755,.,O,3144.0,"Adding sugar had correlation with mechanical properties whereas adding oil had correlation with film suspension characteristics , allowed the sugar and oil to interact and inhibited starch chain mobility due to concentration , sugar type , and oil type ."
91014,Factor,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91015,2,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91016,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91017,characterized,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91018,by,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91019,salad,B-http://purl.obolibrary.org/obo/FOODON_03316042,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91020,and,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91021,cooked,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91022,vegetables,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91023,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91024,was,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91025,inversely,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91026,associated,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91027,with,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91028,diabetes,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91029,.,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91175,Of,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91176,the,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91177,eleven,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91178,free,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91179,-,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91180,living,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91181,subjects,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91182,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91183,were,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91184,normocholesteremic,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91185,",",O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91186,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91187,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91188,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91189,IIa,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91190,hyperlipidemia,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91191,and,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91192,five,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91193,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91194,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91195,VI,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91196,(,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91197,IIb,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91198,),O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91199,.,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91572,Low,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91573,energy,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91574,reporters,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91575,had,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91576,a,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91577,healthier,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91578,diet,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91579,than,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91580,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91581,rest,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91582,with,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91583,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91584,weighed,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91585,record,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91586,.,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
92045,Finally,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92046,",",O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92047,measuring,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92048,progesterone,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92049,concentration,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92050,in,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92051,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92052,helps,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92053,farmers,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92054,detect,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92055,ovulation,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92056,",",O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92057,pregnancy,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92058,",",O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92059,and,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92060,infertility,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92061,.,O,3190.0,"Finally , measuring progesterone concentration in milk helps farmers detect ovulation , pregnancy , and infertility ."
92062,Monitoring,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92063,systems,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92064,for,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92065,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92066,-,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92067,farm,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92068,or,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92069,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92070,-,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92071,line,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92072,analysis,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92073,of,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92074,milk,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92075,composition,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92076,are,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92077,mostly,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92078,based,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92079,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92080,infrared,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92081,spectroscopy,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92082,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92083,optical,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92084,methods,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92085,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92086,biosensors,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92087,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92088,or,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92089,sensor,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92090,arrays,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92091,.,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92128,Growing,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92129,evidence,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92130,suggests,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92131,the,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92132,crucial,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92133,role,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92134,of,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92135,diet,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92136,on,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92137,cancer,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92138,prevention,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92139,and,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92140,treatment,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92141,.,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92266,However,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92267,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92268,additional,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92269,pharmacological,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92270,studies,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92271,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92272,clinical,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92273,trials,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92274,are,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92275,needed,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92276,to,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92277,elucidate,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92278,their,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92279,molecular,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92280,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92281,cellular,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92282,mechanisms,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92283,of,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92284,actions,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92285,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92286,frequency,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92287,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92288,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92289,amount,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92290,of,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92291,consumption,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92292,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92293,possible,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92294,adverse,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92295,effects,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92296,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92297,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92298,optimum,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92299,preparation,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92300,methods,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92301,.,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
93696,Total,O,3251.0,Total IgE was 411 UI / ml .
93697,IgE,O,3251.0,Total IgE was 411 UI / ml .
93698,was,O,3251.0,Total IgE was 411 UI / ml .
93699,411,O,3251.0,Total IgE was 411 UI / ml .
93700,UI,O,3251.0,Total IgE was 411 UI / ml .
93701,/,O,3251.0,Total IgE was 411 UI / ml .
93702,ml,O,3251.0,Total IgE was 411 UI / ml .
93703,.,O,3251.0,Total IgE was 411 UI / ml .
93751,Immunoblot,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93752,of,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93753,raw,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93754,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93755,showed,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93756,a,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93757,single,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93758,IgE,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93759,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93760,binding,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93761,18,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93762,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93763,kDa,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93764,band,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93765,.,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
94047,The,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94048,discussion,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94049,is,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94050,emphasized,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94051,on,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94052,the,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94053,clinical,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94054,aspect,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94055,of,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94056,these,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94057,botanicals,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94058,.,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94059,Due,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94060,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94061,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94062,lack,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94063,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94064,sufficient,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94065,evidence,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94066,from,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94067,clinical,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94068,studies,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94069,for,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94070,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94071,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94072,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94073,botanicals,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94074,reviewed,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94075,",",O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94076,it,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94077,is,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94078,premature,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94079,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94080,actively,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94081,recommend,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94082,use,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94083,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94084,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94085,particular,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94086,herb,B-http://purl.obolibrary.org/obo/FOODON_00003042,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94087,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94088,treat,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94089,either,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94090,glucose,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94091,or,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94092,other,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94093,risk,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94094,factors,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94095,.,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94762,Similar,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94763,results,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94764,were,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94765,also,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94766,obtained,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94767,2,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94768,hours,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94769,after,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94770,the,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94771,test,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94772,meals,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94773,.,O,3286.0,Similar results were also obtained 2 hours after the test meals .
95218,Other,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95219,physiologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95220,and,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95221,psychologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95222,factors,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95223,can,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95224,contribute,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95225,to,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95226,gastrointestinal,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95227,symptoms,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95228,that,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95229,mimic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95230,lactose,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95231,intolerance,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95232,.,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95642,A,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95643,calibration,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95644,study,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95645,in,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95646,a,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95647,subsample,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95648,was,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95649,used,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95650,to,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95651,correct,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95652,for,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95653,dietary,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95654,measurement,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95655,errors,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95656,.,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95868,Since,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95869,avoidance,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95870,of,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95871,dietary,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95872,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95873,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95874,the,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95875,only,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95876,option,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95877,for,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95878,celiac,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95879,patients,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95880,",",O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95881,a,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95882,sensitive,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95883,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95884,detection,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95885,and,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95886,quantitation,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95887,method,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95888,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95889,warranted,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95890,.,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95917,However,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95918,",",O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95919,these,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95920,methods,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95921,may,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95922,exhibit,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95923,differences,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95924,in,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95925,gluten,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95926,quantitation,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95927,from,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95928,different,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95929,gluten,B-http://purl.obolibrary.org/obo/FOODON_03420177,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95930,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95931,containing,I-http://purl.obolibrary.org/obo/FOODON_03420177,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95932,grains,I-http://purl.obolibrary.org/obo/FOODON_03420177,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95933,.,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95955,Intact,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95956,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95957,pepsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95958,-,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95959,trypsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95960,(,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95961,PT)-digested,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95962,prolamin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95963,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95964,glutelin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95965,fractions,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95966,were,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95967,used,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95968,to,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95969,assess,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95970,their,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95971,immunoreactivity,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95972,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95973,gluten,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95974,recovery,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95975,by,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95976,three,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95977,sandwich,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95978,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95979,two,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95980,competitive,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95981,ELISA,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95982,kits,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95983,.,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
96399,Conversely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96400,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96401,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96402,glucoregulatory,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96403,qualities,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96404,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96405,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96406,proteins,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96407,in,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96408,animal,B-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96409,-,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96410,based,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96411,foods,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96412,are,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96413,extremely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96414,divergent,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96415,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96416,with,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96417,a,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96418,higher,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96419,intake,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96420,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96421,certain,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96422,animal,B-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004;http://purl.obolibrary.org/obo/CHEBI_36080,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96423,-,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004;http://purl.obolibrary.org/obo/CHEBI_36080,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96424,based,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004;http://purl.obolibrary.org/obo/CHEBI_36080,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96425,protein,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004;http://purl.obolibrary.org/obo/CHEBI_36080,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96426,foods,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004;http://purl.obolibrary.org/obo/CHEBI_36080,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96427,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96428,negative,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96429,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96430,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96431,and,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96432,others,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96433,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96434,neutral,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96435,or,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96436,positive,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96437,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96438,on,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96439,type,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96440,2,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96441,diabetes,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96442,risk,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96443,.,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96794,Scientific,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96795,research,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96796,has,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96797,demonstrated,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96798,that,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96799,the,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96800,molecules,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96801,present,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96802,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96803,grapes,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96804,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96805,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96806,wine,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96807,alter,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96808,cellular,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96809,metabolism,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96810,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96811,signaling,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96812,",",O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96813,which,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96814,is,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96815,consistent,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96816,mechanistically,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96817,with,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96818,reducing,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96819,arterial,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96820,disease,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96821,.,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
97345,Although,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97346,lectins,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97347,seem,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97348,to,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97349,have,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97350,great,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97351,potential,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97352,as,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97353,anticancer,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97354,agents,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97355,",",O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97356,further,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97357,research,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97358,is,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97359,still,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97360,needed,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97361,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97362,should,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97363,include,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97364,a,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97365,genomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97366,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97367,proteomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97368,approach,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97369,.,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97385,This,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97386,cross,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97387,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97388,sectional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97389,study,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97390,determined,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97391,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97392,frequency,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97393,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97394,consumption,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97395,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97396,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97397,meats,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97398,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97399,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97400,caribou,B-http://purl.obolibrary.org/obo/NCBITaxon_9870,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97401,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97402,polar,B-http://purl.obolibrary.org/obo/NCBITaxon_29073;http://purl.obolibrary.org/obo/FOODON_03412406,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97403,bear,I-http://purl.obolibrary.org/obo/NCBITaxon_29073;http://purl.obolibrary.org/obo/FOODON_03412406,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97404,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97405,seal,B-http://purl.obolibrary.org/obo/NCBITaxon_9709,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97406,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97407,char,B-http://purl.obolibrary.org/obo/FOODON_03414051,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97408,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97409,whale,B-http://purl.obolibrary.org/obo/NCBITaxon_9721;http://purl.obolibrary.org/obo/FOODON_03411343,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97410,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97411,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97412,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97413,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97414,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97415,store,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97416,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97417,bought,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97418,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97419,including,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97420,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97421,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97422,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97423,meats,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97424,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97425,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97426,beef,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97427,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97428,pork,B-http://purl.obolibrary.org/obo/FOODON_00001038,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97429,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97430,chicken,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97431,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97432,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97433,grains,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97434,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97435,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97436,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97437,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97438,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97439,vegetables,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97440,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97441,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97442,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97443,nutrient,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97444,dense,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97445,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97446,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97447,NNDFs,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97448,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97449,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97450,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97451,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97452,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97453,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97454,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97455,chips,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97456,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97457,candy,B-http://purl.obolibrary.org/obo/FOODON_03301051,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97458,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97459,pop,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97460,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97461,by,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97462,Inuvialuit,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97463,adults,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97464,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97465,175,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97466,women,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97467,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97468,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97469,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97470,44,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97471,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97472,14,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97473,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97474,;,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97475,55,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97476,men,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97477,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97478,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97479,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97480,41,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97481,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97482,13,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97483,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97484,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97485,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97486,three,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97487,remote,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97488,communities,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97489,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97490,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97491,Northwest,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97492,Territories,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97493,.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97644,This,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97645,condition,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97646,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97647,chronic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97648,inflammation,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97649,may,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97650,damage,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97651,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97652,vasculature,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97653,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97654,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97655,brain,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97656,or,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97657,be,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97658,directly,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97659,neurotoxic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97660,.,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97747,Published,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97748,trials,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97749,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97750,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97751,benefits,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97752,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97753,grape,B-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123;http://purl.obolibrary.org/obo/FOODON_00002512;http://purl.obolibrary.org/obo/FOODON_03302045;http://purl.obolibrary.org/obo/FOODON_00003541;http://purl.obolibrary.org/obo/FOODON_03315552,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97754,and,I-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123;http://purl.obolibrary.org/obo/FOODON_00002512;http://purl.obolibrary.org/obo/FOODON_03302045;http://purl.obolibrary.org/obo/FOODON_00003541;http://purl.obolibrary.org/obo/FOODON_03315552,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97755,blueberry,I-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123;http://purl.obolibrary.org/obo/FOODON_00002512;http://purl.obolibrary.org/obo/FOODON_03302045;http://purl.obolibrary.org/obo/FOODON_00003541;http://purl.obolibrary.org/obo/FOODON_03315552,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97756,juice,I-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123;http://purl.obolibrary.org/obo/FOODON_00002512;http://purl.obolibrary.org/obo/FOODON_03302045;http://purl.obolibrary.org/obo/FOODON_00003541;http://purl.obolibrary.org/obo/FOODON_03315552,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97757,in,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97758,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97759,treatment,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97760,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97761,small,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97762,numbers,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97763,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97764,cognitively,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97765,impaired,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97766,persons,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97767,have,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97768,recently,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97769,appeared,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97770,.,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97907,276,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97908,(,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97909,24,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97910,%,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97911,),O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97912,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97913,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97914,patients,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97915,reported,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97916,some,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97917,kind,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97918,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97919,allergic,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97920,symptoms,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97921,on,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97922,eating,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97923,or,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97924,handling,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97925,various,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97926,foods,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97927,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97928,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97929,which,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97930,hazel,B-http://purl.obolibrary.org/obo/FOODON_03303171,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97931,nut,I-http://purl.obolibrary.org/obo/FOODON_03303171,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97932,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97933,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97934,and,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97935,shell,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97936,fish,I-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97937,were,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97938,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97939,most,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97940,often,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97941,named,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97942,.,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
98042,The,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98043,connection,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98044,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98045,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98046,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98047,allergy,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98048,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98049,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98050,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98051,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98052,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98053,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98054,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98055,structural,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98056,relationship,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98057,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98058,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98059,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98060,allergen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98061,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98062,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98063,allergens,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98064,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98065,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98066,foodstuffs,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98067,",",O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98068,whereas,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98069,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98070,high,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98071,incidence,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98072,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98073,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98074,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98075,acetylsalicylic,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98076,acid,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98077,-,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98078,intolerant,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98079,patients,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98080,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98081,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98082,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98083,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98084,additives,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98085,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98086,foods,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98087,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98088,well,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98089,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98090,salicylates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98091,or,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98092,benzoates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98093,naturally,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98094,occurring,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98095,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98096,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98097,food,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98098,.,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98217,Saturated,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98218,fat,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98219,/,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98220,cholesterol,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98221,avoidance,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98222,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98223,significantly,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98224,with,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98225,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98226,socioeconomic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98227,status,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98228,in,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98229,both,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98230,ethnic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98231,groups,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98232,.,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98377,We,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98378,conducted,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98379,a,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98380,case,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98381,-,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98382,control,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98383,study,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98384,to,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98385,evaluate,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98386,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98387,association,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98388,between,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98389,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98390,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98391,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98392,consumption,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98393,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98394,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98395,risk,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98396,of,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98397,UADT,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98398,cancer,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98399,.,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98480,In,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98481,contrast,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98482,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98483,consumption,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98484,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98485,three,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98486,or,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98487,more,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98488,cups,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98489,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98490,green,B-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98491,tea,I-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98492,per,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98493,day,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98494,had,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98495,a,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98496,significant,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98497,positive,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98498,association,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98499,with,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98500,UADT,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98501,cancer,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98502,(,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98503,OR,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98504,1.39,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98505,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98506,95,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98507,%,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98508,CI,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98509,1.13,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98510,-,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98511,1.70,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98512,),O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98513,.,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98549,Similarly,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98550,",",O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98551,the,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98552,association,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98553,of,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98554,green,B-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98555,tea,I-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98556,consumption,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98557,was,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98558,observed,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98559,among,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98560,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98561,smokers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98562,and,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98563,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98564,alcohol,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98565,drinkers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98566,.,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
99213,Two,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99214,groups,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99215,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99216,cows,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99217,received,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99218,either,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99219,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99220,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99221,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99222,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99223,as,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99224,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99225,control,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99226,diet,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99227,or,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99228,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99229,same,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99230,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99231,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99232,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99233,supplemented,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99234,with,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99235,1,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99236,%,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99237,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99238,GSGME,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99239,over,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99240,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99241,period,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99242,from,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99243,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99244,3,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99245,prepartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99246,to,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99247,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99248,9,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99249,postpartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99250,.,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99514,Treatments,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99515,continued,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99516,until,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99517,7,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99518,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99519,after,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99520,cows,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99521,received,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99522,an,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99523,infusion,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99524,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99525,10,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99526,microg,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99527,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99528,LPS,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99529,into,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99530,one,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99531,quarter,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99532,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99533,the,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99534,mammary,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99535,gland,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99536,(,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99537,on,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99538,average,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99539,",",O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99540,this,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99541,occurred,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99542,32,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99543,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99544,postcalving,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99545,),O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99546,.,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99619,The,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99620,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99621,infusion,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99622,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99623,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99624,alter,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99625,concentrations,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99626,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99627,vitamin,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99628,C,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99629,in,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99630,plasma,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99631,or,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99632,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99633,",",O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99634,suggesting,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99635,that,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99636,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99637,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99638,model,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99639,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99640,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99641,produce,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99642,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99643,same,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99644,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99645,as,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99646,a,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99647,bacterial,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99648,infection,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99649,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99650,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99651,mammary,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99652,gland,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99653,with,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99654,respect,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99655,to,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99656,antioxidant,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99657,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99658,.,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99837,The,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99838,daily,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99839,intake,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99840,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99841,i,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99842,-,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99843,As,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99844,ranged,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99845,from,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99846,0.61,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99847,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99848,0.78,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99849,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99850,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99851,body,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99852,weight,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99853,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99854,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99855,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99856,in,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99857,children,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99858,up,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99859,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99860,5,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99861,y,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99862,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99863,age,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99864,;,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99865,these,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99866,values,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99867,were,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99868,below,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99869,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99870,maximum,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99871,value,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99872,established,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99873,by,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99874,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99875,EFSA,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99876,Panel,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99877,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99878,8.0,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99879,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99880,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99881,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99882,per,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99883,day,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99884,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99885,",",O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99886,but,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99887,it,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99888,should,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99889,be,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99890,considered,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99891,typical,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99892,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99893,populations,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99894,with,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99895,a,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99896,high,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99897,exposure,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99898,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99899,this,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99900,pollutant,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99901,.,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
100164,Despite,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100165,the,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100166,accumulating,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100167,epidemiological,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100168,research,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100169,",",O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100170,there,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100171,is,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100172,still,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100173,a,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100174,lack,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100175,of,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100176,consistent,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100177,results,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100178,from,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100179,high,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100180,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100181,quality,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100182,studies,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100183,for,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100184,many,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100185,health,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100186,outcomes,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100187,(,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100188,i.e.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100189,certain,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100190,cancers,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100191,and,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100192,metabolism,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100193,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100194,related,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100195,disorders,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100196,),O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100197,.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
101045,High,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101046,intakes,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101047,of,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101048,potassium,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101049,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101050,polyunsaturated,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101051,fatty,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101052,acids,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101053,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101054,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101055,protein,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101056,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101057,along,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101058,with,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101059,exercise,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101060,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101061,possibly,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101062,vitamin,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101063,D,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101064,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101065,may,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101066,reduce,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101067,blood,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101068,pressure,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101069,.,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101222,The,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101223,consumption,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101224,of,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101225,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101226,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101227,vegetables,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101228,exerts,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101229,a,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101230,preventive,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101231,effect,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101232,towards,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101233,cancer,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101234,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101235,in,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101236,recent,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101237,years,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101238,natural,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101239,dietary,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101240,agents,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101241,have,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101242,attracted,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101243,great,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101244,attention,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101245,in,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101246,the,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101247,scientific,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101248,community,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101249,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101250,among,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101251,the,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101252,general,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101253,public,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101254,.,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101514,On,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101515,the,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101516,other,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101517,hand,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101518,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101519,plant,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101520,foods,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101521,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101522,particularly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101523,total,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101524,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101525,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101526,and,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101527,alcoholic,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101528,beverages,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101529,(,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101530,mainly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101531,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101532,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101533,),O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101534,were,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101535,protective,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101536,.,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101614,Mean,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101615,per,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101616,capita,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101617,daily,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101618,consumption,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101619,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101620,calcium,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101621,for,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101622,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101623,total,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101624,U.S.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101625,population,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101626,was,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101627,737,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101628,mg,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101629,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101630,varied,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101631,by,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101632,region,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101633,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101634,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101635,country,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101636,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101637,household,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101638,income,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101639,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101640,ethnic,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101641,group,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101642,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101643,sex,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101644,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101645,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101646,age,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101647,.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
102670,Socio,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102671,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102672,demographic,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102673,and,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102674,food,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102675,consumption,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102676,were,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102677,assessed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102678,using,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102679,a,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102680,structured,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102681,closed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102682,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102683,ended,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102684,questionnaire,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102685,administered,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102686,by,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102687,survey,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102688,officers,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102689,.,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102927,As,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102928,compared,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102929,to,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102930,controls,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102931,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102932,patients,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102933,showed,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102934,an,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102935,impaired,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102936,fat,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102937,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102938,but,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102939,not,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102940,sugar,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102941,perception,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102942,.,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102943,Impairments,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102944,in,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102945,fat,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102946,perception,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102947,overlapped,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102948,with,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102949,the,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102950,anterior,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102951,insula,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102952,and,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102953,frontal,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102954,operculum,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102955,",",O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102956,together,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102957,assumed,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102958,to,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102959,underpin,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102960,gustatory,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102961,processing,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102962,.,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
103162,Odds,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103163,ratios,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103164,(,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103165,ORs,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103166,),O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103167,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103168,95,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103169,%,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103170,confidence,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103171,intervals,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103172,were,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103173,estimated,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103174,using,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103175,conditional,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103176,logistic,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103177,regression,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103178,models,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103179,adjusting,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103180,for,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103181,Helicobacter,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103182,pylori,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103183,infection,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103184,",",O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103185,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103186,other,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103187,potential,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103188,confounders,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103189,.,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103261,The,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103262,cancer,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103263,patient,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103264,group,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103265,included,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103266,persons,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103267,diagnosed,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103268,with,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103269,cancers,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103270,of,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103271,the,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103272,oral,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103273,cavity,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103274,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103275,stomach,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103276,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103277,colon,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103278,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103279,rectum,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103280,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103281,lung,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103282,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103283,breast,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103284,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103285,uterus,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103286,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103287,cervix,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103288,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103289,prostate,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103290,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103291,or,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103292,bladder,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103293,.,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103369,Elevated,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103370,risks,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103371,for,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103372,frequent,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103373,consumption,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103374,of,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103375,whole,B-http://purl.obolibrary.org/obo/UBERON_0001913,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103376,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103377,relative,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103378,to,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103379,not,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103380,drinking,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103381,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103382,were,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103383,observed,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103384,for,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103385,cancers,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103386,of,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103387,the,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103388,oral,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103389,cavity,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103390,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103391,stomach,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103392,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103393,colon,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103394,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103395,rectum,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103396,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103397,lung,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103398,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103399,bladder,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103400,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103401,breast,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103402,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103403,and,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103404,cervix,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103405,.,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103406,Reduced,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103407,risks,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103408,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103409,frequent,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103410,consumption,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103411,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103412,2,B-http://purl.obolibrary.org/obo/UBERON_0001913,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103413,%,I-http://purl.obolibrary.org/obo/UBERON_0001913,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103414,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103415,relative,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103416,to,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103417,not,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103418,drinking,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103419,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103420,were,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103421,observed,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103422,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103423,cancers,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103424,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103425,the,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103426,oral,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103427,cavity,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103428,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103429,stomach,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103430,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103431,rectum,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103432,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103433,lung,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103434,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103435,and,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103436,cervix,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103437,.,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103857,Changes,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103858,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103859,vitamin,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103860,content,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103861,are,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103862,mainly,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103863,observed,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103864,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103865,fermented,B-http://purl.obolibrary.org/obo/UBERON_0001913,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103866,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103867,and,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103868,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103869,.,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103936,CLA,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103937,was,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103938,identified,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103939,as,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103940,a,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103941,component,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103942,of,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103943,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103944,and,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103945,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103946,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103947,over,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103948,20,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103949,years,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103950,ago,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103951,.,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
104028,CLA,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104029,has,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104030,been,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104031,shown,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104032,to,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104033,inhibit,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104034,chemically,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104035,-,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104036,induced,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104037,skin,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104038,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104039,stomach,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104040,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104041,mammary,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104042,or,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104043,colon,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104044,tumours,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104045,in,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104046,mice,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104047,and,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104048,rats,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104049,.,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104568,After,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104569,48,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104570,hours,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104571,",",O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104572,moistness,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104573,ratings,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104574,for,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104575,fat,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104576,-,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104577,free,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104578,cookies,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104579,were,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104580,acceptable,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104581,and,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104582,higher,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104583,than,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104584,CTL,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104585,(,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104586,P<.01,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104587,),O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104588,.,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104616,We,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104617,report,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104618,17,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104619,patients,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104620,with,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104621,immediate,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104622,hypersensitivity,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104623,to,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104624,avocado,B-http://purl.obolibrary.org/obo/FOODON_00003600;http://purl.obolibrary.org/obo/FOODON_03305236;http://purl.obolibrary.org/obo/NCBITaxon_3435,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104625,.,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104663,Skin,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104664,prick,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104665,test,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104666,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104667,SPT,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104668,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104669,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104670,fresh,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104671,avocado,B-http://purl.obolibrary.org/obo/FOODON_00003600;http://purl.obolibrary.org/obo/FOODON_03305236;http://purl.obolibrary.org/obo/NCBITaxon_3435,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104672,was,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104673,positive,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104674,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104675,all,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104676,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104677,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104678,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104679,Strong,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104680,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104681,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104682,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104683,SAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104684,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104685,and,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104686,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104687,14,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104688,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104689,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104690,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104691,Hass,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104692,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104693,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104694,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104695,HAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104696,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104697,.,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104857,Milk,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104858,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104859,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104860,rich,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104861,in,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104862,both,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104863,sucrose,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104864,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104865,fat,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104866,",",O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104867,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104868,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104869,therefore,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104870,considered,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104871,unsuitable,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104872,for,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104873,diabetics,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104874,.,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
105073,The,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105074,area,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105075,under,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105076,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105077,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105078,curve,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105079,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105080,isomalt,B-http://purl.obolibrary.org/obo/FOODON_03413125;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105081,chocolate,I-http://purl.obolibrary.org/obo/FOODON_03413125;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105082,was,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105083,36,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105084,%,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105085,smaller,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105086,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105087,that,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105088,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105089,conventional,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105090,chocolate,I-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105091,(,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105092,P,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105093,less,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105094,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105095,0.05,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105096,),O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105097,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105098,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105099,there,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105100,were,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105101,differences,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105102,in,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105103,insulin,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105104,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105105,lactate,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105106,levels,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105107,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105108,consistent,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105109,with,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105110,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105111,lower,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105112,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105113,effect,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105114,.,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105115,The,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105116,glycaemic,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105117,response,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105118,to,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105119,the,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105120,fructose,B-http://purl.obolibrary.org/obo/CHEBI_28757;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105121,-,I-http://purl.obolibrary.org/obo/CHEBI_28757;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105122,based,I-http://purl.obolibrary.org/obo/CHEBI_28757;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105123,chocolate,I-http://purl.obolibrary.org/obo/CHEBI_28757;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105124,was,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105125,also,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105126,lower,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105127,than,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105128,that,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105129,to,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105130,control,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105131,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105132,but,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105133,the,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105134,difference,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105135,was,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105136,not,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105137,significant,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105138,.,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105191,Although,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105192,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105193,Japanese,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105194,diet,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105195,is,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105196,associated,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105197,with,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105198,higher,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105199,sodium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105200,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105201,and,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105202,lower,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105203,potassium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105204,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105205,",",O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105206,few,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105207,studies,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105208,have,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105209,examined,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105210,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105211,source,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105212,foods,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105213,quantitatively,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105214,.,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105561,Experimental,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105562,evidence,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105563,from,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105564,animals,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105565,have,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105566,shown,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105567,that,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105568,honey,B-http://purl.obolibrary.org/obo/UBERON_0036016,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105569,improves,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105570,glycemic,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105571,control,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105572,and,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105573,lipid,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105574,profile,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105575,with,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105576,consequent,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105577,protection,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105578,from,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105579,endothelial,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105580,dysfunction,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105581,and,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105582,neurodegeneration,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105583,.,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105639,Further,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105640,well,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105641,-,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105642,designed,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105643,and,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105644,controlled,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105645,studies,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105646,are,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105647,necessary,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105648,to,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105649,validate,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105650,these,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105651,benefits,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105652,in,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105653,humans,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105654,.,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105885,More,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105886,research,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105887,needs,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105888,to,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105889,be,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105890,focused,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105891,on,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105892,cereal,B-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105893,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105894,based,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105895,",",I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105896,gluten,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105897,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105898,free,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105899,beverages,I-http://purl.obolibrary.org/obo/FOODON_03420177,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105900,to,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105901,provide,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105902,additional,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105903,options,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105904,for,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105905,CD,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105906,sufferers,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
105907,.,O,3682.0,"More research needs to be focused on cereal - based , gluten - free beverages to provide additional options for CD sufferers ."
106015,Foods,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106016,reviewed,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106017,in,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106018,the,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106019,second,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106020,section,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106021,include,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106022,:,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106023,whole,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106024,grains,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106025,and,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106026,dietary,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106027,fiber,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106028,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106029,vegetables,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106030,and,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106031,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106032,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106033,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106034,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106035,soy,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106036,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106037,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106038,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106039,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106040,alcoholic,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106041,drinks,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106042,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106043,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106044,and,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106045,caffeine,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106046,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106047,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106048,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106049,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106050,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106051,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106052,",",O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106053,and,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106054,eggs,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106055,.,O,3687.0,"Foods reviewed in the second section include : whole grains and dietary fiber , vegetables and fruits , nuts , soy , dairy products , alcoholic drinks , coffee and caffeine , tea , chocolate , garlic , and eggs ."
106321,Consumption,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106322,of,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106323,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106324,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106325,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106326,refined,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106327,grains,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106328,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106329,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106330,whole,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106331,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106332,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106333,dairy,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106334,was,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106335,high,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106336,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106337,while,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106338,that,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106339,of,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106340,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106341,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106342,non,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106343,-,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106344,tuberous,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106345,vegetables,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106346,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106347,eggs,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106348,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106349,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106350,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106351,seeds,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106352,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106353,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106354,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106355,poultry,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106356,",",O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106357,and,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106358,whole,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106359,grains,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106360,was,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106361,low,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106362,.,O,3698.0,"Consumption of red meat , refined grains , and whole - fat dairy was high , while that of fruits , non - tuberous vegetables , eggs , nuts and seeds , fish and poultry , and whole grains was low ."
106363,Dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106364,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106365,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106366,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106367,were,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106368,more,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106369,consumed,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106370,in,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106371,summer,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106372,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106373,winter,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106374,",",O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106375,respectively,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106376,.,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106809,Observational,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106810,studies,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106811,support,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106812,the,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106813,role,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106814,of,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106815,modifying,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106816,lifestyle,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106817,-,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106818,related,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106819,risk,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106820,factors,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106821,such,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106822,as,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106823,diet,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106824,",",O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106825,physical,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106826,activity,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106827,and,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106828,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106829,use,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106830,in,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106831,stroke,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106832,prevention,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106833,.,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
107097,The,O,3723.0,The situation is probably not much better in most other countries .
107098,situation,O,3723.0,The situation is probably not much better in most other countries .
107099,is,O,3723.0,The situation is probably not much better in most other countries .
107100,probably,O,3723.0,The situation is probably not much better in most other countries .
107101,not,O,3723.0,The situation is probably not much better in most other countries .
107102,much,O,3723.0,The situation is probably not much better in most other countries .
107103,better,O,3723.0,The situation is probably not much better in most other countries .
107104,in,O,3723.0,The situation is probably not much better in most other countries .
107105,most,O,3723.0,The situation is probably not much better in most other countries .
107106,other,O,3723.0,The situation is probably not much better in most other countries .
107107,countries,O,3723.0,The situation is probably not much better in most other countries .
107108,.,O,3723.0,The situation is probably not much better in most other countries .
107561,Ochratoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107562,A,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107563,(,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107564,OTA,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107565,),O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107566,is,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107567,a,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107568,mycotoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107569,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107570,or,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107571,fungal,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107572,toxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107573,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107574,that,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107575,contaminates,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107576,multiple,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107577,foodstuffs,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107578,worldwide,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107579,.,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107772,We,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107773,aimed,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107774,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107775,quantify,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107776,the,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107777,association,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107778,between,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107779,dietary,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107780,patterns,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107781,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107782,gastric,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107783,cancer,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107784,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107785,by,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107786,location,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107787,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107788,histological,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107789,type,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107790,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107791,according,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107792,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107793,Helicobacter,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107794,pylori,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107795,infection,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107796,status,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107797,.,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
108443,A,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108444,putative,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108445,regulatory,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108446,pool,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108447,of,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108448,cholesterol,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108449,is,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108450,increased,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108451,with,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108452,saturated,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108453,fat,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108454,feeding,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108455,and,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108456,suppresses,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108457,LDL,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108458,receptor,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108459,activity,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108460,",",O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108461,possibly,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108462,through,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108463,hepatic,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108464,messenger,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108465,RNA,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108466,regulation,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108467,.,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108888,A,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108889,similar,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108890,pattern,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108891,of,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108892,associations,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108893,was,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108894,found,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108895,when,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108896,intake,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108897,was,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108898,expressed,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108899,in,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108900,kcal,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108901,/,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108902,week,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108903,.,O,3786.0,A similar pattern of associations was found when intake was expressed in kcal / week .
108904,Among,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108905,men,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108906,",",O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108907,the,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108908,pattern,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108909,of,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108910,associations,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108911,was,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108912,overall,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108913,found,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108914,to,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108915,be,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108916,similar,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108917,to,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108918,that,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108919,for,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108920,women,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108921,.,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
110182,Anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110183,have,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110184,demonstrated,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110185,antioxidant,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110186,potential,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110187,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110188,both,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110189,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110190,vitro,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110191,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110192,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110193,vivo,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110194,studies,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110195,",",O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110196,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110197,the,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110198,consumption,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110199,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110200,foods,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110201,high,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110202,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110203,anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110204,has,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110205,been,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110206,linked,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110207,to,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110208,lower,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110209,risks,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110210,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110211,chronic,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110212,diseases,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110213,.,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110259,A,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110260,brief,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110261,overview,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110262,of,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110263,the,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110264,antioxidant,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110265,potential,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110266,",",O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110267,and,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110268,current,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110269,research,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110270,on,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110271,the,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110272,health,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110273,effects,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110274,of,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110275,cereal,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110276,-,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110277,based,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110278,anthocyanins,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110279,will,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110280,be,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110281,provided,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110282,.,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110601,For,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110602,none,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110603,of,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110604,the,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110605,associations,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110606,a,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110607,statistically,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110608,significant,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110609,interaction,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110610,with,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110611,smoking,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110612,status,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110613,was,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110614,found,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110615,.,O,3853.0,For none of the associations a statistically significant interaction with smoking status was found .
110663,These,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110664,assumptions,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110665,",",O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110666,however,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110667,",",O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110668,have,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110669,recently,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110670,been,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110671,brought,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110672,into,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110673,question,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110674,by,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110675,current,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110676,research,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110677,on,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110678,regular,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110679,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110680,dairy,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110681,products,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110682,and,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110683,human,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110684,health,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110685,.,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110922,Discrepant,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110923,data,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110924,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110925,however,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110926,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110927,have,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110928,been,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110929,reported,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110930,for,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110931,India,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110932,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110933,Japan,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110934,and,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110935,Korea,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110936,.,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110968,Here,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110969,",",O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110970,studies,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110971,are,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110972,summarized,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110973,pointing,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110974,to,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110975,a,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110976,species,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110977,-,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110978,specific,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110979,risk,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110980,for,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110981,colon,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110982,cancer,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110983,after,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110984,consumption,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110985,of,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110986,beef,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110987,originating,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110988,from,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110989,dairy,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110990,cattle,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110991,.,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
111045,",",O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111046,Br,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111047,J,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111048,Cancer,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111049,2014,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111050,;,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111051,112:149,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111052,-,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111053,52,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111054,),O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111055,seems,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111056,to,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111057,be,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111058,in,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111059,line,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111060,with,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111061,this,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111062,interpretation,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111063,.,O,3869.0,", Br J Cancer 2014 ; 112:149 - 52 ) seems to be in line with this interpretation ."
111149,Systemic,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111150,infections,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111151,early,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111152,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111153,life,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111154,",",O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111155,resulting,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111156,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111157,latency,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111158,and,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111159,prevention,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111160,of,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111161,subsequent,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111162,infections,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111163,with,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111164,the,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111165,same,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111166,agent,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111167,by,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111168,neutralizing,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111169,antibodies,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111170,",",O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111171,would,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111172,require,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111173,reconsideration,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111174,of,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111175,ongoing,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111176,prospective,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111177,studies,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111178,conducted,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111179,in,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111180,the,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111181,adult,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111182,population,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111183,.,O,3873.0,"Systemic infections early in life , resulting in latency and prevention of subsequent infections with the same agent by neutralizing antibodies , would require reconsideration of ongoing prospective studies conducted in the adult population ."
111239,Water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,3876.0,Water used for food processing was simultaneously sampled .
111240,used,O,3876.0,Water used for food processing was simultaneously sampled .
111241,for,O,3876.0,Water used for food processing was simultaneously sampled .
111242,food,O,3876.0,Water used for food processing was simultaneously sampled .
111243,processing,O,3876.0,Water used for food processing was simultaneously sampled .
111244,was,O,3876.0,Water used for food processing was simultaneously sampled .
111245,simultaneously,O,3876.0,Water used for food processing was simultaneously sampled .
111246,sampled,O,3876.0,Water used for food processing was simultaneously sampled .
111247,.,O,3876.0,Water used for food processing was simultaneously sampled .
111411,The,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111412,effect,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111413,of,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111414,vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111415,and,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111416,fruit,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111417,consumption,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111418,on,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111419,breast,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111420,cancer,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111421,risk,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111422,is,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111423,controversial,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111424,.,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111859,Histopathological,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111860,analysis,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111861,in,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111862,rat,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111863,femur,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111864,revealed,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111865,extensive,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111866,bone,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111867,loss,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111868,in,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111869,rats,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111870,intoxicated,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111871,with,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111872,cadmium,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111873,.,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
112174,for,O,3917.0,for 41 wk .
112175,41,O,3917.0,for 41 wk .
112176,wk,O,3917.0,for 41 wk .
112177,.,O,3917.0,for 41 wk .
112472,Therefore,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112473,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112474,we,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112475,aimed,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112476,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112477,evaluate,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112478,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112479,association,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112480,of,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112481,FPS,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112482,with,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112483,excess,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112484,body,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112485,weight,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112486,(,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112487,EBW,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112488,),O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112489,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112490,and,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112491,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112492,monitor,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112493,differences,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112494,in,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112495,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112496,population,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112497,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112498,São,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112499,Paulo,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112500,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112501,Brazil,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112502,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112503,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112504,2003,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112505,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112506,2015,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112507,.,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112608,The,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112609,percentage,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112610,of,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112611,people,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112612,reporting,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112613,the,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112614,intake,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112615,of,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112616,six,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112617,food,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112618,groupings,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112619,(,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112620,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112621,",",O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112622,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112623,meat,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112624,",",O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112625,sweets,B-http://purl.obolibrary.org/obo/FOODON_03316428,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112626,",",O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112627,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112628,",",O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112629,commercial,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112630,juices,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112631,",",O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112632,toasts,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112633,/,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112634,biscuits,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112635,),O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112636,increased,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112637,in,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112638,the,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112639,period,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112640,.,O,3930.0,"The percentage of people reporting the intake of six food groupings ( rice , white meat , sweets , fruits , commercial juices , toasts / biscuits ) increased in the period ."
112704,From,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112705,1984,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112706,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112707,1988,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112708,a,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112709,population,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112710,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112711,based,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112712,case,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112713,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112714,control,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112715,study,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112716,was,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112717,carried,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112718,out,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112719,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112720,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112721,Netherlands,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112722,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112723,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112724,collaboration,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112725,with,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112726,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112727,International,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112728,Agency,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112729,for,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112730,Research,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112731,on,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112732,Cancer,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112733,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112734,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112735,examine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112736,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112737,possible,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112738,relationship,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112739,between,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112740,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112741,habitual,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112742,lifetime,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112743,consumption,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112744,of,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112745,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112746,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112747,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112748,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112749,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112750,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112751,exocrine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112752,pancreatic,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112753,carcinoma,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112754,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112755,176,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112756,cases,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112757,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112758,487,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112759,controls,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112760,.,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
113346,The,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113347,juice,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113348,reductions,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113349,in,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113350,the,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113351,US,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113352,Special,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113353,Supplemental,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113354,Nutrition,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113355,Program,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113356,for,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113357,Women,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113358,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113359,Infants,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113360,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113361,and,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113362,Children,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113363,in,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113364,2009,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113365,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113366,and,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113367,the,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113368,plateauing,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113369,/,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113370,decreasing,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113371,asthma,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113372,prevalence,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113373,(,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113374,2010,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113375,-,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113376,2013,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113377,),O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113378,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113379,particularly,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113380,among,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113381,non,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113382,-,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113383,Hispanic,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113384,black,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113385,children,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113386,",",O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113387,may,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113388,be,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113389,related,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113390,.,O,3950.0,"The juice reductions in the US Special Supplemental Nutrition Program for Women , Infants , and Children in 2009 , and the plateauing / decreasing asthma prevalence ( 2010 - 2013 ) , particularly among non - Hispanic black children , may be related ."
113744,In,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113745,previous,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113746,studies,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113747,that,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113748,determined,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113749,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113750,PTHrP,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113751,concentrations,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113752,in,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113753,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113754,",",O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113755,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113756,pretreatments,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113757,and,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113758,diluent,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113759,composition,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113760,were,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113761,not,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113762,standardized,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113763,.,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113764,Here,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113765,",",O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113766,we,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113767,investigated,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113768,the,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113769,effect,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113770,of,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113771,various,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113772,pretreatment,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113773,procedures,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113774,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113775,diluent,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113776,constitutions,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113777,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113778,the,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113779,consequent,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113780,PTHrP,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113781,concentrations,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113782,in,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113783,commercial,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113784,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113785,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113786,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113787,products,I-http://purl.obolibrary.org/obo/UBERON_0001913,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113788,in,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113789,Japan,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113790,.,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
114055,In,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114056,others,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114057,(,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114058,eg,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114059,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114060,Scandinavia,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114061,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114062,United,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114063,Kingdom,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114064,),O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114065,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114066,the,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114067,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114068,-,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114069,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114070,diet,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114071,may,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114072,include,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114073,foods,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114074,such,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114075,as,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114076,wheat,B-http://purl.obolibrary.org/obo/FOODON_03310075;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/CHEBI_28017,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114077,starch,I-http://purl.obolibrary.org/obo/FOODON_03310075;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/CHEBI_28017,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114078,that,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114079,have,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114080,been,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114081,rendered,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114082,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114083,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114084,but,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114085,nonetheless,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114086,contain,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114087,small,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114088,amounts,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114089,of,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114090,toxic,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114091,prolamins,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114092,.,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114281,Major,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114282,healthful,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114283,contributors,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114284,to,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114285,the,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114286,diets,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114287,of,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114288,many,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114289,people,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114290,include,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114291,the,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114292,protein,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114293,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114294,minerals,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114295,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114296,vitamins,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114297,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114298,and,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114299,fatty,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114300,acids,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114301,present,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114302,in,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114303,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114304,.,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114633,Dietary,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114634,patterns,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114635,were,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114636,:,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114637,low,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114638,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114639,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114640,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114641,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114642,32·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114643,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114644,",",O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114645,moderate,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114646,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114647,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114648,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114649,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114650,42·1,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114651,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114652,and,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114653,high,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114654,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114655,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114656,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114657,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114658,26·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114659,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114660,.,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114929,As,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114930,well,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114931,as,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114932,through,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114933,direct,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114934,mechanisms,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114935,",",O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114936,dairy,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114937,protein,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114938,may,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114939,indirectly,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114940,improve,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114941,metabolic,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114942,health,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114943,by,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114944,aiding,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114945,loss,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114946,of,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114947,body,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114948,weight,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114949,and,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114950,fat,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114951,mass,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114952,through,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114953,enhanced,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114954,satiety,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114955,",",O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114956,whilst,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114957,promoting,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114958,skeletal,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114959,muscle,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114960,growth,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114961,and,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114962,function,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114963,through,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114964,anabolic,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114965,effects,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114966,of,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114967,dairy,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114968,protein,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114969,-,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114970,derived,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114971,branch,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114972,chain,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114973,amino,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114974,acids,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114975,(,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114976,BCAAs,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114977,),O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
114978,.,O,4003.0,"As well as through direct mechanisms , dairy protein may indirectly improve metabolic health by aiding loss of body weight and fat mass through enhanced satiety , whilst promoting skeletal muscle growth and function through anabolic effects of dairy protein - derived branch chain amino acids ( BCAAs ) ."
115878,Intakes,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115879,of,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115880,foods,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115881,that,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115882,are,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115883,major,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115884,sources,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115885,of,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115886,trans,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115887,isomers,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115888,(,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115889,margarine,B-http://purl.obolibrary.org/obo/FOODON_03301672,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115890,",",O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115891,cookies,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115892,[,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115893,biscuits,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115894,],O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115895,",",O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115896,cake,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115897,",",O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115898,and,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115899,white,B-http://purl.obolibrary.org/obo/FOODON_03301055;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115900,bread,I-http://purl.obolibrary.org/obo/FOODON_03301055;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115901,),O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115902,were,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115903,each,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115904,significantly,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115905,associated,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115906,with,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115907,higher,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115908,risks,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115909,of,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115910,CHD,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115911,.,O,4036.0,"Intakes of foods that are major sources of trans isomers ( margarine , cookies [ biscuits ] , cake , and white bread ) were each significantly associated with higher risks of CHD ."
115962,This,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115963,study,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115964,examined,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115965,two,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115966,low,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115967,-,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115968,calorie,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115969,sweeteners,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115970,",",O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115971,tagatose,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115972,and,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115973,stevia,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115974,",",O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115975,in,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115976,comparison,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115977,to,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115978,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115979,in,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115980,dark,B-http://purl.obolibrary.org/obo/FOODON_03303588;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115981,chocolate,I-http://purl.obolibrary.org/obo/FOODON_03303588;http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115982,.,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
116101,Garlic,O,4046.0,Garlic has been used medicinally since antiquity .
116102,has,O,4046.0,Garlic has been used medicinally since antiquity .
116103,been,O,4046.0,Garlic has been used medicinally since antiquity .
116104,used,O,4046.0,Garlic has been used medicinally since antiquity .
116105,medicinally,O,4046.0,Garlic has been used medicinally since antiquity .
116106,since,O,4046.0,Garlic has been used medicinally since antiquity .
116107,antiquity,O,4046.0,Garlic has been used medicinally since antiquity .
116108,.,O,4046.0,Garlic has been used medicinally since antiquity .
116276,The,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116277,current,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116278,state,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116279,of,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116280,knowledge,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116281,does,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116282,not,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116283,recognize,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116284,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116285,as,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116286,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116287,true,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116288,alternative,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116289,",",O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116290,but,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116291,it,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116292,will,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116293,likely,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116294,find,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116295,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116296,place,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116297,for,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116298,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116299,as,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116300,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116301,complement,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116302,to,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116303,established,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116304,methods,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116305,of,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116306,disease,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116307,prevention,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116308,and,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116309,treatment,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116310,.,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116439,Rats,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116440,receiving,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116441,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116442,orally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116443,and,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116444,intraperitoneally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116445,also,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116446,showed,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116447,a,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116448,significant,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116449,reduction,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116450,in,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116451,triglyceride,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116452,levels,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116453,(,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116454,38,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116455,%,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116456,),O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116457,.,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116570,Therefore,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116571,because,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116572,hyperlipidemia,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116573,is,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116574,a,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116575,major,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116576,etiopathological,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116577,factor,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116578,for,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116579,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116580,",",O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116581,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116582,may,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116583,play,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116584,an,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116585,important,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116586,role,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116587,in,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116588,the,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116589,prevention,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116590,of,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116591,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116592,.,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116753,Milk,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116754,is,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116755,often,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116756,seen,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116757,as,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116758,a,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116759,potential,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116760,promotor,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116761,of,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116762,atherosclerosis,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116763,and,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116764,coronary,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116765,heart,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116766,disease,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116767,because,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116768,it,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116769,is,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116770,a,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116771,source,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116772,of,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116773,cholesterol,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116774,and,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116775,saturated,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116776,fatty,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116777,acids,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116778,.,O,4073.0,Milk is often seen as a potential promotor of atherosclerosis and coronary heart disease because it is a source of cholesterol and saturated fatty acids .
116830,Calcium,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116831,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116832,bioactive,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116833,peptides,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116834,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116835,as,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116836,yet,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116837,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116838,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116839,in,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116840,whole,B-http://purl.obolibrary.org/obo/UBERON_0001913,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116841,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116842,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116843,protect,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116844,from,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116845,hypertension,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116846,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116847,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116848,folic,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116849,acid,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116850,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116851,vitamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116852,B6,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116853,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116854,pyridoxine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116855,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116856,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116857,B12,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116858,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116859,cyanocobalamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116860,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116861,or,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116862,other,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116863,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116864,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116865,of,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116866,skim,B-http://purl.obolibrary.org/obo/UBERON_0001913,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116867,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116868,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116869,contribute,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116870,to,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116871,low,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116872,homocysteine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116873,levels,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116874,.,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
117444,An,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117445,approximately,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117446,7,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117447,-,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117448,fold,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117449,difference,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117450,in,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117451,risk,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117452,was,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117453,found,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117454,between,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117455,extreme,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117456,quintiles,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117457,of,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117458,a,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117459,scale,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117460,measuring,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117461,major,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117462,positive,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117463,and,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117464,negative,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117465,associations,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117466,.,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117517,Synergistic,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117518,action,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117519,of,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117520,these,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117521,and,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117522,other,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117523,compounds,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117524,",",O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117525,which,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117526,are,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117527,also,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117528,present,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117529,in,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117530,dried,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117531,plums,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117532,in,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117533,less,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117534,conspicuous,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117535,amounts,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117536,",",O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117537,may,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117538,have,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117539,beneficial,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117540,health,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117541,effects,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117542,when,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117543,dried,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117544,plums,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117545,are,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117546,regularly,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117547,consumed,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117548,.,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
118058,Most,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118059,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118060,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118061,accumulated,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118062,in,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118063,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118064,vacuoles,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118065,of,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118066,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118067,cells,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118068,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118069,except,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118070,what,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118071,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118072,absorbed,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118073,by,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118074,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118075,cell,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118076,wall,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118077,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118078,allowing,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118079,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118080,to,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118081,be,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118082,released,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118083,from,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118084,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118085,tissues,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118086,under,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118087,moderate,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118088,conditions,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118089,.,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118805,After,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118806,adjusting,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118807,for,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118808,age,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118809,and,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118810,energy,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118811,intake,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118812,",",O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118813,we,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118814,found,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118815,that,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118816,the,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118817,traditional,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118818,dietary,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118819,pattern,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118820,was,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118821,inversely,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118822,associated,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118823,with,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118824,BMI,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118825,(,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118826,beta,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118827,=,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118828,-,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118829,1.14,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118830,",",O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118831,P,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118832,<,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118833,0.001,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118834,),O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118835,and,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118836,WC,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118837,(,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118838,beta,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118839,=,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118840,-,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118841,14.9,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118842,",",O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118843,P,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118844,=,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118845,0.002,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118846,),O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118847,among,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118848,females,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
118849,.,O,4142.0,"After adjusting for age and energy intake , we found that the traditional dietary pattern was inversely associated with BMI ( beta = - 1.14 , P < 0.001 ) and WC ( beta = - 14.9 , P = 0.002 ) among females ."
119530,To,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119531,obtain,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119532,an,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119533,average,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119534,plasma,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119535,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119536,concentration,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119537,of,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119538,20,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119539,mmol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119540,/,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119541,l,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119542,in,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119543,each,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119544,rabbit,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119545,during,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119546,the,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119547,13,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119548,-,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119549,week,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119550,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119551,-,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119552,feeding,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119553,period,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119554,",",O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119555,dietary,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119556,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119557,was,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119558,adjusted,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119559,weekly,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119560,.,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119619,The,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119620,source,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119621,of,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119622,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119623,fatty,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119624,acids,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119625,was,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119626,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119627,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119628,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119629,A,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119630,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119631,lard,B-http://purl.obolibrary.org/obo/FOODON_03302051,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119632,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119633,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119634,B,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119635,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119636,coconut,B-http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119637,oil,I-http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119638,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119639,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119640,C,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119641,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119642,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119643,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119644,or,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119645,lard,B-http://purl.obolibrary.org/obo/FOODON_03302051,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119646,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119647,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119648,D.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119649,Generally,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119650,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119651,olive,B-http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119652,oil,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119653,-,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119654,fed,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119655,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119656,received,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119657,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119658,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119659,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119660,tended,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119661,to,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119662,have,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119663,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119664,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119665,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119666,VLDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119667,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119668,less,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119669,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119670,LDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119671,compared,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119672,with,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119673,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119674,receiving,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119675,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119676,fat,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119677,.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119928,Individuals,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119929,who,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119930,had,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119931,ever,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119932,smoked,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119933,cigarettes,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119934,were,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119935,at,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119936,elevated,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119937,risk,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119938,of,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119939,disease,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119940,.,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119980,There,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119981,was,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119982,no,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119983,excess,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119984,risk,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119985,of,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119986,pancreatic,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119987,cancer,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119988,among,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119989,those,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119990,who,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119991,had,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119992,ever,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119993,used,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119994,other,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119995,forms,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119996,of,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119997,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119998,",",O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119999,including,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120000,pipe,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120001,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120002,",",O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120003,cigars,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120004,and,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120005,chewing,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120006,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120007,.,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120340,It,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120341,is,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120342,known,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120343,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120344,bioactive,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120345,metabolites,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120346,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120347,live,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120348,enzymes,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120349,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120350,occur,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120351,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120352,fermentation,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120353,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120354,digestion,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120355,",",O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120356,affect,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120357,the,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120358,health,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120359,positively,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120360,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120361,improving,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120362,gut,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120363,microbiota,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120364,.,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120365,In,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120366,recent,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120367,years,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120368,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120369,the,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120370,prevalence,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120371,of,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120372,metabolic,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120373,syndrome,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120374,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120375,which,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120376,threatens,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120377,public,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120378,health,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120379,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120380,is,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120381,increasing,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120382,rapidly,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120383,.,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120405,It,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120406,has,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120407,been,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120408,demonstrated,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120409,that,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120410,yogurt,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120411,has,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120412,a,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120413,high,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120414,-,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120415,quality,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120416,amino,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120417,acid,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120418,pattern,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120419,",",O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120420,reduces,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120421,energy,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120422,intake,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120423,by,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120424,stimulating,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120425,satiety,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120426,",",O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120427,and,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120428,regulates,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120429,blood,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120430,glucose,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120431,level,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
120432,.,O,4195.0,"It has been demonstrated that yogurt has a high - quality amino acid pattern , reduces energy intake by stimulating satiety , and regulates blood glucose level ."
121677,However,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121678,",",O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121679,the,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121680,evidence,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121681,regarding,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121682,the,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121683,health,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121684,effects,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121685,of,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121686,extracted,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121687,plant,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121688,-,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121689,based,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121690,proteins,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121691,as,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121692,functional,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121693,ingredients,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121694,",",O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121695,other,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121696,than,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121697,soya,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121698,",",O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121699,is,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121700,scarce,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
121701,.,O,4239.0,"However , the evidence regarding the health effects of extracted plant - based proteins as functional ingredients , other than soya , is scarce ."
122325,A,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122326,population,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122327,-,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122328,based,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122329,",",O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122330,incident,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122331,case,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122332,-,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122333,control,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122334,study,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122335,was,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122336,conducted,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122337,in,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122338,Utah,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122339,to,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122340,assess,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122341,the,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122342,relationship,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122343,between,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122344,fluid,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122345,intake,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122346,and,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122347,bladder,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122348,cancer,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122349,.,O,4262.0,"A population - based , incident case - control study was conducted in Utah to assess the relationship between fluid intake and bladder cancer ."
122895,Using,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122896,22,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122897,pre,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122898,-,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122899,defined,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122900,food,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122901,groups,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122902,",",O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122903,three,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122904,DP,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122905,were,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122906,extracted,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122907,.,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
123170,From,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123171,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123172,study,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123173,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123174,we,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123175,now,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123176,report,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123177,measures,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123178,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123179,circulating,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123180,factors,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123181,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123182,may,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123183,influence,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123184,CRC,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123185,initiation,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123186,or,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123187,progression,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123188,including,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123189,malondialdehyde,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123190,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123191,MDA,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123192,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123193,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123194,leptin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123195,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123196,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123197,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123198,like,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123199,growth,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123200,factor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123201,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123202,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123203,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123204,IGF,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123205,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123206,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123207,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123208,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123209,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123210,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123211,matrix,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123212,metalloproteinase-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123213,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123214,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123215,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123216,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123217,tissue,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123218,inhibitor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123219,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123220,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123221,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123222,TIMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123223,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123224,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123225,interleukins,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123226,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123227,IL,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123228,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123229,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123230,and,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123231,short,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123232,chain,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123233,fatty,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123234,acids,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123235,.,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123249,Leptin,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123250,concentrations,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123251,",",O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123252,which,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123253,were,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123254,lower,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123255,for,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123256,chicken,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123257,than,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123258,beef,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123259,at,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123260,the,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123261,35,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123262,%,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123263,level,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123264,in,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123265,the,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123266,absence,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123267,of,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123268,HAMS,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123269,",",O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123270,were,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123271,lowered,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123272,by,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123273,HAMS,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123274,.,O,4293.0,"Leptin concentrations , which were lower for chicken than beef at the 35 % level in the absence of HAMS , were lowered by HAMS ."
123347,Colonic,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123348,DNA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123349,strand,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123350,breakage,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123351,was,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123352,positively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123353,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123354,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123355,circulating,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123356,leptin,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123357,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123358,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123359,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123360,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123361,well,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123362,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123363,tissue,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123364,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123365,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123366,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123367,negatively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123368,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123369,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123370,plasma,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123371,TIMP-2,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123372,concentration,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123373,.,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123374,MMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123375,and,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123376,TIMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123377,positively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123378,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123379,with,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123380,hepatic,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123381,portal,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123382,butyrate,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123383,levels,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123384,but,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123385,leptin,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123386,concentrations,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123387,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123388,negatively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123389,.,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123500,The,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123501,mean,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123502,percent,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123503,recovery,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123504,for,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123505,mustard,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123506,from,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123507,the,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123508,salad,B-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123509,dressing,I-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123510,was,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123511,only,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123512,7.7%+/-,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123513,1.6,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123514,%,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123515,.,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123516,When,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123517,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123518,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123519,of,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123520,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123521,salad,B-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123522,dressing,I-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123523,was,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123524,adjusted,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123525,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123526,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123527,7,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123528,prior,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123529,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123530,spiking,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123531,with,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123532,mustard,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123533,",",O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123534,recovery,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123535,improved,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123536,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123537,94.1%+/-,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123538,7.6,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123539,%,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123540,.,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123841,After,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123842,allowance,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123843,for,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123844,the,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123845,reciprocal,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123846,confounding,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123847,effect,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123848,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123849,various,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123850,dietary,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123851,habits,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123852,",",O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123853,only,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123854,frequent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123855,intake,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123856,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123857,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123858,seemed,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123859,to,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123860,be,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123861,a,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123862,significant,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123863,independent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123864,indicator,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123865,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123866,prostatic,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123867,cancer,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123868,risk,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123869,.,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
124009,The,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124010,presence,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124011,of,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124012,these,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124013,peptides,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124014,is,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124015,reported,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124016,in,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124017,various,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124018,fermented,B-http://purl.obolibrary.org/obo/UBERON_0001913,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124019,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124020,products,I-http://purl.obolibrary.org/obo/UBERON_0001913,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124021,such,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124022,as,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124023,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124024,yoghurt,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124025,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124026,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124027,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124028,sour,B-http://purl.obolibrary.org/obo/UBERON_0001913,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124029,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124030,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124031,etc,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124032,.,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124042,Many,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124043,of,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124044,the,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124045,ACE,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124046,-,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124047,I,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124048,peptides,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124049,formed,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124050,during,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124051,milk,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124052,fermentation,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124053,are,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124054,resistant,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124055,to,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124056,gastrointestinal,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124057,digestion,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124058,and,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124059,inhibit,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124060,angiotensin,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124061,converting,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124062,enzyme,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124063,(,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124064,ACE,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124065,),O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124066,in,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124067,the,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124068,rennin,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124069,angiotension,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124070,system,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124071,(,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124072,RAS,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124073,),O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124074,.,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124075,There,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124076,are,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124077,various,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124078,factors,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124079,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124080,which,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124081,affect,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124082,the,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124083,formation,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124084,ACE,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124085,-,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124086,I,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124087,peptides,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124088,and,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124089,their,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124090,ability,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124091,to,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124092,reach,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124093,the,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124094,target,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124095,tissue,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124096,in,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124097,active,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124098,form,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124099,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124100,which,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124101,includes,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124102,type,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124103,of,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124104,starters,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124105,(,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124106,lactic,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124107,acid,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124108,bacteria,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124109,(,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124110,LAB,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124111,),O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124112,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124113,yeast,B-http://purl.obolibrary.org/obo/FOODON_03411345,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124114,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124115,etc,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124116,.,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124745,Liver,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124746,tumors,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124747,are,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124748,one,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124749,of,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124750,the,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124751,most,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124752,frequently,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124753,found,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124754,tumors,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124755,in,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124756,cancer,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124757,patients,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124758,and,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124759,these,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124760,arise,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124761,from,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124762,either,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124763,primary,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124764,or,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124765,metastatic,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124766,disease,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
124767,.,O,4351.0,Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease .
125357,Sorghum,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125358,is,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125359,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125360,fifth,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125361,cereal,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125362,most,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125363,produced,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125364,in,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125365,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125366,world,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125367,after,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125368,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125369,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125370,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125371,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125372,maize,B-http://purl.obolibrary.org/obo/NCBITaxon_4577;http://purl.obolibrary.org/obo/NCBITaxon_381124,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125373,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125374,and,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125375,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125376,.,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125658,During,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125659,13.4,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125660,years,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125661,of,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125662,follow,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125663,-,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125664,up,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125665,122,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125666,women,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125667,developed,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125668,RCC,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125669,.,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125728,When,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125729,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125730,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125731,vegetables,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125732,were,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125733,examined,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125734,separately,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125735,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125736,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125737,who,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125738,consumed,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125739,more,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125740,than,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125741,75,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125742,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125743,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125744,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125745,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125746,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125747,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125748,vegetables,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125749,had,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125750,multivariate,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125751,relative,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125752,risk,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125753,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125754,0.59,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125755,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125756,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125757,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125758,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125759,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125760,0.27,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125761,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125762,1.25,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125763,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125764,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125765,0.60,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125766,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125767,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125768,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125769,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125770,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125771,0.31,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125772,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125773,1.17,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125774,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125775,respectively,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125776,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125777,compared,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125778,to,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125779,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125780,consuming,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125781,11,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125782,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125783,less,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125784,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125785,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125786,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125787,.,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125788,Within,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125789,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125790,group,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125791,of,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125792,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125793,",",O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125794,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125795,strongest,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125796,inverse,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125797,association,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125798,was,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125799,observed,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125800,for,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125801,banana,B-http://purl.obolibrary.org/obo/FOODON_03311513;http://purl.obolibrary.org/obo/FOODON_03316257;http://purl.obolibrary.org/obo/NCBITaxon_4641,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125802,(,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125803,p,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125804,=,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125805,0.07,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125806,by,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125807,Wald,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125808,test,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125809,),O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125810,.,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125878,Frequent,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125879,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125880,of,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125881,salad,B-http://purl.obolibrary.org/obo/FOODON_03316042,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125882,vegetables,I-http://purl.obolibrary.org/obo/FOODON_03316042,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125883,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125884,once,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125885,or,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125886,more,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125887,per,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125888,day,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125889,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125890,decreased,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125891,the,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125892,risk,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125893,by,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125894,40,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125895,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125896,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125897,RR,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125898,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125899,0.60,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125900,;,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125901,95,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125902,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125903,CI,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125904,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125905,0.30,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125906,-,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125907,1.22,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125908,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125909,",",O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125910,in,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125911,comparison,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125912,to,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125913,no,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125914,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125915,.,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
126219,Risk,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126220,of,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126221,rectal,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126222,cancer,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126223,increased,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126224,among,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126225,estrogen,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126226,-,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126227,negative,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126228,women,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126229,if,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126230,they,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126231,consumed,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126232,any,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126233,beer,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126234,or,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126235,white,B-http://purl.obolibrary.org/obo/FOODON_03310273;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126236,wine,I-http://purl.obolibrary.org/obo/FOODON_03310273;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126237,but,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126238,decreased,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126239,among,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126240,estrogen,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126241,-,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126242,positive,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126243,women,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126244,with,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126245,beer,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126246,.,O,4398.0,Risk of rectal cancer increased among estrogen - negative women if they consumed any beer or white wine but decreased among estrogen - positive women with beer .
126739,Since,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126740,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126741,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126742,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126743,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126744,contain,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126745,differing,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126746,proportions,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126747,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126748,macronutrients,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126749,",",O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126750,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126751,present,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126752,study,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126753,investigated,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126754,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126755,associations,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126756,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126757,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126758,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126759,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126760,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126761,ingested,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126762,at,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126763,various,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126764,times,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126765,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126766,day,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126767,with,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126768,total,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126769,daily,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126770,and,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126771,macronutrient,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126772,intakes,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126773,.,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
127044,The,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127045,study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127046,subjects,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127047,were,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127048,children,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127049,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127050,n,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127051,=,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127052,770,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127053,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127054,who,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127055,participated,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127056,in,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127057,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127058,4th,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127059,year,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127060,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127061,2008,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127062,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127063,of,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127064,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127065,Korean,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127066,Child,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127067,-,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127068,Adolescent,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127069,Cohort,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127070,Study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127071,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127072,KoCAS,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127073,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127074,.,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127160,According,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127161,to,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127162,multiple,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127163,linear,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127164,regression,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127165,analysis,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127166,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127167,there,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127168,were,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127169,no,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127170,significant,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127171,associations,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127172,between,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127173,total,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127174,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127175,intake,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127176,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127177,adiposity,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127178,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127179,cMetS.,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127180,However,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127181,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127182,higher,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127183,intake,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127184,of,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127185,fruit,B-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_03420108,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127186,sugar,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_03420108,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127187,at,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127188,baseline,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127189,was,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127190,significantly,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127191,associated,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127192,with,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127193,lower,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127194,body,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127195,mass,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127196,index,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127197,(,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127198,BMI,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127199,),O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127200,z,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127201,-,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127202,scores,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127203,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127204,body,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127205,fat,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127206,percentages,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127207,at,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127208,baseline,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127209,(,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127210,β,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127211,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127212,-0.10,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127213,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127214,p,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127215,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127216,0.02,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127217,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127218,β,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127219,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127220,-0.78,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127221,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127222,p,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127223,<,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127224,0.01,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127225,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127226,respectively,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127227,),O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127228,.,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127524,After,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127525,baking,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127526,",",O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127527,folic,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127528,acid,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127529,content,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127530,in,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127531,all,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127532,breads,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127533,was,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127534,found,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127535,to,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127536,decrease,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127537,significantly,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
127538,.,O,4439.0,"After baking , folic acid content in all breads was found to decrease significantly ."
128344,In,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128345,skin,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128346,prick,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128347,tests,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128348,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128349,we,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128350,used,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128351,three,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128352,different,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128353,extracts,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128354,(,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128355,juice,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128356,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128357,freeze,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128358,-,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128359,dried,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128360,extract,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128361,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128362,and,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128363,low,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128364,-,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128365,temperature,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128366,acetone,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128367,powder,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128368,extract,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128369,),O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128370,of,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128371,two,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128372,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128373,strains,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128374,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128375,Golden,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128376,Delicious,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128377,and,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128378,Granny,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128379,Smith,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128380,.,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128683,However,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128684,",",O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128685,recent,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128686,human,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128687,studies,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128688,have,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128689,proven,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128690,that,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128691,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128692,has,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128693,beneficial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128694,effects,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128695,on,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128696,some,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128697,pathogenic,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128698,mechanisms,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128699,of,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128700,heart,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128701,disease,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128702,such,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128703,as,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128704,endothelial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128705,function,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128706,and,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128707,blood,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128708,pressure,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128709,.,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
129551,Cohort,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129552,studies,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129553,are,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129554,equivocal,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129555,regarding,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129556,a,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129557,relationship,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129558,between,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129559,regular,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129560,nut,B-http://purl.obolibrary.org/obo/FOODON_03303171,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129561,consumption,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129562,and,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129563,reduced,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129564,risk,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129565,of,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129566,type,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129567,2,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129568,diabetes,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129569,mellitus,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129570,.,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129956,Consumption,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129957,of,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129958,beer,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129959,",",O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129960,wine,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129961,",",O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129962,spirits,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129963,and,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129964,total,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129965,alcohol,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129966,was,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129967,strongly,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129968,associated,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129969,with,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129970,increased,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129971,risk,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129972,.,O,4519.0,"Consumption of beer , wine , spirits and total alcohol was strongly associated with increased risk ."
129973,Of,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129974,23,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129975,food,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129976,and,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129977,beverage,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129978,categories,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129979,",",O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129980,only,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129981,candy,B-http://purl.obolibrary.org/obo/FOODON_03301051,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129982,/,I-http://purl.obolibrary.org/obo/FOODON_03301051,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129983,jelly,I-http://purl.obolibrary.org/obo/FOODON_03301051,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129984,/,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129985,soda,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129986,pop,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129987,consumption,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129988,had,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129989,a,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129990,statistically,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129991,significant,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129992,inverse,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129993,trend,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129994,.,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
130069,A,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130070,panel,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130071,of,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130072,148,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130073,extracts,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130074,from,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130075,37,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130076,food,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130077,products,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130078,was,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130079,prepared,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130080,using,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130081,organic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130082,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130083,aqueous,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130084,solvents,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130085,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130086,both,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130087,neutral,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130088,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130089,acidic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130090,conditions,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130091,.,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130372,Clinical,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130373,symptoms,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130374,from,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130375,ingested,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130376,spices,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130377,were,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130378,noticed,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130379,by,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130380,five,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130381,patients,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130382,.,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130466,The,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130467,majority,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130468,of,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130469,previous,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130470,oil,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130471,dosing,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130472,studies,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130473,conducted,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130474,on,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130475,wild,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130476,-,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130477,caught,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130478,birds,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130479,used,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130480,gavage,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130481,methods,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130482,to,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130483,dose,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130484,birds,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130485,with,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130486,oil,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130487,and,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130488,determine,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130489,toxicity,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130490,.,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
131195,However,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131196,",",O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131197,the,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131198,changes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131199,of,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131200,plasma,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131201,IL-6,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131202,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131203,vascular,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131204,cell,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131205,adhesion,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131206,molecule-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131207,(,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131208,VCAM-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131209,),O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131210,",",O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131211,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131212,lymphocyte,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131213,function,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131214,-,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131215,associated,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131216,antigen-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131217,(,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131218,LFA-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131219,),O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131220,from,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131221,T,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131222,-,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131223,lymphocytes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131224,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131225,CD36,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131226,from,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131227,monocytes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131228,were,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131229,significantly,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131230,greater,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131231,after,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131232,TSOO,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131233,than,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131234,after,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131235,RT,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131236,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131237,TS,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131238,interventions,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131239,.,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131260,Cancer,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131261,initiation,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131262,and,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131263,progression,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131264,are,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131265,the,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131266,result,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131267,of,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131268,genetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131269,and/or,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131270,epigenetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131271,alterations,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131272,.,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131691,The,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131692,bread,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131693,quality,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131694,parameters,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131695,measured,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131696,were,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131697,specific,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131698,volume,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131699,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131700,dry,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131701,matter,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131702,of,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131703,bread,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131704,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131705,crust,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131706,color,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131707,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131708,crumb,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131709,hardness,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131710,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131711,and,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131712,gas,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131713,cell,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131714,size,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131715,distribution,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131716,.,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131839,The,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131840,present,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131841,study,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131842,demonstrated,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131843,that,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131844,the,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131845,zinc,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131846,concentration,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131847,in,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131848,bovine,B-http://purl.obolibrary.org/obo/FOODON_03414374;http://purl.obolibrary.org/obo/UBERON_0001913,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131849,milk,I-http://purl.obolibrary.org/obo/FOODON_03414374;http://purl.obolibrary.org/obo/UBERON_0001913,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131850,and,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131851,blood,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131852,plasma,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131853,is,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131854,significantly,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131855,affected,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131856,by,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131857,the,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131858,intake,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131859,of,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131860,saturated,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131861,fat,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131862,supplements,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131863,.,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131916,A,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131917,high,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131918,de,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131919,novo,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131920,milk,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131921,fat,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131922,diet,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131923,was,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131924,formulated,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131925,by,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131926,adding,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131927,rapeseed,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131928,meal,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131929,and,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131930,molasses,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131931,in,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131932,the,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131933,total,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131934,mixed,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131935,ration,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131936,[,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131937,39,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131938,mg,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131939,of,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131940,Zn,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131941,/,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131942,kg,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131943,of,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131944,dry,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131945,matter,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131946,(,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131947,DM,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131948,),O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131949,],O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131950,",",O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131951,and,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131952,a,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131953,low,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131954,de,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131955,novo,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131956,diet,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131957,by,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131958,adding,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131959,saturated,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131960,fat,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131961,",",O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131962,fat,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131963,-,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131964,rich,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131965,rapeseed,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131966,cake,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131967,",",O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131968,and,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131969,corn,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131970,(,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131971,34,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131972,mg,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131973,of,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131974,Zn,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131975,/,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131976,kg,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131977,of,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131978,DM,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131979,),O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
131980,.,O,4586.0,"A high de novo milk fat diet was formulated by adding rapeseed meal and molasses in the total mixed ration [ 39 mg of Zn / kg of dry matter ( DM ) ] , and a low de novo diet by adding saturated fat , fat - rich rapeseed cake , and corn ( 34 mg of Zn / kg of DM ) ."
132057,Treatments,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132058,did,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132059,not,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132060,influence,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132061,milk,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132062,free,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132063,fatty,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132064,acids,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132065,at,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132066,4,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132067,degrees,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132068,C,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132069,at,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132070,0,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132071,or,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132072,28,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132073,h,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132074,after,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132075,milking,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132076,.,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
